WHO: Spending on Health Increased 6% in 2020; but Detailed Data Mostly Covers Rich Countries 08/12/2022 Stefan Anderson A new WHO report shows rising health expenditure in 2020, the first year of the COVID-19 pandemic. Spending on health increased worldwide by 6% on average in real terms in the year 2020, according to the World Health Organization’s latest global review of health finance. The analysis found that global spending on health reached US$ 9 trillion in 2020, or 10.8% of global gross domestic product (GDP), but remains highly unequal across income groups. But the 6% global increase is skewered by huge outlays in the United States, which is by far the biggest global health spender, said WHO’s Joe Kutzin, the head of WHO’s health finance team that authored the report. In real terms, average country growth was more like 4% he noted in a series of Tweets following the reports publication. And in contrast to previous WHO studies on health spending trends, this latest report only captures more detailed and granular spending patterns for 4 low-income countries and 11 middle-income countries. The remaining 29 countries analyzed are all high-income nations. This means that global spending trends for health care remain difficult to analyse more granularly, WHO officials speaking at Thursday’s report launch event cautioned. With just 4 low-income countries reporting data, spending patterns in this income group in particular cannot be generalized. “While we can put this together globally, to look at these patterns and trends, it’s not a substitute for the country-level work and analysis that’s needed,” said Kutzin. “We need to be careful in drawing conclusions about “the average country” given this limitation. In contrast, a WHO study of data from 2018 found global health expenditures rose by 6% annually but noted that government spending on health in some poor countries was stagnant or even declining, with some pulling back funding due to greater reliance on donors. A study of data from 2019 also found that high-income countries accounted for approximately 80% of global spending on health. Those report had more representative sample of rich, middle income and poor countries. But for the report released on Thursday, the interruptions in routine health system operations caused by the COVID pandemic made it difficult for low-income countries to report their data this year, leading to a heavy bias in findings in favour or rich countries, Kutzin and other panelists at the WHO launch event said. “What we have for only 50 countries in 2020 is a detailed decomposition of spending by “health care function” (inpatient, outpatient, medicines, etc), and indeed it is skewed towards higher income countries,” said Kutzin in a follow up tweet. This underlines the need to improve data availability as the pandemic’s impacts wane. More public spending possibly driven by the COVID response Government spending was the main driver of the increase in total health spending from 2019 to 2020. Per capita government spending on health increased in all income groups and rose faster than in previous years, according to the report. In the countries where data was available, the growth in spending was largely driven by increased public expenditure, the report found. ”The whole growth of health spending is really driven by government spending,” said Dr Ke Xu, the report’s lead author. “This year it has grown much faster than previous years.” While vaccines were not yet widely available in 2020, it is likely some of the increase in government spending was driven by the early stages of the COVID response. Early waves led to sharp increases in hospitalizations, a competitive dash for procurement of items from oxygen to PPE, and bidding wars over vaccine contracts. Spending on COVID accounted for an average of 8% of public spending on health in 2020, but the type of COVID spending varies vastly among country income groups. “In high-income and some upper-middle-income countries, you have significant spending on treatment,” Xu said. “In low-income countries spending is mostly on other preventative measures.” These discrepancies are related to the capacity of countries of differing income levels to set up testing, contact tracing, and provide access to facilities and equipment capable of treating COVID patients. The data may also be influenced by the different approaches taken by countries to control the outbreak at the early stages of the pandemic when the nature of the virus was still unclear. Conversely, out-of-pocket spending per capita fell during the first year of the pandemic, which may reflect reduced health service utilization of out-patient services. Fear of the virus may have encouraged many patients to stay away from hospitals or seek care for basic illnesses, while many health systems were overwhelmed by the weight of the pandemic, leading to reduced capacity to treat other patients. There was also increased government support for items like free PCR diagnostics for people with suspected COVID, potentially lifting financial weight from individuals. The team in charge of the report stressed that further research is needed to understand the whats, whys and hows behind the datasets provided. “We raise issues, and there are clearly hypotheses or questions that might arise from the data,” Kutzin said. “It’s our job to help sharpen those questions, but not really answer policy questions. It is more to provide a foundation so that those questions can be answered.” Low income countries increased health spending While the sample size of low-income countries’ spending was limited to just 4 nations, the report tracks other finance indicators across a larger share of developing countries. Among them, health spending as a share of total government expenditure increased from 2019 to 2020 in all income groups except high income countries. This presumably reflects the greater resources countries had to allocate to COVID response. The spending increase is a welcome development, but panelists warned it is not guaranteed to be a sustained one. “In times of crisis, governments find the money,” Kutzin said. “The challenge is to sustain that over time.” And among the poorest countries, private, out-of-pocket spending increases comprised the largest share of the pie. Low income countries continue to rely heavily on external aid to finance health spending. Little change was observed in external aid funding levels, but it continued to play a critical role in funding health systems in low-income countries. The report found external aid accounted for 29% of health spending on average in the low-income countries that provided data, the same as in 2020. Per capita health spending derived from external aid increased by US$0.70 to $10.80 on average, slightly higher than government spending in these low-income countries, which sits at $9.20 per capita. Health priority rose sharply in low, lower-middle and upper-middle income countries in 2020 The report also noted the continued gap in spending on primary health care versus outpatient care between country income groups. WHO’s 2021 report found primary health care spending for low-income countries sits around 70% of total health spending, while in middle and high income countries, this is reduced to around 50% and 40% respectively. “In low-income countries, most of the spending goes to prevention, while in upper-middle income countries outpatient services take a large share of total government and donor spending” Xu said. Prevention services include population-based services such as information campaigns like brochures or public messaging campaigns, epidemiological surveillance and individual services like immunization, and condition monitoring. Study first to include social spending as part of health spending Health priority rose sharply in low, lower-middle and upper-middle income countries in 2020, the report found. What the WHO finance report lacks in representative data-sets it makes up for in innovation. The 2022 report is the first to consider government spending on social programmes as a factor contributing to overall health outcomes. “Government spending on health does not exist in a vacuum,” the report said. “Health outcomes are also shaped by other social spending, particularly on education and social protection.” The panel defined social protections as in-kind benefits provided to in-need individuals and households. These include standard benefits such as disability, sickness, and child support payments, and transfers and services provided on a collective basis in the form of pension schemes, unemployment assistance or public housing. “We saw in previous years that even if the share of health and overall government spending fell, it didn’t necessarily mean that health was losing its priority because social spending is also good for health,” Kutzin said. “For WHO it’s a big challenge, and not typical for us to stop beyond our sectoral silo, but I think this is important.” While Kutzin stressed the WHO is not planning to become experts in social protections, the added scope of the report aims to acknowledge that medicines and hospitals are not the only contributing factors to health outcomes in a given country. “Health outcomes are also determined by other social and economic sectors,” Xu said. Sometimes, a roof over someone’s head or an accessible education in health literacy can be just as impactful to improving a life as providing disease screening services. –Updated 9 December 2022 with further clarifications from WHO about the features of the global dataset. Digitalisation of Health Must Be Approached in A Holistic Manner 08/12/2022 Megha Kaveri Panelists at a digital health session at this week’s UNITE Global Summit in Lisbon. Digitalization of health services and systems needs to be approached holistically, and take a rights-based approach to services that makes access more equitable, not less so. These were two themes that emerged at a session on ditigal health as an enabler of universal health coverage at the UNITE Global Summit 2022, In Lisbon, Portugal this week. The Summit, from 5-7 December brought health-focused parliamentarians from countries around the world together to see how they might use their legislative clout more effectively to advance global health goals. Achieving universal health coverage by 2030 is part of the global SDG agenda and digitalisation could play a key role that goal, Dr Christoph Benn, the director for global health diplomacy at the Joep Lange Institute, Amsterdam, said at the panel session. But digital health trends could also increase inequalities, he warned. And that is something legislators need to be mindful of when initiating and reviewing digital health investments in their own countries. “There is a fast paced digital transformation that can increase the digital divide and leave more people behind. And I think our discussion is about how we turn that around to make sure that this really serves all people in need.” Dr Christoph Benn Benn added that a global framework on data privacy, ownership and security is another issue that would be important for parliamentarians to tackle at national level and multilaterally. Such frameworks are critical to build confidence in digital health systems that politicians support and people will actively use. “If you are asking me one issue where I feel, you know, parliamentarians can really make a difference, I think it is about legislating data governance principles in your various countries,” he said. In countries with federal systems of government, ensuring consistency in digital health platforms can be particularly complex because health systems, as well as related digital systems and regulations, may not be harmonized across different states or provinces, added Gisela Scaglia, a former member of parliament from Argentina. This is yet another issue for parliamentarians to address. Political will is a main component in transformation of health systems in any country. However, it is equally crucial that civil servants and politicians approach and overcome technical challenges, step by step, said Luis Goes Pinheiro, a senior Portuguese Health Ministry official. He described, for instance, how Portugal has used European Union funding to strengthen telecom infrastructure that would be critical for digital health interactions with the nation’s health centres via peoples’ smart-phones and computers. Infrastructure in about half of the 3,000 health services targeted have been improved over the past few years, he said, but many barriers have had to be overcome. Luis Goes Pinheiro “This is very challenging even for someone who’s been involved in the government,” he said, of the nuts-and-bolts issues that came up around strengthening health systems’ digital capacities. “In Portugal, we have 300 million Euros that we need to use by 2024,” he said. “So this is a major thrust there, but there are also headwinds all over the world. These are trying times when it comes to access to human resources, not just in the field of digital work. We need qualified people which are lacking and we need material resources. There’s been a breakdown in supply chains by the pandemic and made worse by the war in Ukraine.” In addition, political will is not always as strong as it should be, he pointed out, and this is something that legislators can be mindful about: “Creating projects whose results will come in the long term is always very unsettling for the government. Sometimes politicians think short term, but these projects need to have short, medium, and long term perspectives. Legislation is needed to institutionalize digital practices established during pandemic Dr Marisa Aizenberg, a lawyer and researcher in public health at the University of Buenos Aires also flagged the need for new legislation to drive digital transformation in health in the post COVID era, to make improvised telemedicine systems established during the pandemic more permanent. “We have had many emergency laws to validate digital tools like distance care or remote care and others. So I think this is a true challenge, digital transformation. It does not have just to do with public policies, but it’s legal. Legal instruments are necessary for this transformation to take place.” Dr Mariza Aizenberg And while formulating rules and norms around digitalisation is important, it must all be based on a human rights perspective, she added. “Otherwise, legislation may even be widening the inequalities, widening the gap. And when I talk about reasonable costs, I’m thinking about what happens to people with disabilities that won’t have access to these health technologies. I’m also talking about gender perspectives and vulnerabilities (like children and senior citizens) and how these adjustments are so important to include all these groups.” Stressing the need to have proper legislation in place for data protection and citizens’ privacy, Dr Aizenberg said. “Any new legislation must be able to be adapted quickly to the changes that take place and create a single digital health system.” Digitalization often in the Communications Ministry – not Health Digital health is, however, a multisectoral issue, Neema Lugangira, a member of parliament from Tanzania said. And she underlined that many countries place this portfolio under the Information and Communication Technology ministry and not in the health ministry. That can, however, create barriers for fit-for-purpose digital health systems to flourish. “When we’re talking about digital health, there needs to be some sort of alignment between the ICT ministry and the Health Ministry. So one of the first things that can enhance our role as parliamentarians is to have this multi-sector approach.” Neema Lugangira Along with a multi-sectoral approach from the government, Lugangira stressed the importance of viewing digitalisation of health on a continuum. In low- and middle-income countries in particular, this must begin with digital literacy, access to electricity and mobile connectivity. “We need to also look at their entire digital infrastructure. There’s access to electricity, access to just simple mobile connectivity and access to the knowledge and the skills (needed to use devices)…So if it’s digital health, how will that work? So we need to look at all of those things.” Multilateralism on the agenda To bridge the digital divide in developing countries like Mexico, developed countries must come forward to invest resources, said Sarai Nuñez Ceron, a member of parliament from Mexico, stressing the importance of multilateralism in digitalization of health systems. “Digital health should be a priority for the development of health systems everywhere in the world. This requires up to date dynamic regulations that can be a solid basis for the protection of people and also investment in innovation,” Ceron said. Global Progress on AIDS Fight in Danger, UNAIDs Warns 08/12/2022 Stefan Anderson Matthew Kavanagh, Deputy Executive Director of UNAIDS called on Parliamentarians to close the global HIV funding gap. This year, “Equalise” was chosen as the slogan for World AIDS day, observed 1 December. The theme is a call to action around the need to address the injustices that are fuelling the AIDS epidemic as pre-existing inequalities are exacerbated by the serious disruptions to health systems caused by the Ukraine war, COVID-19 pandemic and global economic crisis. New infections have increased in Eastern Europe, Latin America, the Middle East, and Asia, a continent where cases had long been falling. Across the board, Global South countries have been disproportionately impacted. Young African women are at particularly high risk. In the Sub-Saharan region, 6 of every 7 new infections are among adolescents girls aged 15 to 19. Vulnerable populations such as gay men, people who inject drugs, sex workers, and prisoners remain the key at risk demographics. “We are deeply worried about where we are in the AIDS response right now,” Matthew Kavanagh, Deputy Executive Director of UNAIDS said. “We still see the vast majority of new infections are happening in the Global South. This is the legacy of years of insufficient progress on North-South inequalities we know are actually growing.” Cutting-edge treatments remain out of reach for LMICs A new drug designed to prevent HIV infection is now available in the comfort of London, Paris, or New York, but has yet to arrive in the Global South. These long-acting injections can help prevent HIV infection if taken every two months. But the cost of the drug precludes it from being an option in areas with fewer resources. Without this medication gaining traction in the Global South, many will still be at risk of contracting the virus. The lack of access to this new breakthrough is not the first example of HIV treatments being out of reach for Global South countries. Until a few years ago, more people in North America were receiving pre-exposure prophylaxis (PrEP) than in the entire African continent, where the majority of new infections occur. “We need to ensure that we actually make these medicines available,” Kavanagh said. “That means making them generically. It means producing them in Africa, Asia, Latin America and around the world to ensure access and affordable prices.” Kavanagh also stressed the importance of decriminalization, stressing that countries that avoided highly criminalized approaches have fared far better over the last decade than those that maintained legal penalties. Closing the funding gap is critical Underfunding for HIV programmes in low and middle-income countries has left a gap of $8 billion for 2021 in HIV support. A steep figure at first glance, it is a drop in the bucket in comparison to global economic budgets. “That $8 billion is very achievable,” Kavanagh said. “We need a push from parliamentarians in the north and in the south to ensure that this funding actually becomes available. In a moment of economic crisis, this matters the most. “Only with access to this life-saving medication can a real effort be made to tackle HIV/AIDS-related inequalities,” he concluded. “If a larger population can access this HIV prevention injection, then a real change can be made and help save lives around the world.” World’s Biggest Malaria Bed-net Campaign Unfurls in Nigeria 08/12/2022 Orji Sunday Hassana Sa-adu with her children, holds a free mosquito delivered to her household during a door-to-door mosquito distribution in Gabasawa in Kano State, Nigeria. A massive campaign is underway to distribute at least 8.8 million nets to 16 million residents of Kano State in Nigeria to prevent malaria Morning sunlight, bright as a dazzling diamond, sets Mazangudu village in Kano, northern Nigeria, awake. Motorcycle rumbles mix with the boom of microphones calling Muslims to salat prayer. A gentle breeze tickles the green leaves of nearby neem trees, easing the rising warmth with its chill. Behind the curtain of a one-room bungalow, a whisper, a cup of tea, and a smile pass between Yau Mustapha and his wife. Fourty-five-year-old Mustapha gulps the dregs of the tea in his ceramic cup before heading out with his motorcycle. As he rides through Mazangudu, a small farm settlement, mud huts and fumes unfurl behind his stretched shadows. Thousands of volunteers The settlement is a blend of mud huts and cement-walled houses. The mud huts are roundly shaped and made of colored clay. Its thatched roof, spread out like a beach hat, is made of dried millet stalks, stringed into a firm shape. Once settled, Mustapha consults with the rickshaw puller, the educator, and security, all members of his team. Now, they move from house to house, waking residents with an echo of their greetings and a hard tap at the door. “Peace be unto you,” he shouts routinely. “We are to deliver nets to you and your family, so you are fully protected from malaria.” Mustapha is not alone. Across Kano, for a period of two weeks, thousands of trained volunteers would distribute insecticide-treated mosquito nets to millions of Kano residents. “These nets will help my people; they will protect them,” says Mustapha. Residents in Mazangudu believe the chances of a pregnant woman and her children surviving sudden malaria fever attack at midnight are slim. “Many have died as a result of malaria situations,” says Ibrahim Salie, an herbalist in nearby Gwaza. Salie says the community sometimes relies on herbs to manage malaria infections, but the outcome is always a gamble. Unfortunately, the nemeses of Gwaza and Mazangudu are not one-offs. Nigeria, with over 200,000 malaria deaths annually, accounts for more than a quarter of all cases in Africa. The highest burden occurs in northern states like Kano, where poverty, combined with widespread apathy and poor sanitation, increases the risk of infection. Problematic pregnant women? Mustapha Yau, a mosquito net mobilizer and distributor giving a beneficiary mosquito nets in Gabasawa, Kano. One sunset in late September, Mustapha’s wife, a health worker in a nearby village, narrated her experiences with malaria infecting pregnant mothers. “My wife told me that malaria in pregnant women can be more violent and problematic,” says Mustapha. Many nights later, the burden of that single story remained with Mustapha. After a radio jingle announced the upcoming net campaign a few weeks ago, his wife pursued him to enrol as a volunteer. This morning, as he sets out to distribute the nets from house to house, a warm goodbye and smile pass between him and his wife, who wore a long yellow veil. Mustapha is expected to distribute at least 2,800 insecticide-treated mosquito nets to hundreds of households within a period of two weeks. In all, more than 8 million nets will be distributed in Kano to at least 16 million residents. Only two days of the two weeks have passed. However, Mustapha can attest to the dramatic shift in his fame as well as the immediate use of the nets after only two days on duty. “My wife is very happy. She is happy to see her husband greatly involved in an important campaign.” Better than traditional remedies Mazangudu’s residents say the nets are twice as helpful to them as they might have been to any other community because there is no single health facility to cater to the many malaria cases. And when these malaria attacks come by midnight, the only option is to offer traditional remedies and pray. In some cases, the infected person dies before dawn. With financial backing from The Global Fund, this year’s campaign, arguably the largest in Africa, aims to distribute at least 8.8 million nets to 16 million residents of Kano, one of the largest cities in Africa. “Kano is crucial because of the size. Kano, because of its population, looks like a country. If you are fighting malaria and Kano is not in the plan, it is a waste of time,” says Ernest Nwaokolo, the project director for the Global Fund Malaria Project of the Society for Family Health (SFH). SFH’s John Ocholi, who is the manager of the 2022 nets campaign in Kano, says that the state has 44 local governments and 484 wards. “We are working with over 20,000 personnel, which is the most for any Nigerian campaign. It is a large team, drawn from various partners and parts of the country. It takes a lot of experience to pull together to achieve this. We had advocacy visits to the government of Kano State, traditional rulers, and religious bodies in an effort to pull them into the campaign.” Delivery: from camels to canoes Ismail Yusuf and Awalu Iliasu inspect the offloading of mosquito nets bales. Educators trained in behavioral change communication work closely with the house-to-house distributor team. Before the nets are distributed to the households, each family has a brief discussion about net apathy, proper use, trading, and maintenance. More so, community and religious leaders, often revered and obeyed, have been engaged as partners in spreading and reinforcing the net-use messages. Kano has proven to be a bigger puzzle from a logistics point of view. In the absence of precise figures, Chemonics, a global consulting firm that manages logistics for the campaign, says thousands of vehicles and personnel were involved. It is like a pyramid. Nets are moved to local government areas on larger trucks and trailers. Next, the nets are then transported from local government areas in smaller vans and mini trucks. Roads to communities are often narrower and, in some cases, untarred, making smaller vans more suited for moving nets. As the nets move from house to house, the options for transporting them become more diverse and adaptable. In some desert communities, where the risk of sandstorms is higher, and cars sink in sand, camels, donkeys, and cow-carts have been deployed to move the nets to households and between settlements and communities. In a few riverine areas, canoes and paddlers are used. In areas pockmarked by mountains and hills, engage porters. Each distributor is trained and handed a mobile device with an app that allows them to enter records of the number of nets issued per household, the coordinates of the area, and the names of the recipients, often the household head. Digital tracking The data is then uploaded to a central database, which is monitored and analyzed every evening to ascertain the number of nets distributed for the day, absentees, and locations covered. Organizers receive real-time updates from all over Kano. “There is real-time tracking and monitoring of all data in the field.” It is easier to dictate areas where there are issues that deserve urgent attention. It is also faster than using papers and tally sheets. “It makes it easier to provide evidence and verify the work done,” says Asuni. The technology is also designed to flag areas where there is unusually dense or sparse net distribution. When such issues are flagged, monitors are sent to the flagged locations to verify the situation on the ground. On paper, the process sounds smooth, but Asuni says that the Kano campaign presented a couple of familiar issues. Many volunteers are not computer literate and frequently struggle with basic device setup. Secondly, limited network coverage, especially in rural communities, means that data uploads to the central server are delayed and backlogged. Volunteers undergo intense training on device use. Aisha Aliyi Danyar, a mobilisation and distribution team member, is receiving training in Gabasaw LGA, Kano, Nigeria, on how to engage beneficiaries in mosquito net distribution. However, not every ambition can be squeezed into the short timeframe of the net campaign. There are still minimal concerns that net collection is rarely equivalent to use. Some residents say the nets restrict their breathing and have limited ventilation. Myths that link white nets to corpses also build stereotypes that hinder net use. “Fixing these issues can be gradual and long,” says Nwaokolo. Back in Mazangudu, the fruits of Mustapha’s work are instant. Families, who received the nets a few days ago are already putting them to use. They say these nets, more than ever, will ease their burden. The fame of Mustapha grows with every new inch he covers. “My people see me as a hero,” he says. But it’s not the heroism that makes him happy; it’s the lives that will be saved and the medical bills that will be avoided. “This net distribution has brought excitement. “The people are grateful,” says Mustapha. “And no amount invested in mosquito nets is too big. To save a single life is worth more than millions, for we really do not know what the children we are saving today might turn out to be in the future.” Better than a wedding When Aisha Lawal, 35, had to choose between attending a friend’s wedding and staying behind to pick her nets, it was an easy choice. “I didn’t want to miss [the nets],” she says. “If I choose weddings over nets, how would my household sleep peacefully? I have been expecting the new net since two days ago.” Aisha and her family of eight live at Sabon-Gari, Gabasawa, on the outskirts of Kano metropolis, where malaria is rampant. Long lines form at health centers from time to time, she claims. Her own family is also exposed. The last set of nets that came to them three years ago are discolored, torn, and pockmarked. “Receiving these nets feels like I have been given at least 1 million naira (local currency). Everyone craves rest after toiling all day. Without the net here, one can rarely get that desired rest. Mosquitoes are an enemy of good sleep. And without a good sleep, I wake up feeling sick.” As the interview unwinds, Aisha cuddles her baby, Nasiru Yusuf, closer to her ribs, allowing him to wriggle his feet around her waist. He thumped her blouse, trying to get into her nipple. Seeing his attempts ignored, Nasiru Yusuf, began to sniffle and kick. He is prone to malaria, as are the rest of the kids. She hopes that the new nets will reverse the trend and save on medical bills. Aisha Lawal with her child, holds free mosquito delivered to her household during a door-to-door mosquito distribution in Gabasawa, Kano, Nigeria. Aisha is impressed by the format adopted in this campaign. She thinks the house-to-house approach is more efficient than the past model of depositing the nets in a pickup center. More than eight million nets are expected to reach at least 16 million residents in this year’s campaign, making it arguably the largest ever in the world. But she has one bright idea, which might create a bigger impact. Women, she says, are the health managers of their families. In northern Nigeria, where most rural women are uneducated, Aisha says households’ handling of malaria, despite the nets, can be compromised. “More mothers need to be educated. The more education mothers have, the more they can play a role in their family’s health. Mothers are the protectors of the family. Once women are empowered, the communities will remain healthy,” she says. Deadly malaria Each night, as Yusuf Basira closes her eyes to sleep, she dreams of Maila Baila, her two-year-old child laid to rest a few weeks ago. “I always remember him,” says Basira, her face lowered to conceal her dark eyeballs, which have grown red and teary. In the morning of 25 October, Maila Baila experienced a severe malaria fever, which marked the beginning of his death. Basira took her child to Khalifa Sheikh Isyaku Rabiu Paediatric Hospital after two failed attempts at nearby primary health centers to stabilize him. The pediatrician diagnosed severe malaria, which resulted in multiple convulsions. A few hours after their arrival at the hospital, Maila’s body grew cold, and his eyes lost light. The doctors confirmed his death. Basira is among the 16 million residents of Kano who will benefit from the 2022 net campaign, which aims to provide more than eight million nets for households in the state. As she receives the nets, nostalgia returns, bringing with it regrets but also lessons. Prior to Biala’s death, she believed that malaria, though common and costly, was not deadly. Her attitude towards net use was carefree. She now has a new perspective, both from her past mistakes and the brief pep talk that is offered by the net distribution team. “I didn’t have much knowledge about malaria prior to the death of my baby. I never expected it to cause the death of a child. I now know that malaria can cause severe fever, even to the extent of killing a child. I take each sleeping child to the net once it’s past 6 pm. Reporting for this story was supported by the Global Fund. Image Credits: Global Fund. Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan Fight the Fakes held an event in Geneva to highlight the dangers of falsified medicine. There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake medicine and the threat it poses to patients. In October, 99 children died in Indonesia from cough syrup contaminated with anti-freeze chemicals. The previous month, 66 children died in The Gambia – also from contaminated cough syrup. These tragedies echo the deaths of 12 Indian children in 2020 – from cough syrup that had been rendered poisonous after one of the ingredients was replaced by a toxic one. Yet, said Sehmi, most countries treated falsified medicines as a commercial crime such as “product liability or negligence” when they should be treating it “in the same way as narcotics”. “Trust is at the heart of everything. Patients have to trust that the product they’re getting is of the appropriate quality and safety,” said Pernette Esteve, who heads the World Health Organization’s (WHO) team on substandard and falsified medical products. “Gaining the confidence of the public once you’ve lost it is very difficult. Think back to the COVID pandemic. Making sure that people trusted the vaccines, vaccine acceptability, was a key point.” For 10 years, the WHO has been building a database of substandard (unintentionally defective) and falsified (deliberately altered) medicine to understand the scope, scale and harm. From this database, the WHO has identified the three driving forces: lack of access to medicine, poor governance including corruption, and weak technical capacity, said Esteve. The WHO’s response was based on “prevention, detection and response”, she added. The extent of the problem Stanislav Barro, Novartis’s global head of anti-falsified medicines, says that his company has confronted fake medicine in every region of the world. The timely authentication of medicines was both the biggest challenge and the biggest opportunity to stamp out fakes, he said – but warned that it is “a very complicated process”. All the suspect samples have to be brought to a place where they can be actually properly authenticated using forensic means,” said Barro. However, almost 50 pharmaceutical companies were now sharing data via the Pharmaceutical Security Institute, and there had been a 38% increase in the incidence of falsified medicines between 2016 and 2020 in 142 countries, and incidence had surged in 2021 during the early days of the COVID pandemic. “Basically, this is whatever the criminal organisations can make money with. It doesn’t really matter whether it’s falsified, tampered, stolen, illegally diverted. It’s a bit of everything, quite frankly,” added Barro, noting that it usually meant “terrible news for patients”. “We need to find solutions to leverage digital technologies to localise authentication, identify falsified medicines and make that timely. Cut down these timelines from weeks to basically days, hours if possible, and accelerate the reporting to local authorities and to the WHO.” Policing raw materials Sireesha Yadlapalli, vice president for international government and regulatory affairs for United States Pharmacopeia (USP), called for more policing of raw materials. Medicines are made of two components, the active pharmaceutical ingredients (API) and the inactive ingredients or excipients, including reagents, solvents and items related to the taste or look of the product. There was less stringent policing of the excipients, and these were often where problems arose, Yadlapalli said. “There might be an issue with an ingredient but the manufacturer may not know about that particular issue because he just took the supplier’s word and certificate of analysis at face value, and that’s because raw materials are not being tested when they’re accepted from suppliers,” she added. “Manufacturers need to test the raw materials. Regulations should be put in place requiring testing of these raw materials.” Improving regulatory systems Members of the International Generic and Biosimilar Medicines Association made up to 80% of quality-assured medicines around the world, according to its general secretary, Suzette Kox. “We think that the biggest challenge is weak healthcare systems which includes, of course, the insufficiently resourced regulatory system and quality control. Most countries around the world do not have proper regulatory systems in place, and also no proper competition policies.” Oksana Pyzik, who lectures at the UCL School Pharmacy, said that one of the biggest challenges is a lack of public awareness. Pointing to the proliferation of online medical supply outlets during COVID-19, Pyzik said that many patients didn’t know how to verify legal online pharmacies. “Pharmacists are the last line of defence before patients received those medications and take them home with them. And there’s a real opportunity there for patient education as part of wider public awareness,” she said, adding that this was why educating pharmacists about falsified medicines was essential. In Talk on UHC, NY Senator Raises Concern Over Commoditization of Healthcare 07/12/2022 Maayan Hoffman New York State Senator Jose Gustavo Rivera A New York lawmaker warned fellow parliamentarians on Wednesday to “stay as far away from the private sector as you can” when it comes to healthcare. “The main issue in the United States is that healthcare is commodified,” said New York State Senator Jose Gustavo Rivera. “It is true, the best healthcare is available in the US – that is true if you can afford it. But the majority of Americans cannot [afford it] and instead organize their entire existence around how to find the best insurance. “And I put insurance in quotation marks because having insurance does not guarantee care,” he continued. “The commoditization of healthcare is the way to ensure that the people in your country do not get the care they need and deserve.” Less than half of Americans (40%) rate the quality of healthcare in in their country as very good or good, according to a new survey released by the Beryl Institute – Ipsos PX Pulse. Moreover, despite improvements in access to health insurance following the roll out of the Affordable Care Act in 2010, roughly 30 million Americans of all ages had no health insurance in 2021, according to a report by MoneyGeek. ‘Investments in health … are key’ Rivera spoke at the conclusion of Wednesday’s UNITE Global Summit session on universal health coverage (UHC). The session was hosted by UHC2030 and focused on case studies from throughout the world for how to implement UHC. “UHC means that everyone, everywhere, can access the services they need without facing financial burden,” said UHC2030 Steering Committee Co-chair Gabriela Cuevas Barron from Mexico. “Investments in health and healthier populations are key for wider economic and social benefits.” UHC2030 Steering Committee Co-chair Gabriela Cuevas Barron Examples of efforts to roll out UHC were given from Tanzania, Chile and Zambia. In Tanzania, for example, a UHC bill was supposed to be deliberated on in November of this year. However, according to MP Neema Lugangira, discussions were pushed off after concerns with some of the nuances of the bill were raised during public hearings. “We had several discussions and felt there were concrete issues with the bill So, we, as the parliamentary committee, withdrew the bill for improvement and consideration in the areas raised,” Lugangira said. “We were hoping that by the time I would be standing here, perhaps the bill would have been passed. But in an interesting turn of events, we were able to make sure the government takes the bill back and improves on it before it is tabled in parliament. “This shows the power parliamentarians have to understand the issues and advise the government better,” she concluded. ‘Still some work to do’ Zambia, on the other hand, already rolled out the first stages of a universal health coverage plan, explained MP Givem Katuta in her remarks. The initial stage of the UHC plan includes coverage of primary care, said Katuta. But she noted that the bill was moved forward quickly between 2017 and 2018 and the country knows there is still some work to do. For example, one challenge is that the plan uses the National Health Insurance Management Authority, which works well for people who are employed but creates a gap for those who do not have some kind of job. In addition, while people in urban areas can really take advantage of the plan, including getting care at private hospitals of their choice, this has not yet been the case for those in rural areas. “We are on the right track,” Katuta said. “We are looking forward to other stakeholders coming through to spread its wings to rural areas. The goal is to have full UHC by 2030.” Chile’s representative, Marta Bravo, called on the World Health Organization to support the creation of “harmonized and unified criteria” for universal health coverage . “WHO has a powerful voice that is listened to by our government,” she said. “This is our opportunity to ask WHO to be active in this field.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman, Screenshot. In Heated UNITE Event Session, African MPs Call for Greater Inclusion in Global Fund 07/12/2022 Maayan Hoffman Tanzanian MP Neema Lugangira at the UNITE Global Summit in Lisbon A group of African parliamentarians raised a red flag on Tuesday at the UNITE Global Summit when they told representatives that they felt neglected by the Global Fund to Fight AIDS, Tuberculosis and Malaria, which funds billions of dollars of health services in their countries. “Do African parliamentarians only get involved when we have to make an appeal, when it suits our colleagues?” asked Tanzanian MP Neema Lugangira in her remarks at a session titled “The Global Fund Post 7th Replenishment – The Role of Members of Parliament and Domestic Health Financing.” Lugangira said that she was asked to make a fundraising appeal via video on behalf of the Global Fund to the United Kingdom parliament over the summer believes her intervention added value and played a key role in convincing the UK government to provide a more than $1 billion grant. However, despite being in New York in September during Global Fund’s Replenishment event at which donors pledge money for the next three years, she was not invited to attend. Global Fund instead hosted 18 heads of state and governments and many high-level officials from civil society and the private sector at the 400-person event in the city. Lugangira said that “some of my colleagues in Tanzania were surprised I was not invited” because of the video she provided and her deep commitment to public health in Tanzania. “When it is time for the glorious moment, we are not invited,” she said. Lugangira said that Global Fund could generate increased matching domestic financing and distribute its funds more effectively if it worked closely with parliaments, the way it works with civil society. “Civil society was not chosen by our UK parliamentarians to record a clip and make an appeal to parliament. It was me, a member of the African parliament,” she stressed. “It is powerful when you hear the voice of an African parliamentarian representing her people. “Don’t just use us when it suits you. Include us across the entire chain” Lugangira continued. “Parliamentarians should be involved at all levels and be recognised for the impact and power we have.” ‘Confused and surprised’ “The Global Fund Post 7th Replenishment” session on December 6 at the UNITE Global Summit Lugangira had been asked to speak during a panel hosted by the fund that was meant to celebrate the nearly $16 billion it raised in the fall and to examine the positive impact that the more than $55 billion it distributed over the past 20 years has had on health and saving lives. In Tanzania alone, the Global Fund has invested $3 billion to tackle issues of HIV, TB and malaria between 2002 and 2022. Currently, the fund has four core grants in the country totalling $608 million. According to Lugangira, since the fund became involved in her country, there has been a 68% decrease in HIV and people with the virus and a 68% increase – from 18% to 86% – of individuals with HIV enrolled in treatment programs. But after Lugangira and several other parliamentarians criticised the Global Fund for failing to properly leverage local lawmakers and called on it to shift its paradigm, Scott Boule, the Global Fund’s Senior Specialist for Parliamentary Affairs, said he was left “confused and surprised.” “At least one MP sort of implied a feeling of being only utilised when the Global Fund needs to raise funds,” Boule said, “Global Fund is supposed to be a partnership.” ‘You handcuff us’ Some parliamentarians also expressed concerns over the Global Fund model, which involves establishing a Country Coordinating Mechanism (CCM) committee to help distribute funds. Boule said Global Fund mandates that CCMs have broad representation, including from the government, but also from civil society, such as members of the communities that are impacted by the three core diseases. In some countries, parliamentarians sit on the CCMs, but in many countries they are not asked to do so. Moreover, parliamentarians have been ineligible to receive money to help fund their role on these committees. Zimbabwe’s Ruth Labode is one of those MPs. She is a member of her country’s CCM but said she rarely attends meetings due to lack of transport and funding. She only goes when parliament is in session and she has to be in the capital city for work anyway. Otherwise, “it’s too costly” to take part, she told Health Policy Watch. “The CCM has decided not to fund parliamentarians for meetings while they fund members from the civil society, private or any other sector,” Labode said. “The lack of funding shows that the Global Fund is not committed [to the parliamentarians]. It does not think it needs parliamentarians. And yet, when the time comes for replenishment, they are quick to find parliamentarians to lobby for their purpose.” She told Boule during the discussion that “it is about time you advocate for a parliamentary seat on every CCM in every country… If you told them to have a seat for a parliamentarian, it would happen overnight”. Another complaint was that many parliamentarians are not educated about the work of the Global Fund or its accomplishments, which could help them push for further domestic health financing. “You cannot mobilise resources when you are not informed,” said MP Peter Njume from Cameroon. “You work [directly] with the government and then expect us to ask them to be accountable. But parliamentarians are not involved. “You talk about the importance of democracy,” Njume continued. “We represent democracy, but you handcuff us, you make us become vulnerable and helpless. How do you want us to function?” “To own this agenda, we need to be well informed and educated,” Lugangira similarly added. Njume requested that the Global Fund earmark financing for a parliamentary education program. ‘Healthcare financing is a political decision’ Alex Winch, a member of Global Fund’s Advocacy, Health Financing Team speaks at the UNITE Global Summit in Lisbon Global Fund’s Alex Winch acknowledged that “the financing of healthcare is a political decision.” A specialist on Global Fund’s Advocacy, Health Financing Team, he said it is important to understand that the vast majority of the fund’s resources do come from governments prioritising money. “Eighty percent of funding comes from the G7 and the European commission,” explained Boule. “Eleven percent comes from other governments around the world. And 9% comes from the private sector.” To date, the Global Fund is providing 30% of international financing for HIV, 76% for TB and 63% for malaria. The fund gives more money for the battle against TB and malaria than anyone in the world. In addition, about a third of its funding is now going to reward strengthening underlying health systems. The funding has been effective, at least according to the data. Life expectancy, for example, has increased as a result. In sub-Sahara Africa alone, average life expectancy jumped from 52.3 in 2002 to 66.7 in 2019, in large part because of the fund’s efforts. During 2021 in countries and regions where Global Fund invests, some 12.5 million people were reached with HIV prevention services; 670,000 mothers living with HIV received medicine to keep them alive and prevent transmitting HIV to their babies; another 5.3 million people were tested for TB; 110,000 were given treatment for drug-resistant TB; and 133 million mosquito nets were distributed to protect families from malaria, amongst many other efforts. “All of this is made possible by our replenishment,” Boule told Health Policy Watch. “Every third year, we raise funds for the subsequent three years.” Replenishment this year was held on 21 September in New York. Some 47 public and 27 private sector donors pledged $15.7 billion out of the target of $18 billion that the organisation had set to raise for the 2023-2025 period. Boule said that efforts were continuing to try to fill the gap. ‘We are de-investing in health’ But Zimbabwe’s Daniel Molokele said that while the results are stunning, he believes African governments have become too “dependent” on the Global Fund, which puts 72% of its money towards the continent. “I don’t think it is good for Africa, this over-reliance on the Global Fund,” Molokele said. He said that Global Fund’s filling the gap lets off the hook governments who then do not have to commit to fund health in their own countries. In Zimbabwe, he said, domestic health financing dropped several percentage points in the last year. “We are de-investing in health,” Molokele said. Boule explained that recipient countries are required to provide a certain percentage of matching money to receive a grant from the Global Fund, though he said that the fund is often more flexible with low-income countries about achieving their targets. He said that despite the economic challenges the world is facing in the aftermath of COVID-19 and as the war is raging in Ukraine, the fund did see around a 30% increase across the board in domestic health financing from recipient countries. ‘It was ambitious’ Another concern raised from the floor came from French MP Jean-Francois Mbaye, who expressed “disappointment” that his country invested $1.6 billion towards a goal it thought was $18 billion but that fell short “It was ambitious,” Boule admitted to Health Policy Watch. “We did raise $15.7 and that is by far the largest amount we ever raised.” The gap came from some of Global Fund’s largest donors not increasing their gifts by the 30% that the fund expected. “The United States, Germany, Japan, Canada and the European Commission all did increase by 30%,” Boule said. “France increased by 23% and Italy increased by 15%. “The only country amongst our largest donors that went down was the UK, although it still pledged $1.2 billion,” Boule continued. “So we very much had strong support from our donors, and in particular, our largest donors.” Number of donors for Global Fund’s 7th Replenishment On the other hand, faltering exchange rates, and hosting the replenishment seven months after the start of the Ukraine war amid rising interest rates had a negative impact. To illustrate if the pledging session had been held on February 23, 2022, which is the day Global Fund had its preparatory meeting, because of exchange rates, it would have raised around $857 million more. In general, Winch said that achieving funding in the current fiscal environment is becoming increasingly more challenging. He cited a recent report by the World Bank that highlighted how even more countries will find it hard to invest in health or in even sustain existing levels of health investment. He said that “an uncertain global macro-economic environment threatens domestic financing for health.” ‘We need to crowd more resources into health’ Boule said that he plans to take some of the parliamentarians’ concerns back to Geneva, such as providing resources for parliamentarians to sit on CCMs and perhaps developing a fixed parliamentary position on the committees. “I wasn’t aware of the point that Honorable Ruth Labode was making from Zimbabwe, that other members of the CCMs received some sort of support and she did not,” Boule said. He also said he would be interested in finding ways to better involve parliamentary feedback as another means to ensure that the fund is asking the right questions and distributing resources in an optimal way. “Our good results are due to a lot of African political leaders, including parliamentarians, really building and sustaining political will to prioritise health,” Boule said. “It is even harder now with food insecurity, debt crisis and rising interest rates. But we are making the point that even now we need to crowd more resources into health.” Image Credits: Maayan Hoffman, Screenshot. US Wants WTO to Delay Decision on TRIPS Waiver Extension for COVID-19 Tests and Treatment 06/12/2022 Kerry Cullinan US Trade Representative Katherine Tai The US Trade Representative’s (USTR) office announced on Tuesday that it supports extending the deadline on whether the World Trade Organization’s (WTO) Ministerial Decision on the TRIPS Agreement should be extended to COVID-19 diagnostics and therapeutics. Trade ministers adopted the Ministerial Decision on the TRIPS Agreement in June, giving members scope to diversify the production of COVID-19 vaccines and override the exclusive effect of patents through a targeted waiver over the next five years. The TRIPS Council has been discussing whether this should be extended to COVID-19 diagnostics and therapeutics. The US decision was informed by wide-ranging consultations over the past five months with over 24 groups with opposing views on the issue, the USTR said in a statement. While all these groups “shared a concern with saving lives, and with striking a balance between the need to promote innovation in these sectors and the need to promote access to the products of innovation”, there were “key differences”. In light of the differing views, the USTR will ask the US International Trade Commission (USITC) to “launch an investigation into COVID-19 diagnostics and therapeutics and provide information on market dynamics to help inform the discussion around supply and demand, price points, the relationship between testing and treating, and production and access”, the USTR said in a statement. “Over the past five months, USTR officials held robust and constructive consultations with Congress, government experts, a wide range of stakeholders, multilateral institutions, and WTO Members,” said Ambassador Katherine Tai. “Real questions remain on a range of issues, and the additional time, coupled with information from the USITC, will help the world make a more informed decision on whether extending the Ministerial Decision to COVID-19 therapeutics and diagnostics would result in increased access to those products,” added Tai. “Transparency is critical and USTR will continue to consult with Congress, stakeholders, and others as we continue working to end the pandemic and support the global economic recovery.” Those in favour of extending the Ministerial agreement “acknowledge a lack of global demand for COVID-19 products, but they believe that market dynamics are suppressing effective demand”, according to the USTR. Opponents’ concerns include that the extension would “allow countries with anti-competitive approaches to innovation, such as China” to “unfairly obtain and use American innovation to benefit their domestic economies”, harming “American industry and workers by undermining investment and research and development”. The USITC study will explore key issues including: An overview of the products, focusing on WHO-approved COVID-19 diagnostics and therapeutics, including key components, the production process, intellectual property protections, and the supply chain (including the level of diversification in the supply chain); The global manufacturing industry for these products, including information on key producing countries, major firms, and production data, if available; The global market for COVID-19 diagnostics and therapeutics, including information on demand and, to the extent practicable, an assessment of where unmet demand exists for key products and contributing factors; market segmentation; and supply accumulation and distribution; Data and information on global trade in COVID-19 diagnostics and therapeutics, if available, or if not, data and information on global trade in diagnostics and therapeutics generally; and A brief overview of the relevant aspects of the TRIPS Agreement and the UN Medicine Patent Pool (MPP) and a listing of countries seeking to use the Ministerial Decision and those utilizing access to COVID-19 medicines under the MPP. Meanwhile, the US reaffirmed the right of its trading partners to “exercise the full range of existing flexibilities in the TRIPS Agreement, such as in Articles 30, 31, and 31bis, and the Doha Declaration on the TRIPS Agreement and Public Health, as well as the flexibilities in the Ministerial Decision”. ‘Multilateralism’ Essential in Battle Against Pandemics, Says President of Portuguese Parliament 06/12/2022 Maayan Hoffman Augusto Santos Silva, president of the Portuguese parliament The battle against pandemics can only be won through multilateralism, according to Augusto Santos Silva, president of the Portuguese parliament. During a keynote address at the UNITE Global Summit on Tuesday, Silva stressed that “viruses and bacteria know no borders. They do not have to show passports and they are not subject to border control. “To manage [a fast response] requires the efforts of all of us – requires multilateralism,” he said. Silvo, a sociologist and university professor, who has served as president since 2002, told the crowd of more than 30 parliamentarians from around the world and several health officials that “the role of parliamentarians is irreplaceable.” Silvo spoke from the center of the Senate Chamber. He said “the COVID-19 pandemic taught us that we should be prepared for the unexpected,” including “what may come up when we least expect it and, in the form, we least expect it to happen.” He called on governments to have deep ties with scientists and professionals in the health arena, but admitted that ultimately, they cannot run the country in the time of a health crisis. Only politicians, he said, can evaluate issues of the economy and democracy alongside health. “There is not an expert that waves us from our moral and political responsibilities,” Silvo said. The theme of the UNITE event, which kicked off on Monday and runs through Wednesday evening, is “from pandemic to prosperity.” He said that “I like the optimistic tone of this theme” but that parliamentarians must be attuned to the challenges that their countries face. Healthcare, he noted, is one of the objectives of the United Nations’ Sustainable Development Goals, but “we all know that the 17 SDGs are interdependent.” Now, he said, is the time for parliamentarians to evaluate their governments’ efforts toward achieving these SDGs and to redirect them if they are off on their goals. “We have to assess what we have achieved so far, to consolidate these achievements, and correct what has to be corrected or whatever is lagging behind,” Silvo said. “This is also work that is up to parliamentarians to do.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman. Indonesia Bans Extramarital Sex 06/12/2022 Kerry Cullinan Indonesia’s parliament passed a new criminal code that bans extramarital sex and criminalises abortion except for rape survivors on Tuesday, Reuters reports. The code applies to both citizens and visitors, and those who have sex outside marriage face up to a year in prison. Indonesia’s economy is heavily dependent on tourism and its tourism industry has warned that the code could dampen enthusiasm from international tourists. However, pre- and extra-marital sex can only be reported by close relatives: a parent, child or spouse. There has been speculation that the code will be used particularly to prosecute LGBTQ people. Same-sex marriage is banned in the predominantly Muslim country, which has become increasingly conservative in the past few years. The new code also prohibits anyone from insulting Indonesia’s president (transgressors face up to three years in prison), spreading views that contradict state ideology, “black magic”, and staging protests without permission. The code was passed unanimously and replaces a code adopted after Indonesia’s independence from the Netherlands in 1946. However, it is expected to only come into force in three years’ time once regulations have been drawn up to enforce its provisions. The country tried to pass the code in 2019 but faced protests, particularly from students. About 100 people reportedly gathered outside the parliament in Jakarta to protest against the code. Image Credits: Nick Agus Arya/ Unsplash. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Digitalisation of Health Must Be Approached in A Holistic Manner 08/12/2022 Megha Kaveri Panelists at a digital health session at this week’s UNITE Global Summit in Lisbon. Digitalization of health services and systems needs to be approached holistically, and take a rights-based approach to services that makes access more equitable, not less so. These were two themes that emerged at a session on ditigal health as an enabler of universal health coverage at the UNITE Global Summit 2022, In Lisbon, Portugal this week. The Summit, from 5-7 December brought health-focused parliamentarians from countries around the world together to see how they might use their legislative clout more effectively to advance global health goals. Achieving universal health coverage by 2030 is part of the global SDG agenda and digitalisation could play a key role that goal, Dr Christoph Benn, the director for global health diplomacy at the Joep Lange Institute, Amsterdam, said at the panel session. But digital health trends could also increase inequalities, he warned. And that is something legislators need to be mindful of when initiating and reviewing digital health investments in their own countries. “There is a fast paced digital transformation that can increase the digital divide and leave more people behind. And I think our discussion is about how we turn that around to make sure that this really serves all people in need.” Dr Christoph Benn Benn added that a global framework on data privacy, ownership and security is another issue that would be important for parliamentarians to tackle at national level and multilaterally. Such frameworks are critical to build confidence in digital health systems that politicians support and people will actively use. “If you are asking me one issue where I feel, you know, parliamentarians can really make a difference, I think it is about legislating data governance principles in your various countries,” he said. In countries with federal systems of government, ensuring consistency in digital health platforms can be particularly complex because health systems, as well as related digital systems and regulations, may not be harmonized across different states or provinces, added Gisela Scaglia, a former member of parliament from Argentina. This is yet another issue for parliamentarians to address. Political will is a main component in transformation of health systems in any country. However, it is equally crucial that civil servants and politicians approach and overcome technical challenges, step by step, said Luis Goes Pinheiro, a senior Portuguese Health Ministry official. He described, for instance, how Portugal has used European Union funding to strengthen telecom infrastructure that would be critical for digital health interactions with the nation’s health centres via peoples’ smart-phones and computers. Infrastructure in about half of the 3,000 health services targeted have been improved over the past few years, he said, but many barriers have had to be overcome. Luis Goes Pinheiro “This is very challenging even for someone who’s been involved in the government,” he said, of the nuts-and-bolts issues that came up around strengthening health systems’ digital capacities. “In Portugal, we have 300 million Euros that we need to use by 2024,” he said. “So this is a major thrust there, but there are also headwinds all over the world. These are trying times when it comes to access to human resources, not just in the field of digital work. We need qualified people which are lacking and we need material resources. There’s been a breakdown in supply chains by the pandemic and made worse by the war in Ukraine.” In addition, political will is not always as strong as it should be, he pointed out, and this is something that legislators can be mindful about: “Creating projects whose results will come in the long term is always very unsettling for the government. Sometimes politicians think short term, but these projects need to have short, medium, and long term perspectives. Legislation is needed to institutionalize digital practices established during pandemic Dr Marisa Aizenberg, a lawyer and researcher in public health at the University of Buenos Aires also flagged the need for new legislation to drive digital transformation in health in the post COVID era, to make improvised telemedicine systems established during the pandemic more permanent. “We have had many emergency laws to validate digital tools like distance care or remote care and others. So I think this is a true challenge, digital transformation. It does not have just to do with public policies, but it’s legal. Legal instruments are necessary for this transformation to take place.” Dr Mariza Aizenberg And while formulating rules and norms around digitalisation is important, it must all be based on a human rights perspective, she added. “Otherwise, legislation may even be widening the inequalities, widening the gap. And when I talk about reasonable costs, I’m thinking about what happens to people with disabilities that won’t have access to these health technologies. I’m also talking about gender perspectives and vulnerabilities (like children and senior citizens) and how these adjustments are so important to include all these groups.” Stressing the need to have proper legislation in place for data protection and citizens’ privacy, Dr Aizenberg said. “Any new legislation must be able to be adapted quickly to the changes that take place and create a single digital health system.” Digitalization often in the Communications Ministry – not Health Digital health is, however, a multisectoral issue, Neema Lugangira, a member of parliament from Tanzania said. And she underlined that many countries place this portfolio under the Information and Communication Technology ministry and not in the health ministry. That can, however, create barriers for fit-for-purpose digital health systems to flourish. “When we’re talking about digital health, there needs to be some sort of alignment between the ICT ministry and the Health Ministry. So one of the first things that can enhance our role as parliamentarians is to have this multi-sector approach.” Neema Lugangira Along with a multi-sectoral approach from the government, Lugangira stressed the importance of viewing digitalisation of health on a continuum. In low- and middle-income countries in particular, this must begin with digital literacy, access to electricity and mobile connectivity. “We need to also look at their entire digital infrastructure. There’s access to electricity, access to just simple mobile connectivity and access to the knowledge and the skills (needed to use devices)…So if it’s digital health, how will that work? So we need to look at all of those things.” Multilateralism on the agenda To bridge the digital divide in developing countries like Mexico, developed countries must come forward to invest resources, said Sarai Nuñez Ceron, a member of parliament from Mexico, stressing the importance of multilateralism in digitalization of health systems. “Digital health should be a priority for the development of health systems everywhere in the world. This requires up to date dynamic regulations that can be a solid basis for the protection of people and also investment in innovation,” Ceron said. Global Progress on AIDS Fight in Danger, UNAIDs Warns 08/12/2022 Stefan Anderson Matthew Kavanagh, Deputy Executive Director of UNAIDS called on Parliamentarians to close the global HIV funding gap. This year, “Equalise” was chosen as the slogan for World AIDS day, observed 1 December. The theme is a call to action around the need to address the injustices that are fuelling the AIDS epidemic as pre-existing inequalities are exacerbated by the serious disruptions to health systems caused by the Ukraine war, COVID-19 pandemic and global economic crisis. New infections have increased in Eastern Europe, Latin America, the Middle East, and Asia, a continent where cases had long been falling. Across the board, Global South countries have been disproportionately impacted. Young African women are at particularly high risk. In the Sub-Saharan region, 6 of every 7 new infections are among adolescents girls aged 15 to 19. Vulnerable populations such as gay men, people who inject drugs, sex workers, and prisoners remain the key at risk demographics. “We are deeply worried about where we are in the AIDS response right now,” Matthew Kavanagh, Deputy Executive Director of UNAIDS said. “We still see the vast majority of new infections are happening in the Global South. This is the legacy of years of insufficient progress on North-South inequalities we know are actually growing.” Cutting-edge treatments remain out of reach for LMICs A new drug designed to prevent HIV infection is now available in the comfort of London, Paris, or New York, but has yet to arrive in the Global South. These long-acting injections can help prevent HIV infection if taken every two months. But the cost of the drug precludes it from being an option in areas with fewer resources. Without this medication gaining traction in the Global South, many will still be at risk of contracting the virus. The lack of access to this new breakthrough is not the first example of HIV treatments being out of reach for Global South countries. Until a few years ago, more people in North America were receiving pre-exposure prophylaxis (PrEP) than in the entire African continent, where the majority of new infections occur. “We need to ensure that we actually make these medicines available,” Kavanagh said. “That means making them generically. It means producing them in Africa, Asia, Latin America and around the world to ensure access and affordable prices.” Kavanagh also stressed the importance of decriminalization, stressing that countries that avoided highly criminalized approaches have fared far better over the last decade than those that maintained legal penalties. Closing the funding gap is critical Underfunding for HIV programmes in low and middle-income countries has left a gap of $8 billion for 2021 in HIV support. A steep figure at first glance, it is a drop in the bucket in comparison to global economic budgets. “That $8 billion is very achievable,” Kavanagh said. “We need a push from parliamentarians in the north and in the south to ensure that this funding actually becomes available. In a moment of economic crisis, this matters the most. “Only with access to this life-saving medication can a real effort be made to tackle HIV/AIDS-related inequalities,” he concluded. “If a larger population can access this HIV prevention injection, then a real change can be made and help save lives around the world.” World’s Biggest Malaria Bed-net Campaign Unfurls in Nigeria 08/12/2022 Orji Sunday Hassana Sa-adu with her children, holds a free mosquito delivered to her household during a door-to-door mosquito distribution in Gabasawa in Kano State, Nigeria. A massive campaign is underway to distribute at least 8.8 million nets to 16 million residents of Kano State in Nigeria to prevent malaria Morning sunlight, bright as a dazzling diamond, sets Mazangudu village in Kano, northern Nigeria, awake. Motorcycle rumbles mix with the boom of microphones calling Muslims to salat prayer. A gentle breeze tickles the green leaves of nearby neem trees, easing the rising warmth with its chill. Behind the curtain of a one-room bungalow, a whisper, a cup of tea, and a smile pass between Yau Mustapha and his wife. Fourty-five-year-old Mustapha gulps the dregs of the tea in his ceramic cup before heading out with his motorcycle. As he rides through Mazangudu, a small farm settlement, mud huts and fumes unfurl behind his stretched shadows. Thousands of volunteers The settlement is a blend of mud huts and cement-walled houses. The mud huts are roundly shaped and made of colored clay. Its thatched roof, spread out like a beach hat, is made of dried millet stalks, stringed into a firm shape. Once settled, Mustapha consults with the rickshaw puller, the educator, and security, all members of his team. Now, they move from house to house, waking residents with an echo of their greetings and a hard tap at the door. “Peace be unto you,” he shouts routinely. “We are to deliver nets to you and your family, so you are fully protected from malaria.” Mustapha is not alone. Across Kano, for a period of two weeks, thousands of trained volunteers would distribute insecticide-treated mosquito nets to millions of Kano residents. “These nets will help my people; they will protect them,” says Mustapha. Residents in Mazangudu believe the chances of a pregnant woman and her children surviving sudden malaria fever attack at midnight are slim. “Many have died as a result of malaria situations,” says Ibrahim Salie, an herbalist in nearby Gwaza. Salie says the community sometimes relies on herbs to manage malaria infections, but the outcome is always a gamble. Unfortunately, the nemeses of Gwaza and Mazangudu are not one-offs. Nigeria, with over 200,000 malaria deaths annually, accounts for more than a quarter of all cases in Africa. The highest burden occurs in northern states like Kano, where poverty, combined with widespread apathy and poor sanitation, increases the risk of infection. Problematic pregnant women? Mustapha Yau, a mosquito net mobilizer and distributor giving a beneficiary mosquito nets in Gabasawa, Kano. One sunset in late September, Mustapha’s wife, a health worker in a nearby village, narrated her experiences with malaria infecting pregnant mothers. “My wife told me that malaria in pregnant women can be more violent and problematic,” says Mustapha. Many nights later, the burden of that single story remained with Mustapha. After a radio jingle announced the upcoming net campaign a few weeks ago, his wife pursued him to enrol as a volunteer. This morning, as he sets out to distribute the nets from house to house, a warm goodbye and smile pass between him and his wife, who wore a long yellow veil. Mustapha is expected to distribute at least 2,800 insecticide-treated mosquito nets to hundreds of households within a period of two weeks. In all, more than 8 million nets will be distributed in Kano to at least 16 million residents. Only two days of the two weeks have passed. However, Mustapha can attest to the dramatic shift in his fame as well as the immediate use of the nets after only two days on duty. “My wife is very happy. She is happy to see her husband greatly involved in an important campaign.” Better than traditional remedies Mazangudu’s residents say the nets are twice as helpful to them as they might have been to any other community because there is no single health facility to cater to the many malaria cases. And when these malaria attacks come by midnight, the only option is to offer traditional remedies and pray. In some cases, the infected person dies before dawn. With financial backing from The Global Fund, this year’s campaign, arguably the largest in Africa, aims to distribute at least 8.8 million nets to 16 million residents of Kano, one of the largest cities in Africa. “Kano is crucial because of the size. Kano, because of its population, looks like a country. If you are fighting malaria and Kano is not in the plan, it is a waste of time,” says Ernest Nwaokolo, the project director for the Global Fund Malaria Project of the Society for Family Health (SFH). SFH’s John Ocholi, who is the manager of the 2022 nets campaign in Kano, says that the state has 44 local governments and 484 wards. “We are working with over 20,000 personnel, which is the most for any Nigerian campaign. It is a large team, drawn from various partners and parts of the country. It takes a lot of experience to pull together to achieve this. We had advocacy visits to the government of Kano State, traditional rulers, and religious bodies in an effort to pull them into the campaign.” Delivery: from camels to canoes Ismail Yusuf and Awalu Iliasu inspect the offloading of mosquito nets bales. Educators trained in behavioral change communication work closely with the house-to-house distributor team. Before the nets are distributed to the households, each family has a brief discussion about net apathy, proper use, trading, and maintenance. More so, community and religious leaders, often revered and obeyed, have been engaged as partners in spreading and reinforcing the net-use messages. Kano has proven to be a bigger puzzle from a logistics point of view. In the absence of precise figures, Chemonics, a global consulting firm that manages logistics for the campaign, says thousands of vehicles and personnel were involved. It is like a pyramid. Nets are moved to local government areas on larger trucks and trailers. Next, the nets are then transported from local government areas in smaller vans and mini trucks. Roads to communities are often narrower and, in some cases, untarred, making smaller vans more suited for moving nets. As the nets move from house to house, the options for transporting them become more diverse and adaptable. In some desert communities, where the risk of sandstorms is higher, and cars sink in sand, camels, donkeys, and cow-carts have been deployed to move the nets to households and between settlements and communities. In a few riverine areas, canoes and paddlers are used. In areas pockmarked by mountains and hills, engage porters. Each distributor is trained and handed a mobile device with an app that allows them to enter records of the number of nets issued per household, the coordinates of the area, and the names of the recipients, often the household head. Digital tracking The data is then uploaded to a central database, which is monitored and analyzed every evening to ascertain the number of nets distributed for the day, absentees, and locations covered. Organizers receive real-time updates from all over Kano. “There is real-time tracking and monitoring of all data in the field.” It is easier to dictate areas where there are issues that deserve urgent attention. It is also faster than using papers and tally sheets. “It makes it easier to provide evidence and verify the work done,” says Asuni. The technology is also designed to flag areas where there is unusually dense or sparse net distribution. When such issues are flagged, monitors are sent to the flagged locations to verify the situation on the ground. On paper, the process sounds smooth, but Asuni says that the Kano campaign presented a couple of familiar issues. Many volunteers are not computer literate and frequently struggle with basic device setup. Secondly, limited network coverage, especially in rural communities, means that data uploads to the central server are delayed and backlogged. Volunteers undergo intense training on device use. Aisha Aliyi Danyar, a mobilisation and distribution team member, is receiving training in Gabasaw LGA, Kano, Nigeria, on how to engage beneficiaries in mosquito net distribution. However, not every ambition can be squeezed into the short timeframe of the net campaign. There are still minimal concerns that net collection is rarely equivalent to use. Some residents say the nets restrict their breathing and have limited ventilation. Myths that link white nets to corpses also build stereotypes that hinder net use. “Fixing these issues can be gradual and long,” says Nwaokolo. Back in Mazangudu, the fruits of Mustapha’s work are instant. Families, who received the nets a few days ago are already putting them to use. They say these nets, more than ever, will ease their burden. The fame of Mustapha grows with every new inch he covers. “My people see me as a hero,” he says. But it’s not the heroism that makes him happy; it’s the lives that will be saved and the medical bills that will be avoided. “This net distribution has brought excitement. “The people are grateful,” says Mustapha. “And no amount invested in mosquito nets is too big. To save a single life is worth more than millions, for we really do not know what the children we are saving today might turn out to be in the future.” Better than a wedding When Aisha Lawal, 35, had to choose between attending a friend’s wedding and staying behind to pick her nets, it was an easy choice. “I didn’t want to miss [the nets],” she says. “If I choose weddings over nets, how would my household sleep peacefully? I have been expecting the new net since two days ago.” Aisha and her family of eight live at Sabon-Gari, Gabasawa, on the outskirts of Kano metropolis, where malaria is rampant. Long lines form at health centers from time to time, she claims. Her own family is also exposed. The last set of nets that came to them three years ago are discolored, torn, and pockmarked. “Receiving these nets feels like I have been given at least 1 million naira (local currency). Everyone craves rest after toiling all day. Without the net here, one can rarely get that desired rest. Mosquitoes are an enemy of good sleep. And without a good sleep, I wake up feeling sick.” As the interview unwinds, Aisha cuddles her baby, Nasiru Yusuf, closer to her ribs, allowing him to wriggle his feet around her waist. He thumped her blouse, trying to get into her nipple. Seeing his attempts ignored, Nasiru Yusuf, began to sniffle and kick. He is prone to malaria, as are the rest of the kids. She hopes that the new nets will reverse the trend and save on medical bills. Aisha Lawal with her child, holds free mosquito delivered to her household during a door-to-door mosquito distribution in Gabasawa, Kano, Nigeria. Aisha is impressed by the format adopted in this campaign. She thinks the house-to-house approach is more efficient than the past model of depositing the nets in a pickup center. More than eight million nets are expected to reach at least 16 million residents in this year’s campaign, making it arguably the largest ever in the world. But she has one bright idea, which might create a bigger impact. Women, she says, are the health managers of their families. In northern Nigeria, where most rural women are uneducated, Aisha says households’ handling of malaria, despite the nets, can be compromised. “More mothers need to be educated. The more education mothers have, the more they can play a role in their family’s health. Mothers are the protectors of the family. Once women are empowered, the communities will remain healthy,” she says. Deadly malaria Each night, as Yusuf Basira closes her eyes to sleep, she dreams of Maila Baila, her two-year-old child laid to rest a few weeks ago. “I always remember him,” says Basira, her face lowered to conceal her dark eyeballs, which have grown red and teary. In the morning of 25 October, Maila Baila experienced a severe malaria fever, which marked the beginning of his death. Basira took her child to Khalifa Sheikh Isyaku Rabiu Paediatric Hospital after two failed attempts at nearby primary health centers to stabilize him. The pediatrician diagnosed severe malaria, which resulted in multiple convulsions. A few hours after their arrival at the hospital, Maila’s body grew cold, and his eyes lost light. The doctors confirmed his death. Basira is among the 16 million residents of Kano who will benefit from the 2022 net campaign, which aims to provide more than eight million nets for households in the state. As she receives the nets, nostalgia returns, bringing with it regrets but also lessons. Prior to Biala’s death, she believed that malaria, though common and costly, was not deadly. Her attitude towards net use was carefree. She now has a new perspective, both from her past mistakes and the brief pep talk that is offered by the net distribution team. “I didn’t have much knowledge about malaria prior to the death of my baby. I never expected it to cause the death of a child. I now know that malaria can cause severe fever, even to the extent of killing a child. I take each sleeping child to the net once it’s past 6 pm. Reporting for this story was supported by the Global Fund. Image Credits: Global Fund. Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan Fight the Fakes held an event in Geneva to highlight the dangers of falsified medicine. There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake medicine and the threat it poses to patients. In October, 99 children died in Indonesia from cough syrup contaminated with anti-freeze chemicals. The previous month, 66 children died in The Gambia – also from contaminated cough syrup. These tragedies echo the deaths of 12 Indian children in 2020 – from cough syrup that had been rendered poisonous after one of the ingredients was replaced by a toxic one. Yet, said Sehmi, most countries treated falsified medicines as a commercial crime such as “product liability or negligence” when they should be treating it “in the same way as narcotics”. “Trust is at the heart of everything. Patients have to trust that the product they’re getting is of the appropriate quality and safety,” said Pernette Esteve, who heads the World Health Organization’s (WHO) team on substandard and falsified medical products. “Gaining the confidence of the public once you’ve lost it is very difficult. Think back to the COVID pandemic. Making sure that people trusted the vaccines, vaccine acceptability, was a key point.” For 10 years, the WHO has been building a database of substandard (unintentionally defective) and falsified (deliberately altered) medicine to understand the scope, scale and harm. From this database, the WHO has identified the three driving forces: lack of access to medicine, poor governance including corruption, and weak technical capacity, said Esteve. The WHO’s response was based on “prevention, detection and response”, she added. The extent of the problem Stanislav Barro, Novartis’s global head of anti-falsified medicines, says that his company has confronted fake medicine in every region of the world. The timely authentication of medicines was both the biggest challenge and the biggest opportunity to stamp out fakes, he said – but warned that it is “a very complicated process”. All the suspect samples have to be brought to a place where they can be actually properly authenticated using forensic means,” said Barro. However, almost 50 pharmaceutical companies were now sharing data via the Pharmaceutical Security Institute, and there had been a 38% increase in the incidence of falsified medicines between 2016 and 2020 in 142 countries, and incidence had surged in 2021 during the early days of the COVID pandemic. “Basically, this is whatever the criminal organisations can make money with. It doesn’t really matter whether it’s falsified, tampered, stolen, illegally diverted. It’s a bit of everything, quite frankly,” added Barro, noting that it usually meant “terrible news for patients”. “We need to find solutions to leverage digital technologies to localise authentication, identify falsified medicines and make that timely. Cut down these timelines from weeks to basically days, hours if possible, and accelerate the reporting to local authorities and to the WHO.” Policing raw materials Sireesha Yadlapalli, vice president for international government and regulatory affairs for United States Pharmacopeia (USP), called for more policing of raw materials. Medicines are made of two components, the active pharmaceutical ingredients (API) and the inactive ingredients or excipients, including reagents, solvents and items related to the taste or look of the product. There was less stringent policing of the excipients, and these were often where problems arose, Yadlapalli said. “There might be an issue with an ingredient but the manufacturer may not know about that particular issue because he just took the supplier’s word and certificate of analysis at face value, and that’s because raw materials are not being tested when they’re accepted from suppliers,” she added. “Manufacturers need to test the raw materials. Regulations should be put in place requiring testing of these raw materials.” Improving regulatory systems Members of the International Generic and Biosimilar Medicines Association made up to 80% of quality-assured medicines around the world, according to its general secretary, Suzette Kox. “We think that the biggest challenge is weak healthcare systems which includes, of course, the insufficiently resourced regulatory system and quality control. Most countries around the world do not have proper regulatory systems in place, and also no proper competition policies.” Oksana Pyzik, who lectures at the UCL School Pharmacy, said that one of the biggest challenges is a lack of public awareness. Pointing to the proliferation of online medical supply outlets during COVID-19, Pyzik said that many patients didn’t know how to verify legal online pharmacies. “Pharmacists are the last line of defence before patients received those medications and take them home with them. And there’s a real opportunity there for patient education as part of wider public awareness,” she said, adding that this was why educating pharmacists about falsified medicines was essential. In Talk on UHC, NY Senator Raises Concern Over Commoditization of Healthcare 07/12/2022 Maayan Hoffman New York State Senator Jose Gustavo Rivera A New York lawmaker warned fellow parliamentarians on Wednesday to “stay as far away from the private sector as you can” when it comes to healthcare. “The main issue in the United States is that healthcare is commodified,” said New York State Senator Jose Gustavo Rivera. “It is true, the best healthcare is available in the US – that is true if you can afford it. But the majority of Americans cannot [afford it] and instead organize their entire existence around how to find the best insurance. “And I put insurance in quotation marks because having insurance does not guarantee care,” he continued. “The commoditization of healthcare is the way to ensure that the people in your country do not get the care they need and deserve.” Less than half of Americans (40%) rate the quality of healthcare in in their country as very good or good, according to a new survey released by the Beryl Institute – Ipsos PX Pulse. Moreover, despite improvements in access to health insurance following the roll out of the Affordable Care Act in 2010, roughly 30 million Americans of all ages had no health insurance in 2021, according to a report by MoneyGeek. ‘Investments in health … are key’ Rivera spoke at the conclusion of Wednesday’s UNITE Global Summit session on universal health coverage (UHC). The session was hosted by UHC2030 and focused on case studies from throughout the world for how to implement UHC. “UHC means that everyone, everywhere, can access the services they need without facing financial burden,” said UHC2030 Steering Committee Co-chair Gabriela Cuevas Barron from Mexico. “Investments in health and healthier populations are key for wider economic and social benefits.” UHC2030 Steering Committee Co-chair Gabriela Cuevas Barron Examples of efforts to roll out UHC were given from Tanzania, Chile and Zambia. In Tanzania, for example, a UHC bill was supposed to be deliberated on in November of this year. However, according to MP Neema Lugangira, discussions were pushed off after concerns with some of the nuances of the bill were raised during public hearings. “We had several discussions and felt there were concrete issues with the bill So, we, as the parliamentary committee, withdrew the bill for improvement and consideration in the areas raised,” Lugangira said. “We were hoping that by the time I would be standing here, perhaps the bill would have been passed. But in an interesting turn of events, we were able to make sure the government takes the bill back and improves on it before it is tabled in parliament. “This shows the power parliamentarians have to understand the issues and advise the government better,” she concluded. ‘Still some work to do’ Zambia, on the other hand, already rolled out the first stages of a universal health coverage plan, explained MP Givem Katuta in her remarks. The initial stage of the UHC plan includes coverage of primary care, said Katuta. But she noted that the bill was moved forward quickly between 2017 and 2018 and the country knows there is still some work to do. For example, one challenge is that the plan uses the National Health Insurance Management Authority, which works well for people who are employed but creates a gap for those who do not have some kind of job. In addition, while people in urban areas can really take advantage of the plan, including getting care at private hospitals of their choice, this has not yet been the case for those in rural areas. “We are on the right track,” Katuta said. “We are looking forward to other stakeholders coming through to spread its wings to rural areas. The goal is to have full UHC by 2030.” Chile’s representative, Marta Bravo, called on the World Health Organization to support the creation of “harmonized and unified criteria” for universal health coverage . “WHO has a powerful voice that is listened to by our government,” she said. “This is our opportunity to ask WHO to be active in this field.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman, Screenshot. In Heated UNITE Event Session, African MPs Call for Greater Inclusion in Global Fund 07/12/2022 Maayan Hoffman Tanzanian MP Neema Lugangira at the UNITE Global Summit in Lisbon A group of African parliamentarians raised a red flag on Tuesday at the UNITE Global Summit when they told representatives that they felt neglected by the Global Fund to Fight AIDS, Tuberculosis and Malaria, which funds billions of dollars of health services in their countries. “Do African parliamentarians only get involved when we have to make an appeal, when it suits our colleagues?” asked Tanzanian MP Neema Lugangira in her remarks at a session titled “The Global Fund Post 7th Replenishment – The Role of Members of Parliament and Domestic Health Financing.” Lugangira said that she was asked to make a fundraising appeal via video on behalf of the Global Fund to the United Kingdom parliament over the summer believes her intervention added value and played a key role in convincing the UK government to provide a more than $1 billion grant. However, despite being in New York in September during Global Fund’s Replenishment event at which donors pledge money for the next three years, she was not invited to attend. Global Fund instead hosted 18 heads of state and governments and many high-level officials from civil society and the private sector at the 400-person event in the city. Lugangira said that “some of my colleagues in Tanzania were surprised I was not invited” because of the video she provided and her deep commitment to public health in Tanzania. “When it is time for the glorious moment, we are not invited,” she said. Lugangira said that Global Fund could generate increased matching domestic financing and distribute its funds more effectively if it worked closely with parliaments, the way it works with civil society. “Civil society was not chosen by our UK parliamentarians to record a clip and make an appeal to parliament. It was me, a member of the African parliament,” she stressed. “It is powerful when you hear the voice of an African parliamentarian representing her people. “Don’t just use us when it suits you. Include us across the entire chain” Lugangira continued. “Parliamentarians should be involved at all levels and be recognised for the impact and power we have.” ‘Confused and surprised’ “The Global Fund Post 7th Replenishment” session on December 6 at the UNITE Global Summit Lugangira had been asked to speak during a panel hosted by the fund that was meant to celebrate the nearly $16 billion it raised in the fall and to examine the positive impact that the more than $55 billion it distributed over the past 20 years has had on health and saving lives. In Tanzania alone, the Global Fund has invested $3 billion to tackle issues of HIV, TB and malaria between 2002 and 2022. Currently, the fund has four core grants in the country totalling $608 million. According to Lugangira, since the fund became involved in her country, there has been a 68% decrease in HIV and people with the virus and a 68% increase – from 18% to 86% – of individuals with HIV enrolled in treatment programs. But after Lugangira and several other parliamentarians criticised the Global Fund for failing to properly leverage local lawmakers and called on it to shift its paradigm, Scott Boule, the Global Fund’s Senior Specialist for Parliamentary Affairs, said he was left “confused and surprised.” “At least one MP sort of implied a feeling of being only utilised when the Global Fund needs to raise funds,” Boule said, “Global Fund is supposed to be a partnership.” ‘You handcuff us’ Some parliamentarians also expressed concerns over the Global Fund model, which involves establishing a Country Coordinating Mechanism (CCM) committee to help distribute funds. Boule said Global Fund mandates that CCMs have broad representation, including from the government, but also from civil society, such as members of the communities that are impacted by the three core diseases. In some countries, parliamentarians sit on the CCMs, but in many countries they are not asked to do so. Moreover, parliamentarians have been ineligible to receive money to help fund their role on these committees. Zimbabwe’s Ruth Labode is one of those MPs. She is a member of her country’s CCM but said she rarely attends meetings due to lack of transport and funding. She only goes when parliament is in session and she has to be in the capital city for work anyway. Otherwise, “it’s too costly” to take part, she told Health Policy Watch. “The CCM has decided not to fund parliamentarians for meetings while they fund members from the civil society, private or any other sector,” Labode said. “The lack of funding shows that the Global Fund is not committed [to the parliamentarians]. It does not think it needs parliamentarians. And yet, when the time comes for replenishment, they are quick to find parliamentarians to lobby for their purpose.” She told Boule during the discussion that “it is about time you advocate for a parliamentary seat on every CCM in every country… If you told them to have a seat for a parliamentarian, it would happen overnight”. Another complaint was that many parliamentarians are not educated about the work of the Global Fund or its accomplishments, which could help them push for further domestic health financing. “You cannot mobilise resources when you are not informed,” said MP Peter Njume from Cameroon. “You work [directly] with the government and then expect us to ask them to be accountable. But parliamentarians are not involved. “You talk about the importance of democracy,” Njume continued. “We represent democracy, but you handcuff us, you make us become vulnerable and helpless. How do you want us to function?” “To own this agenda, we need to be well informed and educated,” Lugangira similarly added. Njume requested that the Global Fund earmark financing for a parliamentary education program. ‘Healthcare financing is a political decision’ Alex Winch, a member of Global Fund’s Advocacy, Health Financing Team speaks at the UNITE Global Summit in Lisbon Global Fund’s Alex Winch acknowledged that “the financing of healthcare is a political decision.” A specialist on Global Fund’s Advocacy, Health Financing Team, he said it is important to understand that the vast majority of the fund’s resources do come from governments prioritising money. “Eighty percent of funding comes from the G7 and the European commission,” explained Boule. “Eleven percent comes from other governments around the world. And 9% comes from the private sector.” To date, the Global Fund is providing 30% of international financing for HIV, 76% for TB and 63% for malaria. The fund gives more money for the battle against TB and malaria than anyone in the world. In addition, about a third of its funding is now going to reward strengthening underlying health systems. The funding has been effective, at least according to the data. Life expectancy, for example, has increased as a result. In sub-Sahara Africa alone, average life expectancy jumped from 52.3 in 2002 to 66.7 in 2019, in large part because of the fund’s efforts. During 2021 in countries and regions where Global Fund invests, some 12.5 million people were reached with HIV prevention services; 670,000 mothers living with HIV received medicine to keep them alive and prevent transmitting HIV to their babies; another 5.3 million people were tested for TB; 110,000 were given treatment for drug-resistant TB; and 133 million mosquito nets were distributed to protect families from malaria, amongst many other efforts. “All of this is made possible by our replenishment,” Boule told Health Policy Watch. “Every third year, we raise funds for the subsequent three years.” Replenishment this year was held on 21 September in New York. Some 47 public and 27 private sector donors pledged $15.7 billion out of the target of $18 billion that the organisation had set to raise for the 2023-2025 period. Boule said that efforts were continuing to try to fill the gap. ‘We are de-investing in health’ But Zimbabwe’s Daniel Molokele said that while the results are stunning, he believes African governments have become too “dependent” on the Global Fund, which puts 72% of its money towards the continent. “I don’t think it is good for Africa, this over-reliance on the Global Fund,” Molokele said. He said that Global Fund’s filling the gap lets off the hook governments who then do not have to commit to fund health in their own countries. In Zimbabwe, he said, domestic health financing dropped several percentage points in the last year. “We are de-investing in health,” Molokele said. Boule explained that recipient countries are required to provide a certain percentage of matching money to receive a grant from the Global Fund, though he said that the fund is often more flexible with low-income countries about achieving their targets. He said that despite the economic challenges the world is facing in the aftermath of COVID-19 and as the war is raging in Ukraine, the fund did see around a 30% increase across the board in domestic health financing from recipient countries. ‘It was ambitious’ Another concern raised from the floor came from French MP Jean-Francois Mbaye, who expressed “disappointment” that his country invested $1.6 billion towards a goal it thought was $18 billion but that fell short “It was ambitious,” Boule admitted to Health Policy Watch. “We did raise $15.7 and that is by far the largest amount we ever raised.” The gap came from some of Global Fund’s largest donors not increasing their gifts by the 30% that the fund expected. “The United States, Germany, Japan, Canada and the European Commission all did increase by 30%,” Boule said. “France increased by 23% and Italy increased by 15%. “The only country amongst our largest donors that went down was the UK, although it still pledged $1.2 billion,” Boule continued. “So we very much had strong support from our donors, and in particular, our largest donors.” Number of donors for Global Fund’s 7th Replenishment On the other hand, faltering exchange rates, and hosting the replenishment seven months after the start of the Ukraine war amid rising interest rates had a negative impact. To illustrate if the pledging session had been held on February 23, 2022, which is the day Global Fund had its preparatory meeting, because of exchange rates, it would have raised around $857 million more. In general, Winch said that achieving funding in the current fiscal environment is becoming increasingly more challenging. He cited a recent report by the World Bank that highlighted how even more countries will find it hard to invest in health or in even sustain existing levels of health investment. He said that “an uncertain global macro-economic environment threatens domestic financing for health.” ‘We need to crowd more resources into health’ Boule said that he plans to take some of the parliamentarians’ concerns back to Geneva, such as providing resources for parliamentarians to sit on CCMs and perhaps developing a fixed parliamentary position on the committees. “I wasn’t aware of the point that Honorable Ruth Labode was making from Zimbabwe, that other members of the CCMs received some sort of support and she did not,” Boule said. He also said he would be interested in finding ways to better involve parliamentary feedback as another means to ensure that the fund is asking the right questions and distributing resources in an optimal way. “Our good results are due to a lot of African political leaders, including parliamentarians, really building and sustaining political will to prioritise health,” Boule said. “It is even harder now with food insecurity, debt crisis and rising interest rates. But we are making the point that even now we need to crowd more resources into health.” Image Credits: Maayan Hoffman, Screenshot. US Wants WTO to Delay Decision on TRIPS Waiver Extension for COVID-19 Tests and Treatment 06/12/2022 Kerry Cullinan US Trade Representative Katherine Tai The US Trade Representative’s (USTR) office announced on Tuesday that it supports extending the deadline on whether the World Trade Organization’s (WTO) Ministerial Decision on the TRIPS Agreement should be extended to COVID-19 diagnostics and therapeutics. Trade ministers adopted the Ministerial Decision on the TRIPS Agreement in June, giving members scope to diversify the production of COVID-19 vaccines and override the exclusive effect of patents through a targeted waiver over the next five years. The TRIPS Council has been discussing whether this should be extended to COVID-19 diagnostics and therapeutics. The US decision was informed by wide-ranging consultations over the past five months with over 24 groups with opposing views on the issue, the USTR said in a statement. While all these groups “shared a concern with saving lives, and with striking a balance between the need to promote innovation in these sectors and the need to promote access to the products of innovation”, there were “key differences”. In light of the differing views, the USTR will ask the US International Trade Commission (USITC) to “launch an investigation into COVID-19 diagnostics and therapeutics and provide information on market dynamics to help inform the discussion around supply and demand, price points, the relationship between testing and treating, and production and access”, the USTR said in a statement. “Over the past five months, USTR officials held robust and constructive consultations with Congress, government experts, a wide range of stakeholders, multilateral institutions, and WTO Members,” said Ambassador Katherine Tai. “Real questions remain on a range of issues, and the additional time, coupled with information from the USITC, will help the world make a more informed decision on whether extending the Ministerial Decision to COVID-19 therapeutics and diagnostics would result in increased access to those products,” added Tai. “Transparency is critical and USTR will continue to consult with Congress, stakeholders, and others as we continue working to end the pandemic and support the global economic recovery.” Those in favour of extending the Ministerial agreement “acknowledge a lack of global demand for COVID-19 products, but they believe that market dynamics are suppressing effective demand”, according to the USTR. Opponents’ concerns include that the extension would “allow countries with anti-competitive approaches to innovation, such as China” to “unfairly obtain and use American innovation to benefit their domestic economies”, harming “American industry and workers by undermining investment and research and development”. The USITC study will explore key issues including: An overview of the products, focusing on WHO-approved COVID-19 diagnostics and therapeutics, including key components, the production process, intellectual property protections, and the supply chain (including the level of diversification in the supply chain); The global manufacturing industry for these products, including information on key producing countries, major firms, and production data, if available; The global market for COVID-19 diagnostics and therapeutics, including information on demand and, to the extent practicable, an assessment of where unmet demand exists for key products and contributing factors; market segmentation; and supply accumulation and distribution; Data and information on global trade in COVID-19 diagnostics and therapeutics, if available, or if not, data and information on global trade in diagnostics and therapeutics generally; and A brief overview of the relevant aspects of the TRIPS Agreement and the UN Medicine Patent Pool (MPP) and a listing of countries seeking to use the Ministerial Decision and those utilizing access to COVID-19 medicines under the MPP. Meanwhile, the US reaffirmed the right of its trading partners to “exercise the full range of existing flexibilities in the TRIPS Agreement, such as in Articles 30, 31, and 31bis, and the Doha Declaration on the TRIPS Agreement and Public Health, as well as the flexibilities in the Ministerial Decision”. ‘Multilateralism’ Essential in Battle Against Pandemics, Says President of Portuguese Parliament 06/12/2022 Maayan Hoffman Augusto Santos Silva, president of the Portuguese parliament The battle against pandemics can only be won through multilateralism, according to Augusto Santos Silva, president of the Portuguese parliament. During a keynote address at the UNITE Global Summit on Tuesday, Silva stressed that “viruses and bacteria know no borders. They do not have to show passports and they are not subject to border control. “To manage [a fast response] requires the efforts of all of us – requires multilateralism,” he said. Silvo, a sociologist and university professor, who has served as president since 2002, told the crowd of more than 30 parliamentarians from around the world and several health officials that “the role of parliamentarians is irreplaceable.” Silvo spoke from the center of the Senate Chamber. He said “the COVID-19 pandemic taught us that we should be prepared for the unexpected,” including “what may come up when we least expect it and, in the form, we least expect it to happen.” He called on governments to have deep ties with scientists and professionals in the health arena, but admitted that ultimately, they cannot run the country in the time of a health crisis. Only politicians, he said, can evaluate issues of the economy and democracy alongside health. “There is not an expert that waves us from our moral and political responsibilities,” Silvo said. The theme of the UNITE event, which kicked off on Monday and runs through Wednesday evening, is “from pandemic to prosperity.” He said that “I like the optimistic tone of this theme” but that parliamentarians must be attuned to the challenges that their countries face. Healthcare, he noted, is one of the objectives of the United Nations’ Sustainable Development Goals, but “we all know that the 17 SDGs are interdependent.” Now, he said, is the time for parliamentarians to evaluate their governments’ efforts toward achieving these SDGs and to redirect them if they are off on their goals. “We have to assess what we have achieved so far, to consolidate these achievements, and correct what has to be corrected or whatever is lagging behind,” Silvo said. “This is also work that is up to parliamentarians to do.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman. Indonesia Bans Extramarital Sex 06/12/2022 Kerry Cullinan Indonesia’s parliament passed a new criminal code that bans extramarital sex and criminalises abortion except for rape survivors on Tuesday, Reuters reports. The code applies to both citizens and visitors, and those who have sex outside marriage face up to a year in prison. Indonesia’s economy is heavily dependent on tourism and its tourism industry has warned that the code could dampen enthusiasm from international tourists. However, pre- and extra-marital sex can only be reported by close relatives: a parent, child or spouse. There has been speculation that the code will be used particularly to prosecute LGBTQ people. Same-sex marriage is banned in the predominantly Muslim country, which has become increasingly conservative in the past few years. The new code also prohibits anyone from insulting Indonesia’s president (transgressors face up to three years in prison), spreading views that contradict state ideology, “black magic”, and staging protests without permission. The code was passed unanimously and replaces a code adopted after Indonesia’s independence from the Netherlands in 1946. However, it is expected to only come into force in three years’ time once regulations have been drawn up to enforce its provisions. The country tried to pass the code in 2019 but faced protests, particularly from students. About 100 people reportedly gathered outside the parliament in Jakarta to protest against the code. Image Credits: Nick Agus Arya/ Unsplash. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Progress on AIDS Fight in Danger, UNAIDs Warns 08/12/2022 Stefan Anderson Matthew Kavanagh, Deputy Executive Director of UNAIDS called on Parliamentarians to close the global HIV funding gap. This year, “Equalise” was chosen as the slogan for World AIDS day, observed 1 December. The theme is a call to action around the need to address the injustices that are fuelling the AIDS epidemic as pre-existing inequalities are exacerbated by the serious disruptions to health systems caused by the Ukraine war, COVID-19 pandemic and global economic crisis. New infections have increased in Eastern Europe, Latin America, the Middle East, and Asia, a continent where cases had long been falling. Across the board, Global South countries have been disproportionately impacted. Young African women are at particularly high risk. In the Sub-Saharan region, 6 of every 7 new infections are among adolescents girls aged 15 to 19. Vulnerable populations such as gay men, people who inject drugs, sex workers, and prisoners remain the key at risk demographics. “We are deeply worried about where we are in the AIDS response right now,” Matthew Kavanagh, Deputy Executive Director of UNAIDS said. “We still see the vast majority of new infections are happening in the Global South. This is the legacy of years of insufficient progress on North-South inequalities we know are actually growing.” Cutting-edge treatments remain out of reach for LMICs A new drug designed to prevent HIV infection is now available in the comfort of London, Paris, or New York, but has yet to arrive in the Global South. These long-acting injections can help prevent HIV infection if taken every two months. But the cost of the drug precludes it from being an option in areas with fewer resources. Without this medication gaining traction in the Global South, many will still be at risk of contracting the virus. The lack of access to this new breakthrough is not the first example of HIV treatments being out of reach for Global South countries. Until a few years ago, more people in North America were receiving pre-exposure prophylaxis (PrEP) than in the entire African continent, where the majority of new infections occur. “We need to ensure that we actually make these medicines available,” Kavanagh said. “That means making them generically. It means producing them in Africa, Asia, Latin America and around the world to ensure access and affordable prices.” Kavanagh also stressed the importance of decriminalization, stressing that countries that avoided highly criminalized approaches have fared far better over the last decade than those that maintained legal penalties. Closing the funding gap is critical Underfunding for HIV programmes in low and middle-income countries has left a gap of $8 billion for 2021 in HIV support. A steep figure at first glance, it is a drop in the bucket in comparison to global economic budgets. “That $8 billion is very achievable,” Kavanagh said. “We need a push from parliamentarians in the north and in the south to ensure that this funding actually becomes available. In a moment of economic crisis, this matters the most. “Only with access to this life-saving medication can a real effort be made to tackle HIV/AIDS-related inequalities,” he concluded. “If a larger population can access this HIV prevention injection, then a real change can be made and help save lives around the world.” World’s Biggest Malaria Bed-net Campaign Unfurls in Nigeria 08/12/2022 Orji Sunday Hassana Sa-adu with her children, holds a free mosquito delivered to her household during a door-to-door mosquito distribution in Gabasawa in Kano State, Nigeria. A massive campaign is underway to distribute at least 8.8 million nets to 16 million residents of Kano State in Nigeria to prevent malaria Morning sunlight, bright as a dazzling diamond, sets Mazangudu village in Kano, northern Nigeria, awake. Motorcycle rumbles mix with the boom of microphones calling Muslims to salat prayer. A gentle breeze tickles the green leaves of nearby neem trees, easing the rising warmth with its chill. Behind the curtain of a one-room bungalow, a whisper, a cup of tea, and a smile pass between Yau Mustapha and his wife. Fourty-five-year-old Mustapha gulps the dregs of the tea in his ceramic cup before heading out with his motorcycle. As he rides through Mazangudu, a small farm settlement, mud huts and fumes unfurl behind his stretched shadows. Thousands of volunteers The settlement is a blend of mud huts and cement-walled houses. The mud huts are roundly shaped and made of colored clay. Its thatched roof, spread out like a beach hat, is made of dried millet stalks, stringed into a firm shape. Once settled, Mustapha consults with the rickshaw puller, the educator, and security, all members of his team. Now, they move from house to house, waking residents with an echo of their greetings and a hard tap at the door. “Peace be unto you,” he shouts routinely. “We are to deliver nets to you and your family, so you are fully protected from malaria.” Mustapha is not alone. Across Kano, for a period of two weeks, thousands of trained volunteers would distribute insecticide-treated mosquito nets to millions of Kano residents. “These nets will help my people; they will protect them,” says Mustapha. Residents in Mazangudu believe the chances of a pregnant woman and her children surviving sudden malaria fever attack at midnight are slim. “Many have died as a result of malaria situations,” says Ibrahim Salie, an herbalist in nearby Gwaza. Salie says the community sometimes relies on herbs to manage malaria infections, but the outcome is always a gamble. Unfortunately, the nemeses of Gwaza and Mazangudu are not one-offs. Nigeria, with over 200,000 malaria deaths annually, accounts for more than a quarter of all cases in Africa. The highest burden occurs in northern states like Kano, where poverty, combined with widespread apathy and poor sanitation, increases the risk of infection. Problematic pregnant women? Mustapha Yau, a mosquito net mobilizer and distributor giving a beneficiary mosquito nets in Gabasawa, Kano. One sunset in late September, Mustapha’s wife, a health worker in a nearby village, narrated her experiences with malaria infecting pregnant mothers. “My wife told me that malaria in pregnant women can be more violent and problematic,” says Mustapha. Many nights later, the burden of that single story remained with Mustapha. After a radio jingle announced the upcoming net campaign a few weeks ago, his wife pursued him to enrol as a volunteer. This morning, as he sets out to distribute the nets from house to house, a warm goodbye and smile pass between him and his wife, who wore a long yellow veil. Mustapha is expected to distribute at least 2,800 insecticide-treated mosquito nets to hundreds of households within a period of two weeks. In all, more than 8 million nets will be distributed in Kano to at least 16 million residents. Only two days of the two weeks have passed. However, Mustapha can attest to the dramatic shift in his fame as well as the immediate use of the nets after only two days on duty. “My wife is very happy. She is happy to see her husband greatly involved in an important campaign.” Better than traditional remedies Mazangudu’s residents say the nets are twice as helpful to them as they might have been to any other community because there is no single health facility to cater to the many malaria cases. And when these malaria attacks come by midnight, the only option is to offer traditional remedies and pray. In some cases, the infected person dies before dawn. With financial backing from The Global Fund, this year’s campaign, arguably the largest in Africa, aims to distribute at least 8.8 million nets to 16 million residents of Kano, one of the largest cities in Africa. “Kano is crucial because of the size. Kano, because of its population, looks like a country. If you are fighting malaria and Kano is not in the plan, it is a waste of time,” says Ernest Nwaokolo, the project director for the Global Fund Malaria Project of the Society for Family Health (SFH). SFH’s John Ocholi, who is the manager of the 2022 nets campaign in Kano, says that the state has 44 local governments and 484 wards. “We are working with over 20,000 personnel, which is the most for any Nigerian campaign. It is a large team, drawn from various partners and parts of the country. It takes a lot of experience to pull together to achieve this. We had advocacy visits to the government of Kano State, traditional rulers, and religious bodies in an effort to pull them into the campaign.” Delivery: from camels to canoes Ismail Yusuf and Awalu Iliasu inspect the offloading of mosquito nets bales. Educators trained in behavioral change communication work closely with the house-to-house distributor team. Before the nets are distributed to the households, each family has a brief discussion about net apathy, proper use, trading, and maintenance. More so, community and religious leaders, often revered and obeyed, have been engaged as partners in spreading and reinforcing the net-use messages. Kano has proven to be a bigger puzzle from a logistics point of view. In the absence of precise figures, Chemonics, a global consulting firm that manages logistics for the campaign, says thousands of vehicles and personnel were involved. It is like a pyramid. Nets are moved to local government areas on larger trucks and trailers. Next, the nets are then transported from local government areas in smaller vans and mini trucks. Roads to communities are often narrower and, in some cases, untarred, making smaller vans more suited for moving nets. As the nets move from house to house, the options for transporting them become more diverse and adaptable. In some desert communities, where the risk of sandstorms is higher, and cars sink in sand, camels, donkeys, and cow-carts have been deployed to move the nets to households and between settlements and communities. In a few riverine areas, canoes and paddlers are used. In areas pockmarked by mountains and hills, engage porters. Each distributor is trained and handed a mobile device with an app that allows them to enter records of the number of nets issued per household, the coordinates of the area, and the names of the recipients, often the household head. Digital tracking The data is then uploaded to a central database, which is monitored and analyzed every evening to ascertain the number of nets distributed for the day, absentees, and locations covered. Organizers receive real-time updates from all over Kano. “There is real-time tracking and monitoring of all data in the field.” It is easier to dictate areas where there are issues that deserve urgent attention. It is also faster than using papers and tally sheets. “It makes it easier to provide evidence and verify the work done,” says Asuni. The technology is also designed to flag areas where there is unusually dense or sparse net distribution. When such issues are flagged, monitors are sent to the flagged locations to verify the situation on the ground. On paper, the process sounds smooth, but Asuni says that the Kano campaign presented a couple of familiar issues. Many volunteers are not computer literate and frequently struggle with basic device setup. Secondly, limited network coverage, especially in rural communities, means that data uploads to the central server are delayed and backlogged. Volunteers undergo intense training on device use. Aisha Aliyi Danyar, a mobilisation and distribution team member, is receiving training in Gabasaw LGA, Kano, Nigeria, on how to engage beneficiaries in mosquito net distribution. However, not every ambition can be squeezed into the short timeframe of the net campaign. There are still minimal concerns that net collection is rarely equivalent to use. Some residents say the nets restrict their breathing and have limited ventilation. Myths that link white nets to corpses also build stereotypes that hinder net use. “Fixing these issues can be gradual and long,” says Nwaokolo. Back in Mazangudu, the fruits of Mustapha’s work are instant. Families, who received the nets a few days ago are already putting them to use. They say these nets, more than ever, will ease their burden. The fame of Mustapha grows with every new inch he covers. “My people see me as a hero,” he says. But it’s not the heroism that makes him happy; it’s the lives that will be saved and the medical bills that will be avoided. “This net distribution has brought excitement. “The people are grateful,” says Mustapha. “And no amount invested in mosquito nets is too big. To save a single life is worth more than millions, for we really do not know what the children we are saving today might turn out to be in the future.” Better than a wedding When Aisha Lawal, 35, had to choose between attending a friend’s wedding and staying behind to pick her nets, it was an easy choice. “I didn’t want to miss [the nets],” she says. “If I choose weddings over nets, how would my household sleep peacefully? I have been expecting the new net since two days ago.” Aisha and her family of eight live at Sabon-Gari, Gabasawa, on the outskirts of Kano metropolis, where malaria is rampant. Long lines form at health centers from time to time, she claims. Her own family is also exposed. The last set of nets that came to them three years ago are discolored, torn, and pockmarked. “Receiving these nets feels like I have been given at least 1 million naira (local currency). Everyone craves rest after toiling all day. Without the net here, one can rarely get that desired rest. Mosquitoes are an enemy of good sleep. And without a good sleep, I wake up feeling sick.” As the interview unwinds, Aisha cuddles her baby, Nasiru Yusuf, closer to her ribs, allowing him to wriggle his feet around her waist. He thumped her blouse, trying to get into her nipple. Seeing his attempts ignored, Nasiru Yusuf, began to sniffle and kick. He is prone to malaria, as are the rest of the kids. She hopes that the new nets will reverse the trend and save on medical bills. Aisha Lawal with her child, holds free mosquito delivered to her household during a door-to-door mosquito distribution in Gabasawa, Kano, Nigeria. Aisha is impressed by the format adopted in this campaign. She thinks the house-to-house approach is more efficient than the past model of depositing the nets in a pickup center. More than eight million nets are expected to reach at least 16 million residents in this year’s campaign, making it arguably the largest ever in the world. But she has one bright idea, which might create a bigger impact. Women, she says, are the health managers of their families. In northern Nigeria, where most rural women are uneducated, Aisha says households’ handling of malaria, despite the nets, can be compromised. “More mothers need to be educated. The more education mothers have, the more they can play a role in their family’s health. Mothers are the protectors of the family. Once women are empowered, the communities will remain healthy,” she says. Deadly malaria Each night, as Yusuf Basira closes her eyes to sleep, she dreams of Maila Baila, her two-year-old child laid to rest a few weeks ago. “I always remember him,” says Basira, her face lowered to conceal her dark eyeballs, which have grown red and teary. In the morning of 25 October, Maila Baila experienced a severe malaria fever, which marked the beginning of his death. Basira took her child to Khalifa Sheikh Isyaku Rabiu Paediatric Hospital after two failed attempts at nearby primary health centers to stabilize him. The pediatrician diagnosed severe malaria, which resulted in multiple convulsions. A few hours after their arrival at the hospital, Maila’s body grew cold, and his eyes lost light. The doctors confirmed his death. Basira is among the 16 million residents of Kano who will benefit from the 2022 net campaign, which aims to provide more than eight million nets for households in the state. As she receives the nets, nostalgia returns, bringing with it regrets but also lessons. Prior to Biala’s death, she believed that malaria, though common and costly, was not deadly. Her attitude towards net use was carefree. She now has a new perspective, both from her past mistakes and the brief pep talk that is offered by the net distribution team. “I didn’t have much knowledge about malaria prior to the death of my baby. I never expected it to cause the death of a child. I now know that malaria can cause severe fever, even to the extent of killing a child. I take each sleeping child to the net once it’s past 6 pm. Reporting for this story was supported by the Global Fund. Image Credits: Global Fund. Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan Fight the Fakes held an event in Geneva to highlight the dangers of falsified medicine. There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake medicine and the threat it poses to patients. In October, 99 children died in Indonesia from cough syrup contaminated with anti-freeze chemicals. The previous month, 66 children died in The Gambia – also from contaminated cough syrup. These tragedies echo the deaths of 12 Indian children in 2020 – from cough syrup that had been rendered poisonous after one of the ingredients was replaced by a toxic one. Yet, said Sehmi, most countries treated falsified medicines as a commercial crime such as “product liability or negligence” when they should be treating it “in the same way as narcotics”. “Trust is at the heart of everything. Patients have to trust that the product they’re getting is of the appropriate quality and safety,” said Pernette Esteve, who heads the World Health Organization’s (WHO) team on substandard and falsified medical products. “Gaining the confidence of the public once you’ve lost it is very difficult. Think back to the COVID pandemic. Making sure that people trusted the vaccines, vaccine acceptability, was a key point.” For 10 years, the WHO has been building a database of substandard (unintentionally defective) and falsified (deliberately altered) medicine to understand the scope, scale and harm. From this database, the WHO has identified the three driving forces: lack of access to medicine, poor governance including corruption, and weak technical capacity, said Esteve. The WHO’s response was based on “prevention, detection and response”, she added. The extent of the problem Stanislav Barro, Novartis’s global head of anti-falsified medicines, says that his company has confronted fake medicine in every region of the world. The timely authentication of medicines was both the biggest challenge and the biggest opportunity to stamp out fakes, he said – but warned that it is “a very complicated process”. All the suspect samples have to be brought to a place where they can be actually properly authenticated using forensic means,” said Barro. However, almost 50 pharmaceutical companies were now sharing data via the Pharmaceutical Security Institute, and there had been a 38% increase in the incidence of falsified medicines between 2016 and 2020 in 142 countries, and incidence had surged in 2021 during the early days of the COVID pandemic. “Basically, this is whatever the criminal organisations can make money with. It doesn’t really matter whether it’s falsified, tampered, stolen, illegally diverted. It’s a bit of everything, quite frankly,” added Barro, noting that it usually meant “terrible news for patients”. “We need to find solutions to leverage digital technologies to localise authentication, identify falsified medicines and make that timely. Cut down these timelines from weeks to basically days, hours if possible, and accelerate the reporting to local authorities and to the WHO.” Policing raw materials Sireesha Yadlapalli, vice president for international government and regulatory affairs for United States Pharmacopeia (USP), called for more policing of raw materials. Medicines are made of two components, the active pharmaceutical ingredients (API) and the inactive ingredients or excipients, including reagents, solvents and items related to the taste or look of the product. There was less stringent policing of the excipients, and these were often where problems arose, Yadlapalli said. “There might be an issue with an ingredient but the manufacturer may not know about that particular issue because he just took the supplier’s word and certificate of analysis at face value, and that’s because raw materials are not being tested when they’re accepted from suppliers,” she added. “Manufacturers need to test the raw materials. Regulations should be put in place requiring testing of these raw materials.” Improving regulatory systems Members of the International Generic and Biosimilar Medicines Association made up to 80% of quality-assured medicines around the world, according to its general secretary, Suzette Kox. “We think that the biggest challenge is weak healthcare systems which includes, of course, the insufficiently resourced regulatory system and quality control. Most countries around the world do not have proper regulatory systems in place, and also no proper competition policies.” Oksana Pyzik, who lectures at the UCL School Pharmacy, said that one of the biggest challenges is a lack of public awareness. Pointing to the proliferation of online medical supply outlets during COVID-19, Pyzik said that many patients didn’t know how to verify legal online pharmacies. “Pharmacists are the last line of defence before patients received those medications and take them home with them. And there’s a real opportunity there for patient education as part of wider public awareness,” she said, adding that this was why educating pharmacists about falsified medicines was essential. In Talk on UHC, NY Senator Raises Concern Over Commoditization of Healthcare 07/12/2022 Maayan Hoffman New York State Senator Jose Gustavo Rivera A New York lawmaker warned fellow parliamentarians on Wednesday to “stay as far away from the private sector as you can” when it comes to healthcare. “The main issue in the United States is that healthcare is commodified,” said New York State Senator Jose Gustavo Rivera. “It is true, the best healthcare is available in the US – that is true if you can afford it. But the majority of Americans cannot [afford it] and instead organize their entire existence around how to find the best insurance. “And I put insurance in quotation marks because having insurance does not guarantee care,” he continued. “The commoditization of healthcare is the way to ensure that the people in your country do not get the care they need and deserve.” Less than half of Americans (40%) rate the quality of healthcare in in their country as very good or good, according to a new survey released by the Beryl Institute – Ipsos PX Pulse. Moreover, despite improvements in access to health insurance following the roll out of the Affordable Care Act in 2010, roughly 30 million Americans of all ages had no health insurance in 2021, according to a report by MoneyGeek. ‘Investments in health … are key’ Rivera spoke at the conclusion of Wednesday’s UNITE Global Summit session on universal health coverage (UHC). The session was hosted by UHC2030 and focused on case studies from throughout the world for how to implement UHC. “UHC means that everyone, everywhere, can access the services they need without facing financial burden,” said UHC2030 Steering Committee Co-chair Gabriela Cuevas Barron from Mexico. “Investments in health and healthier populations are key for wider economic and social benefits.” UHC2030 Steering Committee Co-chair Gabriela Cuevas Barron Examples of efforts to roll out UHC were given from Tanzania, Chile and Zambia. In Tanzania, for example, a UHC bill was supposed to be deliberated on in November of this year. However, according to MP Neema Lugangira, discussions were pushed off after concerns with some of the nuances of the bill were raised during public hearings. “We had several discussions and felt there were concrete issues with the bill So, we, as the parliamentary committee, withdrew the bill for improvement and consideration in the areas raised,” Lugangira said. “We were hoping that by the time I would be standing here, perhaps the bill would have been passed. But in an interesting turn of events, we were able to make sure the government takes the bill back and improves on it before it is tabled in parliament. “This shows the power parliamentarians have to understand the issues and advise the government better,” she concluded. ‘Still some work to do’ Zambia, on the other hand, already rolled out the first stages of a universal health coverage plan, explained MP Givem Katuta in her remarks. The initial stage of the UHC plan includes coverage of primary care, said Katuta. But she noted that the bill was moved forward quickly between 2017 and 2018 and the country knows there is still some work to do. For example, one challenge is that the plan uses the National Health Insurance Management Authority, which works well for people who are employed but creates a gap for those who do not have some kind of job. In addition, while people in urban areas can really take advantage of the plan, including getting care at private hospitals of their choice, this has not yet been the case for those in rural areas. “We are on the right track,” Katuta said. “We are looking forward to other stakeholders coming through to spread its wings to rural areas. The goal is to have full UHC by 2030.” Chile’s representative, Marta Bravo, called on the World Health Organization to support the creation of “harmonized and unified criteria” for universal health coverage . “WHO has a powerful voice that is listened to by our government,” she said. “This is our opportunity to ask WHO to be active in this field.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman, Screenshot. In Heated UNITE Event Session, African MPs Call for Greater Inclusion in Global Fund 07/12/2022 Maayan Hoffman Tanzanian MP Neema Lugangira at the UNITE Global Summit in Lisbon A group of African parliamentarians raised a red flag on Tuesday at the UNITE Global Summit when they told representatives that they felt neglected by the Global Fund to Fight AIDS, Tuberculosis and Malaria, which funds billions of dollars of health services in their countries. “Do African parliamentarians only get involved when we have to make an appeal, when it suits our colleagues?” asked Tanzanian MP Neema Lugangira in her remarks at a session titled “The Global Fund Post 7th Replenishment – The Role of Members of Parliament and Domestic Health Financing.” Lugangira said that she was asked to make a fundraising appeal via video on behalf of the Global Fund to the United Kingdom parliament over the summer believes her intervention added value and played a key role in convincing the UK government to provide a more than $1 billion grant. However, despite being in New York in September during Global Fund’s Replenishment event at which donors pledge money for the next three years, she was not invited to attend. Global Fund instead hosted 18 heads of state and governments and many high-level officials from civil society and the private sector at the 400-person event in the city. Lugangira said that “some of my colleagues in Tanzania were surprised I was not invited” because of the video she provided and her deep commitment to public health in Tanzania. “When it is time for the glorious moment, we are not invited,” she said. Lugangira said that Global Fund could generate increased matching domestic financing and distribute its funds more effectively if it worked closely with parliaments, the way it works with civil society. “Civil society was not chosen by our UK parliamentarians to record a clip and make an appeal to parliament. It was me, a member of the African parliament,” she stressed. “It is powerful when you hear the voice of an African parliamentarian representing her people. “Don’t just use us when it suits you. Include us across the entire chain” Lugangira continued. “Parliamentarians should be involved at all levels and be recognised for the impact and power we have.” ‘Confused and surprised’ “The Global Fund Post 7th Replenishment” session on December 6 at the UNITE Global Summit Lugangira had been asked to speak during a panel hosted by the fund that was meant to celebrate the nearly $16 billion it raised in the fall and to examine the positive impact that the more than $55 billion it distributed over the past 20 years has had on health and saving lives. In Tanzania alone, the Global Fund has invested $3 billion to tackle issues of HIV, TB and malaria between 2002 and 2022. Currently, the fund has four core grants in the country totalling $608 million. According to Lugangira, since the fund became involved in her country, there has been a 68% decrease in HIV and people with the virus and a 68% increase – from 18% to 86% – of individuals with HIV enrolled in treatment programs. But after Lugangira and several other parliamentarians criticised the Global Fund for failing to properly leverage local lawmakers and called on it to shift its paradigm, Scott Boule, the Global Fund’s Senior Specialist for Parliamentary Affairs, said he was left “confused and surprised.” “At least one MP sort of implied a feeling of being only utilised when the Global Fund needs to raise funds,” Boule said, “Global Fund is supposed to be a partnership.” ‘You handcuff us’ Some parliamentarians also expressed concerns over the Global Fund model, which involves establishing a Country Coordinating Mechanism (CCM) committee to help distribute funds. Boule said Global Fund mandates that CCMs have broad representation, including from the government, but also from civil society, such as members of the communities that are impacted by the three core diseases. In some countries, parliamentarians sit on the CCMs, but in many countries they are not asked to do so. Moreover, parliamentarians have been ineligible to receive money to help fund their role on these committees. Zimbabwe’s Ruth Labode is one of those MPs. She is a member of her country’s CCM but said she rarely attends meetings due to lack of transport and funding. She only goes when parliament is in session and she has to be in the capital city for work anyway. Otherwise, “it’s too costly” to take part, she told Health Policy Watch. “The CCM has decided not to fund parliamentarians for meetings while they fund members from the civil society, private or any other sector,” Labode said. “The lack of funding shows that the Global Fund is not committed [to the parliamentarians]. It does not think it needs parliamentarians. And yet, when the time comes for replenishment, they are quick to find parliamentarians to lobby for their purpose.” She told Boule during the discussion that “it is about time you advocate for a parliamentary seat on every CCM in every country… If you told them to have a seat for a parliamentarian, it would happen overnight”. Another complaint was that many parliamentarians are not educated about the work of the Global Fund or its accomplishments, which could help them push for further domestic health financing. “You cannot mobilise resources when you are not informed,” said MP Peter Njume from Cameroon. “You work [directly] with the government and then expect us to ask them to be accountable. But parliamentarians are not involved. “You talk about the importance of democracy,” Njume continued. “We represent democracy, but you handcuff us, you make us become vulnerable and helpless. How do you want us to function?” “To own this agenda, we need to be well informed and educated,” Lugangira similarly added. Njume requested that the Global Fund earmark financing for a parliamentary education program. ‘Healthcare financing is a political decision’ Alex Winch, a member of Global Fund’s Advocacy, Health Financing Team speaks at the UNITE Global Summit in Lisbon Global Fund’s Alex Winch acknowledged that “the financing of healthcare is a political decision.” A specialist on Global Fund’s Advocacy, Health Financing Team, he said it is important to understand that the vast majority of the fund’s resources do come from governments prioritising money. “Eighty percent of funding comes from the G7 and the European commission,” explained Boule. “Eleven percent comes from other governments around the world. And 9% comes from the private sector.” To date, the Global Fund is providing 30% of international financing for HIV, 76% for TB and 63% for malaria. The fund gives more money for the battle against TB and malaria than anyone in the world. In addition, about a third of its funding is now going to reward strengthening underlying health systems. The funding has been effective, at least according to the data. Life expectancy, for example, has increased as a result. In sub-Sahara Africa alone, average life expectancy jumped from 52.3 in 2002 to 66.7 in 2019, in large part because of the fund’s efforts. During 2021 in countries and regions where Global Fund invests, some 12.5 million people were reached with HIV prevention services; 670,000 mothers living with HIV received medicine to keep them alive and prevent transmitting HIV to their babies; another 5.3 million people were tested for TB; 110,000 were given treatment for drug-resistant TB; and 133 million mosquito nets were distributed to protect families from malaria, amongst many other efforts. “All of this is made possible by our replenishment,” Boule told Health Policy Watch. “Every third year, we raise funds for the subsequent three years.” Replenishment this year was held on 21 September in New York. Some 47 public and 27 private sector donors pledged $15.7 billion out of the target of $18 billion that the organisation had set to raise for the 2023-2025 period. Boule said that efforts were continuing to try to fill the gap. ‘We are de-investing in health’ But Zimbabwe’s Daniel Molokele said that while the results are stunning, he believes African governments have become too “dependent” on the Global Fund, which puts 72% of its money towards the continent. “I don’t think it is good for Africa, this over-reliance on the Global Fund,” Molokele said. He said that Global Fund’s filling the gap lets off the hook governments who then do not have to commit to fund health in their own countries. In Zimbabwe, he said, domestic health financing dropped several percentage points in the last year. “We are de-investing in health,” Molokele said. Boule explained that recipient countries are required to provide a certain percentage of matching money to receive a grant from the Global Fund, though he said that the fund is often more flexible with low-income countries about achieving their targets. He said that despite the economic challenges the world is facing in the aftermath of COVID-19 and as the war is raging in Ukraine, the fund did see around a 30% increase across the board in domestic health financing from recipient countries. ‘It was ambitious’ Another concern raised from the floor came from French MP Jean-Francois Mbaye, who expressed “disappointment” that his country invested $1.6 billion towards a goal it thought was $18 billion but that fell short “It was ambitious,” Boule admitted to Health Policy Watch. “We did raise $15.7 and that is by far the largest amount we ever raised.” The gap came from some of Global Fund’s largest donors not increasing their gifts by the 30% that the fund expected. “The United States, Germany, Japan, Canada and the European Commission all did increase by 30%,” Boule said. “France increased by 23% and Italy increased by 15%. “The only country amongst our largest donors that went down was the UK, although it still pledged $1.2 billion,” Boule continued. “So we very much had strong support from our donors, and in particular, our largest donors.” Number of donors for Global Fund’s 7th Replenishment On the other hand, faltering exchange rates, and hosting the replenishment seven months after the start of the Ukraine war amid rising interest rates had a negative impact. To illustrate if the pledging session had been held on February 23, 2022, which is the day Global Fund had its preparatory meeting, because of exchange rates, it would have raised around $857 million more. In general, Winch said that achieving funding in the current fiscal environment is becoming increasingly more challenging. He cited a recent report by the World Bank that highlighted how even more countries will find it hard to invest in health or in even sustain existing levels of health investment. He said that “an uncertain global macro-economic environment threatens domestic financing for health.” ‘We need to crowd more resources into health’ Boule said that he plans to take some of the parliamentarians’ concerns back to Geneva, such as providing resources for parliamentarians to sit on CCMs and perhaps developing a fixed parliamentary position on the committees. “I wasn’t aware of the point that Honorable Ruth Labode was making from Zimbabwe, that other members of the CCMs received some sort of support and she did not,” Boule said. He also said he would be interested in finding ways to better involve parliamentary feedback as another means to ensure that the fund is asking the right questions and distributing resources in an optimal way. “Our good results are due to a lot of African political leaders, including parliamentarians, really building and sustaining political will to prioritise health,” Boule said. “It is even harder now with food insecurity, debt crisis and rising interest rates. But we are making the point that even now we need to crowd more resources into health.” Image Credits: Maayan Hoffman, Screenshot. US Wants WTO to Delay Decision on TRIPS Waiver Extension for COVID-19 Tests and Treatment 06/12/2022 Kerry Cullinan US Trade Representative Katherine Tai The US Trade Representative’s (USTR) office announced on Tuesday that it supports extending the deadline on whether the World Trade Organization’s (WTO) Ministerial Decision on the TRIPS Agreement should be extended to COVID-19 diagnostics and therapeutics. Trade ministers adopted the Ministerial Decision on the TRIPS Agreement in June, giving members scope to diversify the production of COVID-19 vaccines and override the exclusive effect of patents through a targeted waiver over the next five years. The TRIPS Council has been discussing whether this should be extended to COVID-19 diagnostics and therapeutics. The US decision was informed by wide-ranging consultations over the past five months with over 24 groups with opposing views on the issue, the USTR said in a statement. While all these groups “shared a concern with saving lives, and with striking a balance between the need to promote innovation in these sectors and the need to promote access to the products of innovation”, there were “key differences”. In light of the differing views, the USTR will ask the US International Trade Commission (USITC) to “launch an investigation into COVID-19 diagnostics and therapeutics and provide information on market dynamics to help inform the discussion around supply and demand, price points, the relationship between testing and treating, and production and access”, the USTR said in a statement. “Over the past five months, USTR officials held robust and constructive consultations with Congress, government experts, a wide range of stakeholders, multilateral institutions, and WTO Members,” said Ambassador Katherine Tai. “Real questions remain on a range of issues, and the additional time, coupled with information from the USITC, will help the world make a more informed decision on whether extending the Ministerial Decision to COVID-19 therapeutics and diagnostics would result in increased access to those products,” added Tai. “Transparency is critical and USTR will continue to consult with Congress, stakeholders, and others as we continue working to end the pandemic and support the global economic recovery.” Those in favour of extending the Ministerial agreement “acknowledge a lack of global demand for COVID-19 products, but they believe that market dynamics are suppressing effective demand”, according to the USTR. Opponents’ concerns include that the extension would “allow countries with anti-competitive approaches to innovation, such as China” to “unfairly obtain and use American innovation to benefit their domestic economies”, harming “American industry and workers by undermining investment and research and development”. The USITC study will explore key issues including: An overview of the products, focusing on WHO-approved COVID-19 diagnostics and therapeutics, including key components, the production process, intellectual property protections, and the supply chain (including the level of diversification in the supply chain); The global manufacturing industry for these products, including information on key producing countries, major firms, and production data, if available; The global market for COVID-19 diagnostics and therapeutics, including information on demand and, to the extent practicable, an assessment of where unmet demand exists for key products and contributing factors; market segmentation; and supply accumulation and distribution; Data and information on global trade in COVID-19 diagnostics and therapeutics, if available, or if not, data and information on global trade in diagnostics and therapeutics generally; and A brief overview of the relevant aspects of the TRIPS Agreement and the UN Medicine Patent Pool (MPP) and a listing of countries seeking to use the Ministerial Decision and those utilizing access to COVID-19 medicines under the MPP. Meanwhile, the US reaffirmed the right of its trading partners to “exercise the full range of existing flexibilities in the TRIPS Agreement, such as in Articles 30, 31, and 31bis, and the Doha Declaration on the TRIPS Agreement and Public Health, as well as the flexibilities in the Ministerial Decision”. ‘Multilateralism’ Essential in Battle Against Pandemics, Says President of Portuguese Parliament 06/12/2022 Maayan Hoffman Augusto Santos Silva, president of the Portuguese parliament The battle against pandemics can only be won through multilateralism, according to Augusto Santos Silva, president of the Portuguese parliament. During a keynote address at the UNITE Global Summit on Tuesday, Silva stressed that “viruses and bacteria know no borders. They do not have to show passports and they are not subject to border control. “To manage [a fast response] requires the efforts of all of us – requires multilateralism,” he said. Silvo, a sociologist and university professor, who has served as president since 2002, told the crowd of more than 30 parliamentarians from around the world and several health officials that “the role of parliamentarians is irreplaceable.” Silvo spoke from the center of the Senate Chamber. He said “the COVID-19 pandemic taught us that we should be prepared for the unexpected,” including “what may come up when we least expect it and, in the form, we least expect it to happen.” He called on governments to have deep ties with scientists and professionals in the health arena, but admitted that ultimately, they cannot run the country in the time of a health crisis. Only politicians, he said, can evaluate issues of the economy and democracy alongside health. “There is not an expert that waves us from our moral and political responsibilities,” Silvo said. The theme of the UNITE event, which kicked off on Monday and runs through Wednesday evening, is “from pandemic to prosperity.” He said that “I like the optimistic tone of this theme” but that parliamentarians must be attuned to the challenges that their countries face. Healthcare, he noted, is one of the objectives of the United Nations’ Sustainable Development Goals, but “we all know that the 17 SDGs are interdependent.” Now, he said, is the time for parliamentarians to evaluate their governments’ efforts toward achieving these SDGs and to redirect them if they are off on their goals. “We have to assess what we have achieved so far, to consolidate these achievements, and correct what has to be corrected or whatever is lagging behind,” Silvo said. “This is also work that is up to parliamentarians to do.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman. Indonesia Bans Extramarital Sex 06/12/2022 Kerry Cullinan Indonesia’s parliament passed a new criminal code that bans extramarital sex and criminalises abortion except for rape survivors on Tuesday, Reuters reports. The code applies to both citizens and visitors, and those who have sex outside marriage face up to a year in prison. Indonesia’s economy is heavily dependent on tourism and its tourism industry has warned that the code could dampen enthusiasm from international tourists. However, pre- and extra-marital sex can only be reported by close relatives: a parent, child or spouse. There has been speculation that the code will be used particularly to prosecute LGBTQ people. Same-sex marriage is banned in the predominantly Muslim country, which has become increasingly conservative in the past few years. The new code also prohibits anyone from insulting Indonesia’s president (transgressors face up to three years in prison), spreading views that contradict state ideology, “black magic”, and staging protests without permission. The code was passed unanimously and replaces a code adopted after Indonesia’s independence from the Netherlands in 1946. However, it is expected to only come into force in three years’ time once regulations have been drawn up to enforce its provisions. The country tried to pass the code in 2019 but faced protests, particularly from students. About 100 people reportedly gathered outside the parliament in Jakarta to protest against the code. Image Credits: Nick Agus Arya/ Unsplash. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World’s Biggest Malaria Bed-net Campaign Unfurls in Nigeria 08/12/2022 Orji Sunday Hassana Sa-adu with her children, holds a free mosquito delivered to her household during a door-to-door mosquito distribution in Gabasawa in Kano State, Nigeria. A massive campaign is underway to distribute at least 8.8 million nets to 16 million residents of Kano State in Nigeria to prevent malaria Morning sunlight, bright as a dazzling diamond, sets Mazangudu village in Kano, northern Nigeria, awake. Motorcycle rumbles mix with the boom of microphones calling Muslims to salat prayer. A gentle breeze tickles the green leaves of nearby neem trees, easing the rising warmth with its chill. Behind the curtain of a one-room bungalow, a whisper, a cup of tea, and a smile pass between Yau Mustapha and his wife. Fourty-five-year-old Mustapha gulps the dregs of the tea in his ceramic cup before heading out with his motorcycle. As he rides through Mazangudu, a small farm settlement, mud huts and fumes unfurl behind his stretched shadows. Thousands of volunteers The settlement is a blend of mud huts and cement-walled houses. The mud huts are roundly shaped and made of colored clay. Its thatched roof, spread out like a beach hat, is made of dried millet stalks, stringed into a firm shape. Once settled, Mustapha consults with the rickshaw puller, the educator, and security, all members of his team. Now, they move from house to house, waking residents with an echo of their greetings and a hard tap at the door. “Peace be unto you,” he shouts routinely. “We are to deliver nets to you and your family, so you are fully protected from malaria.” Mustapha is not alone. Across Kano, for a period of two weeks, thousands of trained volunteers would distribute insecticide-treated mosquito nets to millions of Kano residents. “These nets will help my people; they will protect them,” says Mustapha. Residents in Mazangudu believe the chances of a pregnant woman and her children surviving sudden malaria fever attack at midnight are slim. “Many have died as a result of malaria situations,” says Ibrahim Salie, an herbalist in nearby Gwaza. Salie says the community sometimes relies on herbs to manage malaria infections, but the outcome is always a gamble. Unfortunately, the nemeses of Gwaza and Mazangudu are not one-offs. Nigeria, with over 200,000 malaria deaths annually, accounts for more than a quarter of all cases in Africa. The highest burden occurs in northern states like Kano, where poverty, combined with widespread apathy and poor sanitation, increases the risk of infection. Problematic pregnant women? Mustapha Yau, a mosquito net mobilizer and distributor giving a beneficiary mosquito nets in Gabasawa, Kano. One sunset in late September, Mustapha’s wife, a health worker in a nearby village, narrated her experiences with malaria infecting pregnant mothers. “My wife told me that malaria in pregnant women can be more violent and problematic,” says Mustapha. Many nights later, the burden of that single story remained with Mustapha. After a radio jingle announced the upcoming net campaign a few weeks ago, his wife pursued him to enrol as a volunteer. This morning, as he sets out to distribute the nets from house to house, a warm goodbye and smile pass between him and his wife, who wore a long yellow veil. Mustapha is expected to distribute at least 2,800 insecticide-treated mosquito nets to hundreds of households within a period of two weeks. In all, more than 8 million nets will be distributed in Kano to at least 16 million residents. Only two days of the two weeks have passed. However, Mustapha can attest to the dramatic shift in his fame as well as the immediate use of the nets after only two days on duty. “My wife is very happy. She is happy to see her husband greatly involved in an important campaign.” Better than traditional remedies Mazangudu’s residents say the nets are twice as helpful to them as they might have been to any other community because there is no single health facility to cater to the many malaria cases. And when these malaria attacks come by midnight, the only option is to offer traditional remedies and pray. In some cases, the infected person dies before dawn. With financial backing from The Global Fund, this year’s campaign, arguably the largest in Africa, aims to distribute at least 8.8 million nets to 16 million residents of Kano, one of the largest cities in Africa. “Kano is crucial because of the size. Kano, because of its population, looks like a country. If you are fighting malaria and Kano is not in the plan, it is a waste of time,” says Ernest Nwaokolo, the project director for the Global Fund Malaria Project of the Society for Family Health (SFH). SFH’s John Ocholi, who is the manager of the 2022 nets campaign in Kano, says that the state has 44 local governments and 484 wards. “We are working with over 20,000 personnel, which is the most for any Nigerian campaign. It is a large team, drawn from various partners and parts of the country. It takes a lot of experience to pull together to achieve this. We had advocacy visits to the government of Kano State, traditional rulers, and religious bodies in an effort to pull them into the campaign.” Delivery: from camels to canoes Ismail Yusuf and Awalu Iliasu inspect the offloading of mosquito nets bales. Educators trained in behavioral change communication work closely with the house-to-house distributor team. Before the nets are distributed to the households, each family has a brief discussion about net apathy, proper use, trading, and maintenance. More so, community and religious leaders, often revered and obeyed, have been engaged as partners in spreading and reinforcing the net-use messages. Kano has proven to be a bigger puzzle from a logistics point of view. In the absence of precise figures, Chemonics, a global consulting firm that manages logistics for the campaign, says thousands of vehicles and personnel were involved. It is like a pyramid. Nets are moved to local government areas on larger trucks and trailers. Next, the nets are then transported from local government areas in smaller vans and mini trucks. Roads to communities are often narrower and, in some cases, untarred, making smaller vans more suited for moving nets. As the nets move from house to house, the options for transporting them become more diverse and adaptable. In some desert communities, where the risk of sandstorms is higher, and cars sink in sand, camels, donkeys, and cow-carts have been deployed to move the nets to households and between settlements and communities. In a few riverine areas, canoes and paddlers are used. In areas pockmarked by mountains and hills, engage porters. Each distributor is trained and handed a mobile device with an app that allows them to enter records of the number of nets issued per household, the coordinates of the area, and the names of the recipients, often the household head. Digital tracking The data is then uploaded to a central database, which is monitored and analyzed every evening to ascertain the number of nets distributed for the day, absentees, and locations covered. Organizers receive real-time updates from all over Kano. “There is real-time tracking and monitoring of all data in the field.” It is easier to dictate areas where there are issues that deserve urgent attention. It is also faster than using papers and tally sheets. “It makes it easier to provide evidence and verify the work done,” says Asuni. The technology is also designed to flag areas where there is unusually dense or sparse net distribution. When such issues are flagged, monitors are sent to the flagged locations to verify the situation on the ground. On paper, the process sounds smooth, but Asuni says that the Kano campaign presented a couple of familiar issues. Many volunteers are not computer literate and frequently struggle with basic device setup. Secondly, limited network coverage, especially in rural communities, means that data uploads to the central server are delayed and backlogged. Volunteers undergo intense training on device use. Aisha Aliyi Danyar, a mobilisation and distribution team member, is receiving training in Gabasaw LGA, Kano, Nigeria, on how to engage beneficiaries in mosquito net distribution. However, not every ambition can be squeezed into the short timeframe of the net campaign. There are still minimal concerns that net collection is rarely equivalent to use. Some residents say the nets restrict their breathing and have limited ventilation. Myths that link white nets to corpses also build stereotypes that hinder net use. “Fixing these issues can be gradual and long,” says Nwaokolo. Back in Mazangudu, the fruits of Mustapha’s work are instant. Families, who received the nets a few days ago are already putting them to use. They say these nets, more than ever, will ease their burden. The fame of Mustapha grows with every new inch he covers. “My people see me as a hero,” he says. But it’s not the heroism that makes him happy; it’s the lives that will be saved and the medical bills that will be avoided. “This net distribution has brought excitement. “The people are grateful,” says Mustapha. “And no amount invested in mosquito nets is too big. To save a single life is worth more than millions, for we really do not know what the children we are saving today might turn out to be in the future.” Better than a wedding When Aisha Lawal, 35, had to choose between attending a friend’s wedding and staying behind to pick her nets, it was an easy choice. “I didn’t want to miss [the nets],” she says. “If I choose weddings over nets, how would my household sleep peacefully? I have been expecting the new net since two days ago.” Aisha and her family of eight live at Sabon-Gari, Gabasawa, on the outskirts of Kano metropolis, where malaria is rampant. Long lines form at health centers from time to time, she claims. Her own family is also exposed. The last set of nets that came to them three years ago are discolored, torn, and pockmarked. “Receiving these nets feels like I have been given at least 1 million naira (local currency). Everyone craves rest after toiling all day. Without the net here, one can rarely get that desired rest. Mosquitoes are an enemy of good sleep. And without a good sleep, I wake up feeling sick.” As the interview unwinds, Aisha cuddles her baby, Nasiru Yusuf, closer to her ribs, allowing him to wriggle his feet around her waist. He thumped her blouse, trying to get into her nipple. Seeing his attempts ignored, Nasiru Yusuf, began to sniffle and kick. He is prone to malaria, as are the rest of the kids. She hopes that the new nets will reverse the trend and save on medical bills. Aisha Lawal with her child, holds free mosquito delivered to her household during a door-to-door mosquito distribution in Gabasawa, Kano, Nigeria. Aisha is impressed by the format adopted in this campaign. She thinks the house-to-house approach is more efficient than the past model of depositing the nets in a pickup center. More than eight million nets are expected to reach at least 16 million residents in this year’s campaign, making it arguably the largest ever in the world. But she has one bright idea, which might create a bigger impact. Women, she says, are the health managers of their families. In northern Nigeria, where most rural women are uneducated, Aisha says households’ handling of malaria, despite the nets, can be compromised. “More mothers need to be educated. The more education mothers have, the more they can play a role in their family’s health. Mothers are the protectors of the family. Once women are empowered, the communities will remain healthy,” she says. Deadly malaria Each night, as Yusuf Basira closes her eyes to sleep, she dreams of Maila Baila, her two-year-old child laid to rest a few weeks ago. “I always remember him,” says Basira, her face lowered to conceal her dark eyeballs, which have grown red and teary. In the morning of 25 October, Maila Baila experienced a severe malaria fever, which marked the beginning of his death. Basira took her child to Khalifa Sheikh Isyaku Rabiu Paediatric Hospital after two failed attempts at nearby primary health centers to stabilize him. The pediatrician diagnosed severe malaria, which resulted in multiple convulsions. A few hours after their arrival at the hospital, Maila’s body grew cold, and his eyes lost light. The doctors confirmed his death. Basira is among the 16 million residents of Kano who will benefit from the 2022 net campaign, which aims to provide more than eight million nets for households in the state. As she receives the nets, nostalgia returns, bringing with it regrets but also lessons. Prior to Biala’s death, she believed that malaria, though common and costly, was not deadly. Her attitude towards net use was carefree. She now has a new perspective, both from her past mistakes and the brief pep talk that is offered by the net distribution team. “I didn’t have much knowledge about malaria prior to the death of my baby. I never expected it to cause the death of a child. I now know that malaria can cause severe fever, even to the extent of killing a child. I take each sleeping child to the net once it’s past 6 pm. Reporting for this story was supported by the Global Fund. Image Credits: Global Fund. Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan Fight the Fakes held an event in Geneva to highlight the dangers of falsified medicine. There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake medicine and the threat it poses to patients. In October, 99 children died in Indonesia from cough syrup contaminated with anti-freeze chemicals. The previous month, 66 children died in The Gambia – also from contaminated cough syrup. These tragedies echo the deaths of 12 Indian children in 2020 – from cough syrup that had been rendered poisonous after one of the ingredients was replaced by a toxic one. Yet, said Sehmi, most countries treated falsified medicines as a commercial crime such as “product liability or negligence” when they should be treating it “in the same way as narcotics”. “Trust is at the heart of everything. Patients have to trust that the product they’re getting is of the appropriate quality and safety,” said Pernette Esteve, who heads the World Health Organization’s (WHO) team on substandard and falsified medical products. “Gaining the confidence of the public once you’ve lost it is very difficult. Think back to the COVID pandemic. Making sure that people trusted the vaccines, vaccine acceptability, was a key point.” For 10 years, the WHO has been building a database of substandard (unintentionally defective) and falsified (deliberately altered) medicine to understand the scope, scale and harm. From this database, the WHO has identified the three driving forces: lack of access to medicine, poor governance including corruption, and weak technical capacity, said Esteve. The WHO’s response was based on “prevention, detection and response”, she added. The extent of the problem Stanislav Barro, Novartis’s global head of anti-falsified medicines, says that his company has confronted fake medicine in every region of the world. The timely authentication of medicines was both the biggest challenge and the biggest opportunity to stamp out fakes, he said – but warned that it is “a very complicated process”. All the suspect samples have to be brought to a place where they can be actually properly authenticated using forensic means,” said Barro. However, almost 50 pharmaceutical companies were now sharing data via the Pharmaceutical Security Institute, and there had been a 38% increase in the incidence of falsified medicines between 2016 and 2020 in 142 countries, and incidence had surged in 2021 during the early days of the COVID pandemic. “Basically, this is whatever the criminal organisations can make money with. It doesn’t really matter whether it’s falsified, tampered, stolen, illegally diverted. It’s a bit of everything, quite frankly,” added Barro, noting that it usually meant “terrible news for patients”. “We need to find solutions to leverage digital technologies to localise authentication, identify falsified medicines and make that timely. Cut down these timelines from weeks to basically days, hours if possible, and accelerate the reporting to local authorities and to the WHO.” Policing raw materials Sireesha Yadlapalli, vice president for international government and regulatory affairs for United States Pharmacopeia (USP), called for more policing of raw materials. Medicines are made of two components, the active pharmaceutical ingredients (API) and the inactive ingredients or excipients, including reagents, solvents and items related to the taste or look of the product. There was less stringent policing of the excipients, and these were often where problems arose, Yadlapalli said. “There might be an issue with an ingredient but the manufacturer may not know about that particular issue because he just took the supplier’s word and certificate of analysis at face value, and that’s because raw materials are not being tested when they’re accepted from suppliers,” she added. “Manufacturers need to test the raw materials. Regulations should be put in place requiring testing of these raw materials.” Improving regulatory systems Members of the International Generic and Biosimilar Medicines Association made up to 80% of quality-assured medicines around the world, according to its general secretary, Suzette Kox. “We think that the biggest challenge is weak healthcare systems which includes, of course, the insufficiently resourced regulatory system and quality control. Most countries around the world do not have proper regulatory systems in place, and also no proper competition policies.” Oksana Pyzik, who lectures at the UCL School Pharmacy, said that one of the biggest challenges is a lack of public awareness. Pointing to the proliferation of online medical supply outlets during COVID-19, Pyzik said that many patients didn’t know how to verify legal online pharmacies. “Pharmacists are the last line of defence before patients received those medications and take them home with them. And there’s a real opportunity there for patient education as part of wider public awareness,” she said, adding that this was why educating pharmacists about falsified medicines was essential. In Talk on UHC, NY Senator Raises Concern Over Commoditization of Healthcare 07/12/2022 Maayan Hoffman New York State Senator Jose Gustavo Rivera A New York lawmaker warned fellow parliamentarians on Wednesday to “stay as far away from the private sector as you can” when it comes to healthcare. “The main issue in the United States is that healthcare is commodified,” said New York State Senator Jose Gustavo Rivera. “It is true, the best healthcare is available in the US – that is true if you can afford it. But the majority of Americans cannot [afford it] and instead organize their entire existence around how to find the best insurance. “And I put insurance in quotation marks because having insurance does not guarantee care,” he continued. “The commoditization of healthcare is the way to ensure that the people in your country do not get the care they need and deserve.” Less than half of Americans (40%) rate the quality of healthcare in in their country as very good or good, according to a new survey released by the Beryl Institute – Ipsos PX Pulse. Moreover, despite improvements in access to health insurance following the roll out of the Affordable Care Act in 2010, roughly 30 million Americans of all ages had no health insurance in 2021, according to a report by MoneyGeek. ‘Investments in health … are key’ Rivera spoke at the conclusion of Wednesday’s UNITE Global Summit session on universal health coverage (UHC). The session was hosted by UHC2030 and focused on case studies from throughout the world for how to implement UHC. “UHC means that everyone, everywhere, can access the services they need without facing financial burden,” said UHC2030 Steering Committee Co-chair Gabriela Cuevas Barron from Mexico. “Investments in health and healthier populations are key for wider economic and social benefits.” UHC2030 Steering Committee Co-chair Gabriela Cuevas Barron Examples of efforts to roll out UHC were given from Tanzania, Chile and Zambia. In Tanzania, for example, a UHC bill was supposed to be deliberated on in November of this year. However, according to MP Neema Lugangira, discussions were pushed off after concerns with some of the nuances of the bill were raised during public hearings. “We had several discussions and felt there were concrete issues with the bill So, we, as the parliamentary committee, withdrew the bill for improvement and consideration in the areas raised,” Lugangira said. “We were hoping that by the time I would be standing here, perhaps the bill would have been passed. But in an interesting turn of events, we were able to make sure the government takes the bill back and improves on it before it is tabled in parliament. “This shows the power parliamentarians have to understand the issues and advise the government better,” she concluded. ‘Still some work to do’ Zambia, on the other hand, already rolled out the first stages of a universal health coverage plan, explained MP Givem Katuta in her remarks. The initial stage of the UHC plan includes coverage of primary care, said Katuta. But she noted that the bill was moved forward quickly between 2017 and 2018 and the country knows there is still some work to do. For example, one challenge is that the plan uses the National Health Insurance Management Authority, which works well for people who are employed but creates a gap for those who do not have some kind of job. In addition, while people in urban areas can really take advantage of the plan, including getting care at private hospitals of their choice, this has not yet been the case for those in rural areas. “We are on the right track,” Katuta said. “We are looking forward to other stakeholders coming through to spread its wings to rural areas. The goal is to have full UHC by 2030.” Chile’s representative, Marta Bravo, called on the World Health Organization to support the creation of “harmonized and unified criteria” for universal health coverage . “WHO has a powerful voice that is listened to by our government,” she said. “This is our opportunity to ask WHO to be active in this field.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman, Screenshot. In Heated UNITE Event Session, African MPs Call for Greater Inclusion in Global Fund 07/12/2022 Maayan Hoffman Tanzanian MP Neema Lugangira at the UNITE Global Summit in Lisbon A group of African parliamentarians raised a red flag on Tuesday at the UNITE Global Summit when they told representatives that they felt neglected by the Global Fund to Fight AIDS, Tuberculosis and Malaria, which funds billions of dollars of health services in their countries. “Do African parliamentarians only get involved when we have to make an appeal, when it suits our colleagues?” asked Tanzanian MP Neema Lugangira in her remarks at a session titled “The Global Fund Post 7th Replenishment – The Role of Members of Parliament and Domestic Health Financing.” Lugangira said that she was asked to make a fundraising appeal via video on behalf of the Global Fund to the United Kingdom parliament over the summer believes her intervention added value and played a key role in convincing the UK government to provide a more than $1 billion grant. However, despite being in New York in September during Global Fund’s Replenishment event at which donors pledge money for the next three years, she was not invited to attend. Global Fund instead hosted 18 heads of state and governments and many high-level officials from civil society and the private sector at the 400-person event in the city. Lugangira said that “some of my colleagues in Tanzania were surprised I was not invited” because of the video she provided and her deep commitment to public health in Tanzania. “When it is time for the glorious moment, we are not invited,” she said. Lugangira said that Global Fund could generate increased matching domestic financing and distribute its funds more effectively if it worked closely with parliaments, the way it works with civil society. “Civil society was not chosen by our UK parliamentarians to record a clip and make an appeal to parliament. It was me, a member of the African parliament,” she stressed. “It is powerful when you hear the voice of an African parliamentarian representing her people. “Don’t just use us when it suits you. Include us across the entire chain” Lugangira continued. “Parliamentarians should be involved at all levels and be recognised for the impact and power we have.” ‘Confused and surprised’ “The Global Fund Post 7th Replenishment” session on December 6 at the UNITE Global Summit Lugangira had been asked to speak during a panel hosted by the fund that was meant to celebrate the nearly $16 billion it raised in the fall and to examine the positive impact that the more than $55 billion it distributed over the past 20 years has had on health and saving lives. In Tanzania alone, the Global Fund has invested $3 billion to tackle issues of HIV, TB and malaria between 2002 and 2022. Currently, the fund has four core grants in the country totalling $608 million. According to Lugangira, since the fund became involved in her country, there has been a 68% decrease in HIV and people with the virus and a 68% increase – from 18% to 86% – of individuals with HIV enrolled in treatment programs. But after Lugangira and several other parliamentarians criticised the Global Fund for failing to properly leverage local lawmakers and called on it to shift its paradigm, Scott Boule, the Global Fund’s Senior Specialist for Parliamentary Affairs, said he was left “confused and surprised.” “At least one MP sort of implied a feeling of being only utilised when the Global Fund needs to raise funds,” Boule said, “Global Fund is supposed to be a partnership.” ‘You handcuff us’ Some parliamentarians also expressed concerns over the Global Fund model, which involves establishing a Country Coordinating Mechanism (CCM) committee to help distribute funds. Boule said Global Fund mandates that CCMs have broad representation, including from the government, but also from civil society, such as members of the communities that are impacted by the three core diseases. In some countries, parliamentarians sit on the CCMs, but in many countries they are not asked to do so. Moreover, parliamentarians have been ineligible to receive money to help fund their role on these committees. Zimbabwe’s Ruth Labode is one of those MPs. She is a member of her country’s CCM but said she rarely attends meetings due to lack of transport and funding. She only goes when parliament is in session and she has to be in the capital city for work anyway. Otherwise, “it’s too costly” to take part, she told Health Policy Watch. “The CCM has decided not to fund parliamentarians for meetings while they fund members from the civil society, private or any other sector,” Labode said. “The lack of funding shows that the Global Fund is not committed [to the parliamentarians]. It does not think it needs parliamentarians. And yet, when the time comes for replenishment, they are quick to find parliamentarians to lobby for their purpose.” She told Boule during the discussion that “it is about time you advocate for a parliamentary seat on every CCM in every country… If you told them to have a seat for a parliamentarian, it would happen overnight”. Another complaint was that many parliamentarians are not educated about the work of the Global Fund or its accomplishments, which could help them push for further domestic health financing. “You cannot mobilise resources when you are not informed,” said MP Peter Njume from Cameroon. “You work [directly] with the government and then expect us to ask them to be accountable. But parliamentarians are not involved. “You talk about the importance of democracy,” Njume continued. “We represent democracy, but you handcuff us, you make us become vulnerable and helpless. How do you want us to function?” “To own this agenda, we need to be well informed and educated,” Lugangira similarly added. Njume requested that the Global Fund earmark financing for a parliamentary education program. ‘Healthcare financing is a political decision’ Alex Winch, a member of Global Fund’s Advocacy, Health Financing Team speaks at the UNITE Global Summit in Lisbon Global Fund’s Alex Winch acknowledged that “the financing of healthcare is a political decision.” A specialist on Global Fund’s Advocacy, Health Financing Team, he said it is important to understand that the vast majority of the fund’s resources do come from governments prioritising money. “Eighty percent of funding comes from the G7 and the European commission,” explained Boule. “Eleven percent comes from other governments around the world. And 9% comes from the private sector.” To date, the Global Fund is providing 30% of international financing for HIV, 76% for TB and 63% for malaria. The fund gives more money for the battle against TB and malaria than anyone in the world. In addition, about a third of its funding is now going to reward strengthening underlying health systems. The funding has been effective, at least according to the data. Life expectancy, for example, has increased as a result. In sub-Sahara Africa alone, average life expectancy jumped from 52.3 in 2002 to 66.7 in 2019, in large part because of the fund’s efforts. During 2021 in countries and regions where Global Fund invests, some 12.5 million people were reached with HIV prevention services; 670,000 mothers living with HIV received medicine to keep them alive and prevent transmitting HIV to their babies; another 5.3 million people were tested for TB; 110,000 were given treatment for drug-resistant TB; and 133 million mosquito nets were distributed to protect families from malaria, amongst many other efforts. “All of this is made possible by our replenishment,” Boule told Health Policy Watch. “Every third year, we raise funds for the subsequent three years.” Replenishment this year was held on 21 September in New York. Some 47 public and 27 private sector donors pledged $15.7 billion out of the target of $18 billion that the organisation had set to raise for the 2023-2025 period. Boule said that efforts were continuing to try to fill the gap. ‘We are de-investing in health’ But Zimbabwe’s Daniel Molokele said that while the results are stunning, he believes African governments have become too “dependent” on the Global Fund, which puts 72% of its money towards the continent. “I don’t think it is good for Africa, this over-reliance on the Global Fund,” Molokele said. He said that Global Fund’s filling the gap lets off the hook governments who then do not have to commit to fund health in their own countries. In Zimbabwe, he said, domestic health financing dropped several percentage points in the last year. “We are de-investing in health,” Molokele said. Boule explained that recipient countries are required to provide a certain percentage of matching money to receive a grant from the Global Fund, though he said that the fund is often more flexible with low-income countries about achieving their targets. He said that despite the economic challenges the world is facing in the aftermath of COVID-19 and as the war is raging in Ukraine, the fund did see around a 30% increase across the board in domestic health financing from recipient countries. ‘It was ambitious’ Another concern raised from the floor came from French MP Jean-Francois Mbaye, who expressed “disappointment” that his country invested $1.6 billion towards a goal it thought was $18 billion but that fell short “It was ambitious,” Boule admitted to Health Policy Watch. “We did raise $15.7 and that is by far the largest amount we ever raised.” The gap came from some of Global Fund’s largest donors not increasing their gifts by the 30% that the fund expected. “The United States, Germany, Japan, Canada and the European Commission all did increase by 30%,” Boule said. “France increased by 23% and Italy increased by 15%. “The only country amongst our largest donors that went down was the UK, although it still pledged $1.2 billion,” Boule continued. “So we very much had strong support from our donors, and in particular, our largest donors.” Number of donors for Global Fund’s 7th Replenishment On the other hand, faltering exchange rates, and hosting the replenishment seven months after the start of the Ukraine war amid rising interest rates had a negative impact. To illustrate if the pledging session had been held on February 23, 2022, which is the day Global Fund had its preparatory meeting, because of exchange rates, it would have raised around $857 million more. In general, Winch said that achieving funding in the current fiscal environment is becoming increasingly more challenging. He cited a recent report by the World Bank that highlighted how even more countries will find it hard to invest in health or in even sustain existing levels of health investment. He said that “an uncertain global macro-economic environment threatens domestic financing for health.” ‘We need to crowd more resources into health’ Boule said that he plans to take some of the parliamentarians’ concerns back to Geneva, such as providing resources for parliamentarians to sit on CCMs and perhaps developing a fixed parliamentary position on the committees. “I wasn’t aware of the point that Honorable Ruth Labode was making from Zimbabwe, that other members of the CCMs received some sort of support and she did not,” Boule said. He also said he would be interested in finding ways to better involve parliamentary feedback as another means to ensure that the fund is asking the right questions and distributing resources in an optimal way. “Our good results are due to a lot of African political leaders, including parliamentarians, really building and sustaining political will to prioritise health,” Boule said. “It is even harder now with food insecurity, debt crisis and rising interest rates. But we are making the point that even now we need to crowd more resources into health.” Image Credits: Maayan Hoffman, Screenshot. US Wants WTO to Delay Decision on TRIPS Waiver Extension for COVID-19 Tests and Treatment 06/12/2022 Kerry Cullinan US Trade Representative Katherine Tai The US Trade Representative’s (USTR) office announced on Tuesday that it supports extending the deadline on whether the World Trade Organization’s (WTO) Ministerial Decision on the TRIPS Agreement should be extended to COVID-19 diagnostics and therapeutics. Trade ministers adopted the Ministerial Decision on the TRIPS Agreement in June, giving members scope to diversify the production of COVID-19 vaccines and override the exclusive effect of patents through a targeted waiver over the next five years. The TRIPS Council has been discussing whether this should be extended to COVID-19 diagnostics and therapeutics. The US decision was informed by wide-ranging consultations over the past five months with over 24 groups with opposing views on the issue, the USTR said in a statement. While all these groups “shared a concern with saving lives, and with striking a balance between the need to promote innovation in these sectors and the need to promote access to the products of innovation”, there were “key differences”. In light of the differing views, the USTR will ask the US International Trade Commission (USITC) to “launch an investigation into COVID-19 diagnostics and therapeutics and provide information on market dynamics to help inform the discussion around supply and demand, price points, the relationship between testing and treating, and production and access”, the USTR said in a statement. “Over the past five months, USTR officials held robust and constructive consultations with Congress, government experts, a wide range of stakeholders, multilateral institutions, and WTO Members,” said Ambassador Katherine Tai. “Real questions remain on a range of issues, and the additional time, coupled with information from the USITC, will help the world make a more informed decision on whether extending the Ministerial Decision to COVID-19 therapeutics and diagnostics would result in increased access to those products,” added Tai. “Transparency is critical and USTR will continue to consult with Congress, stakeholders, and others as we continue working to end the pandemic and support the global economic recovery.” Those in favour of extending the Ministerial agreement “acknowledge a lack of global demand for COVID-19 products, but they believe that market dynamics are suppressing effective demand”, according to the USTR. Opponents’ concerns include that the extension would “allow countries with anti-competitive approaches to innovation, such as China” to “unfairly obtain and use American innovation to benefit their domestic economies”, harming “American industry and workers by undermining investment and research and development”. The USITC study will explore key issues including: An overview of the products, focusing on WHO-approved COVID-19 diagnostics and therapeutics, including key components, the production process, intellectual property protections, and the supply chain (including the level of diversification in the supply chain); The global manufacturing industry for these products, including information on key producing countries, major firms, and production data, if available; The global market for COVID-19 diagnostics and therapeutics, including information on demand and, to the extent practicable, an assessment of where unmet demand exists for key products and contributing factors; market segmentation; and supply accumulation and distribution; Data and information on global trade in COVID-19 diagnostics and therapeutics, if available, or if not, data and information on global trade in diagnostics and therapeutics generally; and A brief overview of the relevant aspects of the TRIPS Agreement and the UN Medicine Patent Pool (MPP) and a listing of countries seeking to use the Ministerial Decision and those utilizing access to COVID-19 medicines under the MPP. Meanwhile, the US reaffirmed the right of its trading partners to “exercise the full range of existing flexibilities in the TRIPS Agreement, such as in Articles 30, 31, and 31bis, and the Doha Declaration on the TRIPS Agreement and Public Health, as well as the flexibilities in the Ministerial Decision”. ‘Multilateralism’ Essential in Battle Against Pandemics, Says President of Portuguese Parliament 06/12/2022 Maayan Hoffman Augusto Santos Silva, president of the Portuguese parliament The battle against pandemics can only be won through multilateralism, according to Augusto Santos Silva, president of the Portuguese parliament. During a keynote address at the UNITE Global Summit on Tuesday, Silva stressed that “viruses and bacteria know no borders. They do not have to show passports and they are not subject to border control. “To manage [a fast response] requires the efforts of all of us – requires multilateralism,” he said. Silvo, a sociologist and university professor, who has served as president since 2002, told the crowd of more than 30 parliamentarians from around the world and several health officials that “the role of parliamentarians is irreplaceable.” Silvo spoke from the center of the Senate Chamber. He said “the COVID-19 pandemic taught us that we should be prepared for the unexpected,” including “what may come up when we least expect it and, in the form, we least expect it to happen.” He called on governments to have deep ties with scientists and professionals in the health arena, but admitted that ultimately, they cannot run the country in the time of a health crisis. Only politicians, he said, can evaluate issues of the economy and democracy alongside health. “There is not an expert that waves us from our moral and political responsibilities,” Silvo said. The theme of the UNITE event, which kicked off on Monday and runs through Wednesday evening, is “from pandemic to prosperity.” He said that “I like the optimistic tone of this theme” but that parliamentarians must be attuned to the challenges that their countries face. Healthcare, he noted, is one of the objectives of the United Nations’ Sustainable Development Goals, but “we all know that the 17 SDGs are interdependent.” Now, he said, is the time for parliamentarians to evaluate their governments’ efforts toward achieving these SDGs and to redirect them if they are off on their goals. “We have to assess what we have achieved so far, to consolidate these achievements, and correct what has to be corrected or whatever is lagging behind,” Silvo said. “This is also work that is up to parliamentarians to do.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman. Indonesia Bans Extramarital Sex 06/12/2022 Kerry Cullinan Indonesia’s parliament passed a new criminal code that bans extramarital sex and criminalises abortion except for rape survivors on Tuesday, Reuters reports. The code applies to both citizens and visitors, and those who have sex outside marriage face up to a year in prison. Indonesia’s economy is heavily dependent on tourism and its tourism industry has warned that the code could dampen enthusiasm from international tourists. However, pre- and extra-marital sex can only be reported by close relatives: a parent, child or spouse. There has been speculation that the code will be used particularly to prosecute LGBTQ people. Same-sex marriage is banned in the predominantly Muslim country, which has become increasingly conservative in the past few years. The new code also prohibits anyone from insulting Indonesia’s president (transgressors face up to three years in prison), spreading views that contradict state ideology, “black magic”, and staging protests without permission. The code was passed unanimously and replaces a code adopted after Indonesia’s independence from the Netherlands in 1946. However, it is expected to only come into force in three years’ time once regulations have been drawn up to enforce its provisions. The country tried to pass the code in 2019 but faced protests, particularly from students. About 100 people reportedly gathered outside the parliament in Jakarta to protest against the code. Image Credits: Nick Agus Arya/ Unsplash. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan Fight the Fakes held an event in Geneva to highlight the dangers of falsified medicine. There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake medicine and the threat it poses to patients. In October, 99 children died in Indonesia from cough syrup contaminated with anti-freeze chemicals. The previous month, 66 children died in The Gambia – also from contaminated cough syrup. These tragedies echo the deaths of 12 Indian children in 2020 – from cough syrup that had been rendered poisonous after one of the ingredients was replaced by a toxic one. Yet, said Sehmi, most countries treated falsified medicines as a commercial crime such as “product liability or negligence” when they should be treating it “in the same way as narcotics”. “Trust is at the heart of everything. Patients have to trust that the product they’re getting is of the appropriate quality and safety,” said Pernette Esteve, who heads the World Health Organization’s (WHO) team on substandard and falsified medical products. “Gaining the confidence of the public once you’ve lost it is very difficult. Think back to the COVID pandemic. Making sure that people trusted the vaccines, vaccine acceptability, was a key point.” For 10 years, the WHO has been building a database of substandard (unintentionally defective) and falsified (deliberately altered) medicine to understand the scope, scale and harm. From this database, the WHO has identified the three driving forces: lack of access to medicine, poor governance including corruption, and weak technical capacity, said Esteve. The WHO’s response was based on “prevention, detection and response”, she added. The extent of the problem Stanislav Barro, Novartis’s global head of anti-falsified medicines, says that his company has confronted fake medicine in every region of the world. The timely authentication of medicines was both the biggest challenge and the biggest opportunity to stamp out fakes, he said – but warned that it is “a very complicated process”. All the suspect samples have to be brought to a place where they can be actually properly authenticated using forensic means,” said Barro. However, almost 50 pharmaceutical companies were now sharing data via the Pharmaceutical Security Institute, and there had been a 38% increase in the incidence of falsified medicines between 2016 and 2020 in 142 countries, and incidence had surged in 2021 during the early days of the COVID pandemic. “Basically, this is whatever the criminal organisations can make money with. It doesn’t really matter whether it’s falsified, tampered, stolen, illegally diverted. It’s a bit of everything, quite frankly,” added Barro, noting that it usually meant “terrible news for patients”. “We need to find solutions to leverage digital technologies to localise authentication, identify falsified medicines and make that timely. Cut down these timelines from weeks to basically days, hours if possible, and accelerate the reporting to local authorities and to the WHO.” Policing raw materials Sireesha Yadlapalli, vice president for international government and regulatory affairs for United States Pharmacopeia (USP), called for more policing of raw materials. Medicines are made of two components, the active pharmaceutical ingredients (API) and the inactive ingredients or excipients, including reagents, solvents and items related to the taste or look of the product. There was less stringent policing of the excipients, and these were often where problems arose, Yadlapalli said. “There might be an issue with an ingredient but the manufacturer may not know about that particular issue because he just took the supplier’s word and certificate of analysis at face value, and that’s because raw materials are not being tested when they’re accepted from suppliers,” she added. “Manufacturers need to test the raw materials. Regulations should be put in place requiring testing of these raw materials.” Improving regulatory systems Members of the International Generic and Biosimilar Medicines Association made up to 80% of quality-assured medicines around the world, according to its general secretary, Suzette Kox. “We think that the biggest challenge is weak healthcare systems which includes, of course, the insufficiently resourced regulatory system and quality control. Most countries around the world do not have proper regulatory systems in place, and also no proper competition policies.” Oksana Pyzik, who lectures at the UCL School Pharmacy, said that one of the biggest challenges is a lack of public awareness. Pointing to the proliferation of online medical supply outlets during COVID-19, Pyzik said that many patients didn’t know how to verify legal online pharmacies. “Pharmacists are the last line of defence before patients received those medications and take them home with them. And there’s a real opportunity there for patient education as part of wider public awareness,” she said, adding that this was why educating pharmacists about falsified medicines was essential. In Talk on UHC, NY Senator Raises Concern Over Commoditization of Healthcare 07/12/2022 Maayan Hoffman New York State Senator Jose Gustavo Rivera A New York lawmaker warned fellow parliamentarians on Wednesday to “stay as far away from the private sector as you can” when it comes to healthcare. “The main issue in the United States is that healthcare is commodified,” said New York State Senator Jose Gustavo Rivera. “It is true, the best healthcare is available in the US – that is true if you can afford it. But the majority of Americans cannot [afford it] and instead organize their entire existence around how to find the best insurance. “And I put insurance in quotation marks because having insurance does not guarantee care,” he continued. “The commoditization of healthcare is the way to ensure that the people in your country do not get the care they need and deserve.” Less than half of Americans (40%) rate the quality of healthcare in in their country as very good or good, according to a new survey released by the Beryl Institute – Ipsos PX Pulse. Moreover, despite improvements in access to health insurance following the roll out of the Affordable Care Act in 2010, roughly 30 million Americans of all ages had no health insurance in 2021, according to a report by MoneyGeek. ‘Investments in health … are key’ Rivera spoke at the conclusion of Wednesday’s UNITE Global Summit session on universal health coverage (UHC). The session was hosted by UHC2030 and focused on case studies from throughout the world for how to implement UHC. “UHC means that everyone, everywhere, can access the services they need without facing financial burden,” said UHC2030 Steering Committee Co-chair Gabriela Cuevas Barron from Mexico. “Investments in health and healthier populations are key for wider economic and social benefits.” UHC2030 Steering Committee Co-chair Gabriela Cuevas Barron Examples of efforts to roll out UHC were given from Tanzania, Chile and Zambia. In Tanzania, for example, a UHC bill was supposed to be deliberated on in November of this year. However, according to MP Neema Lugangira, discussions were pushed off after concerns with some of the nuances of the bill were raised during public hearings. “We had several discussions and felt there were concrete issues with the bill So, we, as the parliamentary committee, withdrew the bill for improvement and consideration in the areas raised,” Lugangira said. “We were hoping that by the time I would be standing here, perhaps the bill would have been passed. But in an interesting turn of events, we were able to make sure the government takes the bill back and improves on it before it is tabled in parliament. “This shows the power parliamentarians have to understand the issues and advise the government better,” she concluded. ‘Still some work to do’ Zambia, on the other hand, already rolled out the first stages of a universal health coverage plan, explained MP Givem Katuta in her remarks. The initial stage of the UHC plan includes coverage of primary care, said Katuta. But she noted that the bill was moved forward quickly between 2017 and 2018 and the country knows there is still some work to do. For example, one challenge is that the plan uses the National Health Insurance Management Authority, which works well for people who are employed but creates a gap for those who do not have some kind of job. In addition, while people in urban areas can really take advantage of the plan, including getting care at private hospitals of their choice, this has not yet been the case for those in rural areas. “We are on the right track,” Katuta said. “We are looking forward to other stakeholders coming through to spread its wings to rural areas. The goal is to have full UHC by 2030.” Chile’s representative, Marta Bravo, called on the World Health Organization to support the creation of “harmonized and unified criteria” for universal health coverage . “WHO has a powerful voice that is listened to by our government,” she said. “This is our opportunity to ask WHO to be active in this field.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman, Screenshot. In Heated UNITE Event Session, African MPs Call for Greater Inclusion in Global Fund 07/12/2022 Maayan Hoffman Tanzanian MP Neema Lugangira at the UNITE Global Summit in Lisbon A group of African parliamentarians raised a red flag on Tuesday at the UNITE Global Summit when they told representatives that they felt neglected by the Global Fund to Fight AIDS, Tuberculosis and Malaria, which funds billions of dollars of health services in their countries. “Do African parliamentarians only get involved when we have to make an appeal, when it suits our colleagues?” asked Tanzanian MP Neema Lugangira in her remarks at a session titled “The Global Fund Post 7th Replenishment – The Role of Members of Parliament and Domestic Health Financing.” Lugangira said that she was asked to make a fundraising appeal via video on behalf of the Global Fund to the United Kingdom parliament over the summer believes her intervention added value and played a key role in convincing the UK government to provide a more than $1 billion grant. However, despite being in New York in September during Global Fund’s Replenishment event at which donors pledge money for the next three years, she was not invited to attend. Global Fund instead hosted 18 heads of state and governments and many high-level officials from civil society and the private sector at the 400-person event in the city. Lugangira said that “some of my colleagues in Tanzania were surprised I was not invited” because of the video she provided and her deep commitment to public health in Tanzania. “When it is time for the glorious moment, we are not invited,” she said. Lugangira said that Global Fund could generate increased matching domestic financing and distribute its funds more effectively if it worked closely with parliaments, the way it works with civil society. “Civil society was not chosen by our UK parliamentarians to record a clip and make an appeal to parliament. It was me, a member of the African parliament,” she stressed. “It is powerful when you hear the voice of an African parliamentarian representing her people. “Don’t just use us when it suits you. Include us across the entire chain” Lugangira continued. “Parliamentarians should be involved at all levels and be recognised for the impact and power we have.” ‘Confused and surprised’ “The Global Fund Post 7th Replenishment” session on December 6 at the UNITE Global Summit Lugangira had been asked to speak during a panel hosted by the fund that was meant to celebrate the nearly $16 billion it raised in the fall and to examine the positive impact that the more than $55 billion it distributed over the past 20 years has had on health and saving lives. In Tanzania alone, the Global Fund has invested $3 billion to tackle issues of HIV, TB and malaria between 2002 and 2022. Currently, the fund has four core grants in the country totalling $608 million. According to Lugangira, since the fund became involved in her country, there has been a 68% decrease in HIV and people with the virus and a 68% increase – from 18% to 86% – of individuals with HIV enrolled in treatment programs. But after Lugangira and several other parliamentarians criticised the Global Fund for failing to properly leverage local lawmakers and called on it to shift its paradigm, Scott Boule, the Global Fund’s Senior Specialist for Parliamentary Affairs, said he was left “confused and surprised.” “At least one MP sort of implied a feeling of being only utilised when the Global Fund needs to raise funds,” Boule said, “Global Fund is supposed to be a partnership.” ‘You handcuff us’ Some parliamentarians also expressed concerns over the Global Fund model, which involves establishing a Country Coordinating Mechanism (CCM) committee to help distribute funds. Boule said Global Fund mandates that CCMs have broad representation, including from the government, but also from civil society, such as members of the communities that are impacted by the three core diseases. In some countries, parliamentarians sit on the CCMs, but in many countries they are not asked to do so. Moreover, parliamentarians have been ineligible to receive money to help fund their role on these committees. Zimbabwe’s Ruth Labode is one of those MPs. She is a member of her country’s CCM but said she rarely attends meetings due to lack of transport and funding. She only goes when parliament is in session and she has to be in the capital city for work anyway. Otherwise, “it’s too costly” to take part, she told Health Policy Watch. “The CCM has decided not to fund parliamentarians for meetings while they fund members from the civil society, private or any other sector,” Labode said. “The lack of funding shows that the Global Fund is not committed [to the parliamentarians]. It does not think it needs parliamentarians. And yet, when the time comes for replenishment, they are quick to find parliamentarians to lobby for their purpose.” She told Boule during the discussion that “it is about time you advocate for a parliamentary seat on every CCM in every country… If you told them to have a seat for a parliamentarian, it would happen overnight”. Another complaint was that many parliamentarians are not educated about the work of the Global Fund or its accomplishments, which could help them push for further domestic health financing. “You cannot mobilise resources when you are not informed,” said MP Peter Njume from Cameroon. “You work [directly] with the government and then expect us to ask them to be accountable. But parliamentarians are not involved. “You talk about the importance of democracy,” Njume continued. “We represent democracy, but you handcuff us, you make us become vulnerable and helpless. How do you want us to function?” “To own this agenda, we need to be well informed and educated,” Lugangira similarly added. Njume requested that the Global Fund earmark financing for a parliamentary education program. ‘Healthcare financing is a political decision’ Alex Winch, a member of Global Fund’s Advocacy, Health Financing Team speaks at the UNITE Global Summit in Lisbon Global Fund’s Alex Winch acknowledged that “the financing of healthcare is a political decision.” A specialist on Global Fund’s Advocacy, Health Financing Team, he said it is important to understand that the vast majority of the fund’s resources do come from governments prioritising money. “Eighty percent of funding comes from the G7 and the European commission,” explained Boule. “Eleven percent comes from other governments around the world. And 9% comes from the private sector.” To date, the Global Fund is providing 30% of international financing for HIV, 76% for TB and 63% for malaria. The fund gives more money for the battle against TB and malaria than anyone in the world. In addition, about a third of its funding is now going to reward strengthening underlying health systems. The funding has been effective, at least according to the data. Life expectancy, for example, has increased as a result. In sub-Sahara Africa alone, average life expectancy jumped from 52.3 in 2002 to 66.7 in 2019, in large part because of the fund’s efforts. During 2021 in countries and regions where Global Fund invests, some 12.5 million people were reached with HIV prevention services; 670,000 mothers living with HIV received medicine to keep them alive and prevent transmitting HIV to their babies; another 5.3 million people were tested for TB; 110,000 were given treatment for drug-resistant TB; and 133 million mosquito nets were distributed to protect families from malaria, amongst many other efforts. “All of this is made possible by our replenishment,” Boule told Health Policy Watch. “Every third year, we raise funds for the subsequent three years.” Replenishment this year was held on 21 September in New York. Some 47 public and 27 private sector donors pledged $15.7 billion out of the target of $18 billion that the organisation had set to raise for the 2023-2025 period. Boule said that efforts were continuing to try to fill the gap. ‘We are de-investing in health’ But Zimbabwe’s Daniel Molokele said that while the results are stunning, he believes African governments have become too “dependent” on the Global Fund, which puts 72% of its money towards the continent. “I don’t think it is good for Africa, this over-reliance on the Global Fund,” Molokele said. He said that Global Fund’s filling the gap lets off the hook governments who then do not have to commit to fund health in their own countries. In Zimbabwe, he said, domestic health financing dropped several percentage points in the last year. “We are de-investing in health,” Molokele said. Boule explained that recipient countries are required to provide a certain percentage of matching money to receive a grant from the Global Fund, though he said that the fund is often more flexible with low-income countries about achieving their targets. He said that despite the economic challenges the world is facing in the aftermath of COVID-19 and as the war is raging in Ukraine, the fund did see around a 30% increase across the board in domestic health financing from recipient countries. ‘It was ambitious’ Another concern raised from the floor came from French MP Jean-Francois Mbaye, who expressed “disappointment” that his country invested $1.6 billion towards a goal it thought was $18 billion but that fell short “It was ambitious,” Boule admitted to Health Policy Watch. “We did raise $15.7 and that is by far the largest amount we ever raised.” The gap came from some of Global Fund’s largest donors not increasing their gifts by the 30% that the fund expected. “The United States, Germany, Japan, Canada and the European Commission all did increase by 30%,” Boule said. “France increased by 23% and Italy increased by 15%. “The only country amongst our largest donors that went down was the UK, although it still pledged $1.2 billion,” Boule continued. “So we very much had strong support from our donors, and in particular, our largest donors.” Number of donors for Global Fund’s 7th Replenishment On the other hand, faltering exchange rates, and hosting the replenishment seven months after the start of the Ukraine war amid rising interest rates had a negative impact. To illustrate if the pledging session had been held on February 23, 2022, which is the day Global Fund had its preparatory meeting, because of exchange rates, it would have raised around $857 million more. In general, Winch said that achieving funding in the current fiscal environment is becoming increasingly more challenging. He cited a recent report by the World Bank that highlighted how even more countries will find it hard to invest in health or in even sustain existing levels of health investment. He said that “an uncertain global macro-economic environment threatens domestic financing for health.” ‘We need to crowd more resources into health’ Boule said that he plans to take some of the parliamentarians’ concerns back to Geneva, such as providing resources for parliamentarians to sit on CCMs and perhaps developing a fixed parliamentary position on the committees. “I wasn’t aware of the point that Honorable Ruth Labode was making from Zimbabwe, that other members of the CCMs received some sort of support and she did not,” Boule said. He also said he would be interested in finding ways to better involve parliamentary feedback as another means to ensure that the fund is asking the right questions and distributing resources in an optimal way. “Our good results are due to a lot of African political leaders, including parliamentarians, really building and sustaining political will to prioritise health,” Boule said. “It is even harder now with food insecurity, debt crisis and rising interest rates. But we are making the point that even now we need to crowd more resources into health.” Image Credits: Maayan Hoffman, Screenshot. US Wants WTO to Delay Decision on TRIPS Waiver Extension for COVID-19 Tests and Treatment 06/12/2022 Kerry Cullinan US Trade Representative Katherine Tai The US Trade Representative’s (USTR) office announced on Tuesday that it supports extending the deadline on whether the World Trade Organization’s (WTO) Ministerial Decision on the TRIPS Agreement should be extended to COVID-19 diagnostics and therapeutics. Trade ministers adopted the Ministerial Decision on the TRIPS Agreement in June, giving members scope to diversify the production of COVID-19 vaccines and override the exclusive effect of patents through a targeted waiver over the next five years. The TRIPS Council has been discussing whether this should be extended to COVID-19 diagnostics and therapeutics. The US decision was informed by wide-ranging consultations over the past five months with over 24 groups with opposing views on the issue, the USTR said in a statement. While all these groups “shared a concern with saving lives, and with striking a balance between the need to promote innovation in these sectors and the need to promote access to the products of innovation”, there were “key differences”. In light of the differing views, the USTR will ask the US International Trade Commission (USITC) to “launch an investigation into COVID-19 diagnostics and therapeutics and provide information on market dynamics to help inform the discussion around supply and demand, price points, the relationship between testing and treating, and production and access”, the USTR said in a statement. “Over the past five months, USTR officials held robust and constructive consultations with Congress, government experts, a wide range of stakeholders, multilateral institutions, and WTO Members,” said Ambassador Katherine Tai. “Real questions remain on a range of issues, and the additional time, coupled with information from the USITC, will help the world make a more informed decision on whether extending the Ministerial Decision to COVID-19 therapeutics and diagnostics would result in increased access to those products,” added Tai. “Transparency is critical and USTR will continue to consult with Congress, stakeholders, and others as we continue working to end the pandemic and support the global economic recovery.” Those in favour of extending the Ministerial agreement “acknowledge a lack of global demand for COVID-19 products, but they believe that market dynamics are suppressing effective demand”, according to the USTR. Opponents’ concerns include that the extension would “allow countries with anti-competitive approaches to innovation, such as China” to “unfairly obtain and use American innovation to benefit their domestic economies”, harming “American industry and workers by undermining investment and research and development”. The USITC study will explore key issues including: An overview of the products, focusing on WHO-approved COVID-19 diagnostics and therapeutics, including key components, the production process, intellectual property protections, and the supply chain (including the level of diversification in the supply chain); The global manufacturing industry for these products, including information on key producing countries, major firms, and production data, if available; The global market for COVID-19 diagnostics and therapeutics, including information on demand and, to the extent practicable, an assessment of where unmet demand exists for key products and contributing factors; market segmentation; and supply accumulation and distribution; Data and information on global trade in COVID-19 diagnostics and therapeutics, if available, or if not, data and information on global trade in diagnostics and therapeutics generally; and A brief overview of the relevant aspects of the TRIPS Agreement and the UN Medicine Patent Pool (MPP) and a listing of countries seeking to use the Ministerial Decision and those utilizing access to COVID-19 medicines under the MPP. Meanwhile, the US reaffirmed the right of its trading partners to “exercise the full range of existing flexibilities in the TRIPS Agreement, such as in Articles 30, 31, and 31bis, and the Doha Declaration on the TRIPS Agreement and Public Health, as well as the flexibilities in the Ministerial Decision”. ‘Multilateralism’ Essential in Battle Against Pandemics, Says President of Portuguese Parliament 06/12/2022 Maayan Hoffman Augusto Santos Silva, president of the Portuguese parliament The battle against pandemics can only be won through multilateralism, according to Augusto Santos Silva, president of the Portuguese parliament. During a keynote address at the UNITE Global Summit on Tuesday, Silva stressed that “viruses and bacteria know no borders. They do not have to show passports and they are not subject to border control. “To manage [a fast response] requires the efforts of all of us – requires multilateralism,” he said. Silvo, a sociologist and university professor, who has served as president since 2002, told the crowd of more than 30 parliamentarians from around the world and several health officials that “the role of parliamentarians is irreplaceable.” Silvo spoke from the center of the Senate Chamber. He said “the COVID-19 pandemic taught us that we should be prepared for the unexpected,” including “what may come up when we least expect it and, in the form, we least expect it to happen.” He called on governments to have deep ties with scientists and professionals in the health arena, but admitted that ultimately, they cannot run the country in the time of a health crisis. Only politicians, he said, can evaluate issues of the economy and democracy alongside health. “There is not an expert that waves us from our moral and political responsibilities,” Silvo said. The theme of the UNITE event, which kicked off on Monday and runs through Wednesday evening, is “from pandemic to prosperity.” He said that “I like the optimistic tone of this theme” but that parliamentarians must be attuned to the challenges that their countries face. Healthcare, he noted, is one of the objectives of the United Nations’ Sustainable Development Goals, but “we all know that the 17 SDGs are interdependent.” Now, he said, is the time for parliamentarians to evaluate their governments’ efforts toward achieving these SDGs and to redirect them if they are off on their goals. “We have to assess what we have achieved so far, to consolidate these achievements, and correct what has to be corrected or whatever is lagging behind,” Silvo said. “This is also work that is up to parliamentarians to do.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman. Indonesia Bans Extramarital Sex 06/12/2022 Kerry Cullinan Indonesia’s parliament passed a new criminal code that bans extramarital sex and criminalises abortion except for rape survivors on Tuesday, Reuters reports. The code applies to both citizens and visitors, and those who have sex outside marriage face up to a year in prison. Indonesia’s economy is heavily dependent on tourism and its tourism industry has warned that the code could dampen enthusiasm from international tourists. However, pre- and extra-marital sex can only be reported by close relatives: a parent, child or spouse. There has been speculation that the code will be used particularly to prosecute LGBTQ people. Same-sex marriage is banned in the predominantly Muslim country, which has become increasingly conservative in the past few years. The new code also prohibits anyone from insulting Indonesia’s president (transgressors face up to three years in prison), spreading views that contradict state ideology, “black magic”, and staging protests without permission. The code was passed unanimously and replaces a code adopted after Indonesia’s independence from the Netherlands in 1946. However, it is expected to only come into force in three years’ time once regulations have been drawn up to enforce its provisions. The country tried to pass the code in 2019 but faced protests, particularly from students. About 100 people reportedly gathered outside the parliament in Jakarta to protest against the code. Image Credits: Nick Agus Arya/ Unsplash. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
In Talk on UHC, NY Senator Raises Concern Over Commoditization of Healthcare 07/12/2022 Maayan Hoffman New York State Senator Jose Gustavo Rivera A New York lawmaker warned fellow parliamentarians on Wednesday to “stay as far away from the private sector as you can” when it comes to healthcare. “The main issue in the United States is that healthcare is commodified,” said New York State Senator Jose Gustavo Rivera. “It is true, the best healthcare is available in the US – that is true if you can afford it. But the majority of Americans cannot [afford it] and instead organize their entire existence around how to find the best insurance. “And I put insurance in quotation marks because having insurance does not guarantee care,” he continued. “The commoditization of healthcare is the way to ensure that the people in your country do not get the care they need and deserve.” Less than half of Americans (40%) rate the quality of healthcare in in their country as very good or good, according to a new survey released by the Beryl Institute – Ipsos PX Pulse. Moreover, despite improvements in access to health insurance following the roll out of the Affordable Care Act in 2010, roughly 30 million Americans of all ages had no health insurance in 2021, according to a report by MoneyGeek. ‘Investments in health … are key’ Rivera spoke at the conclusion of Wednesday’s UNITE Global Summit session on universal health coverage (UHC). The session was hosted by UHC2030 and focused on case studies from throughout the world for how to implement UHC. “UHC means that everyone, everywhere, can access the services they need without facing financial burden,” said UHC2030 Steering Committee Co-chair Gabriela Cuevas Barron from Mexico. “Investments in health and healthier populations are key for wider economic and social benefits.” UHC2030 Steering Committee Co-chair Gabriela Cuevas Barron Examples of efforts to roll out UHC were given from Tanzania, Chile and Zambia. In Tanzania, for example, a UHC bill was supposed to be deliberated on in November of this year. However, according to MP Neema Lugangira, discussions were pushed off after concerns with some of the nuances of the bill were raised during public hearings. “We had several discussions and felt there were concrete issues with the bill So, we, as the parliamentary committee, withdrew the bill for improvement and consideration in the areas raised,” Lugangira said. “We were hoping that by the time I would be standing here, perhaps the bill would have been passed. But in an interesting turn of events, we were able to make sure the government takes the bill back and improves on it before it is tabled in parliament. “This shows the power parliamentarians have to understand the issues and advise the government better,” she concluded. ‘Still some work to do’ Zambia, on the other hand, already rolled out the first stages of a universal health coverage plan, explained MP Givem Katuta in her remarks. The initial stage of the UHC plan includes coverage of primary care, said Katuta. But she noted that the bill was moved forward quickly between 2017 and 2018 and the country knows there is still some work to do. For example, one challenge is that the plan uses the National Health Insurance Management Authority, which works well for people who are employed but creates a gap for those who do not have some kind of job. In addition, while people in urban areas can really take advantage of the plan, including getting care at private hospitals of their choice, this has not yet been the case for those in rural areas. “We are on the right track,” Katuta said. “We are looking forward to other stakeholders coming through to spread its wings to rural areas. The goal is to have full UHC by 2030.” Chile’s representative, Marta Bravo, called on the World Health Organization to support the creation of “harmonized and unified criteria” for universal health coverage . “WHO has a powerful voice that is listened to by our government,” she said. “This is our opportunity to ask WHO to be active in this field.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman, Screenshot. In Heated UNITE Event Session, African MPs Call for Greater Inclusion in Global Fund 07/12/2022 Maayan Hoffman Tanzanian MP Neema Lugangira at the UNITE Global Summit in Lisbon A group of African parliamentarians raised a red flag on Tuesday at the UNITE Global Summit when they told representatives that they felt neglected by the Global Fund to Fight AIDS, Tuberculosis and Malaria, which funds billions of dollars of health services in their countries. “Do African parliamentarians only get involved when we have to make an appeal, when it suits our colleagues?” asked Tanzanian MP Neema Lugangira in her remarks at a session titled “The Global Fund Post 7th Replenishment – The Role of Members of Parliament and Domestic Health Financing.” Lugangira said that she was asked to make a fundraising appeal via video on behalf of the Global Fund to the United Kingdom parliament over the summer believes her intervention added value and played a key role in convincing the UK government to provide a more than $1 billion grant. However, despite being in New York in September during Global Fund’s Replenishment event at which donors pledge money for the next three years, she was not invited to attend. Global Fund instead hosted 18 heads of state and governments and many high-level officials from civil society and the private sector at the 400-person event in the city. Lugangira said that “some of my colleagues in Tanzania were surprised I was not invited” because of the video she provided and her deep commitment to public health in Tanzania. “When it is time for the glorious moment, we are not invited,” she said. Lugangira said that Global Fund could generate increased matching domestic financing and distribute its funds more effectively if it worked closely with parliaments, the way it works with civil society. “Civil society was not chosen by our UK parliamentarians to record a clip and make an appeal to parliament. It was me, a member of the African parliament,” she stressed. “It is powerful when you hear the voice of an African parliamentarian representing her people. “Don’t just use us when it suits you. Include us across the entire chain” Lugangira continued. “Parliamentarians should be involved at all levels and be recognised for the impact and power we have.” ‘Confused and surprised’ “The Global Fund Post 7th Replenishment” session on December 6 at the UNITE Global Summit Lugangira had been asked to speak during a panel hosted by the fund that was meant to celebrate the nearly $16 billion it raised in the fall and to examine the positive impact that the more than $55 billion it distributed over the past 20 years has had on health and saving lives. In Tanzania alone, the Global Fund has invested $3 billion to tackle issues of HIV, TB and malaria between 2002 and 2022. Currently, the fund has four core grants in the country totalling $608 million. According to Lugangira, since the fund became involved in her country, there has been a 68% decrease in HIV and people with the virus and a 68% increase – from 18% to 86% – of individuals with HIV enrolled in treatment programs. But after Lugangira and several other parliamentarians criticised the Global Fund for failing to properly leverage local lawmakers and called on it to shift its paradigm, Scott Boule, the Global Fund’s Senior Specialist for Parliamentary Affairs, said he was left “confused and surprised.” “At least one MP sort of implied a feeling of being only utilised when the Global Fund needs to raise funds,” Boule said, “Global Fund is supposed to be a partnership.” ‘You handcuff us’ Some parliamentarians also expressed concerns over the Global Fund model, which involves establishing a Country Coordinating Mechanism (CCM) committee to help distribute funds. Boule said Global Fund mandates that CCMs have broad representation, including from the government, but also from civil society, such as members of the communities that are impacted by the three core diseases. In some countries, parliamentarians sit on the CCMs, but in many countries they are not asked to do so. Moreover, parliamentarians have been ineligible to receive money to help fund their role on these committees. Zimbabwe’s Ruth Labode is one of those MPs. She is a member of her country’s CCM but said she rarely attends meetings due to lack of transport and funding. She only goes when parliament is in session and she has to be in the capital city for work anyway. Otherwise, “it’s too costly” to take part, she told Health Policy Watch. “The CCM has decided not to fund parliamentarians for meetings while they fund members from the civil society, private or any other sector,” Labode said. “The lack of funding shows that the Global Fund is not committed [to the parliamentarians]. It does not think it needs parliamentarians. And yet, when the time comes for replenishment, they are quick to find parliamentarians to lobby for their purpose.” She told Boule during the discussion that “it is about time you advocate for a parliamentary seat on every CCM in every country… If you told them to have a seat for a parliamentarian, it would happen overnight”. Another complaint was that many parliamentarians are not educated about the work of the Global Fund or its accomplishments, which could help them push for further domestic health financing. “You cannot mobilise resources when you are not informed,” said MP Peter Njume from Cameroon. “You work [directly] with the government and then expect us to ask them to be accountable. But parliamentarians are not involved. “You talk about the importance of democracy,” Njume continued. “We represent democracy, but you handcuff us, you make us become vulnerable and helpless. How do you want us to function?” “To own this agenda, we need to be well informed and educated,” Lugangira similarly added. Njume requested that the Global Fund earmark financing for a parliamentary education program. ‘Healthcare financing is a political decision’ Alex Winch, a member of Global Fund’s Advocacy, Health Financing Team speaks at the UNITE Global Summit in Lisbon Global Fund’s Alex Winch acknowledged that “the financing of healthcare is a political decision.” A specialist on Global Fund’s Advocacy, Health Financing Team, he said it is important to understand that the vast majority of the fund’s resources do come from governments prioritising money. “Eighty percent of funding comes from the G7 and the European commission,” explained Boule. “Eleven percent comes from other governments around the world. And 9% comes from the private sector.” To date, the Global Fund is providing 30% of international financing for HIV, 76% for TB and 63% for malaria. The fund gives more money for the battle against TB and malaria than anyone in the world. In addition, about a third of its funding is now going to reward strengthening underlying health systems. The funding has been effective, at least according to the data. Life expectancy, for example, has increased as a result. In sub-Sahara Africa alone, average life expectancy jumped from 52.3 in 2002 to 66.7 in 2019, in large part because of the fund’s efforts. During 2021 in countries and regions where Global Fund invests, some 12.5 million people were reached with HIV prevention services; 670,000 mothers living with HIV received medicine to keep them alive and prevent transmitting HIV to their babies; another 5.3 million people were tested for TB; 110,000 were given treatment for drug-resistant TB; and 133 million mosquito nets were distributed to protect families from malaria, amongst many other efforts. “All of this is made possible by our replenishment,” Boule told Health Policy Watch. “Every third year, we raise funds for the subsequent three years.” Replenishment this year was held on 21 September in New York. Some 47 public and 27 private sector donors pledged $15.7 billion out of the target of $18 billion that the organisation had set to raise for the 2023-2025 period. Boule said that efforts were continuing to try to fill the gap. ‘We are de-investing in health’ But Zimbabwe’s Daniel Molokele said that while the results are stunning, he believes African governments have become too “dependent” on the Global Fund, which puts 72% of its money towards the continent. “I don’t think it is good for Africa, this over-reliance on the Global Fund,” Molokele said. He said that Global Fund’s filling the gap lets off the hook governments who then do not have to commit to fund health in their own countries. In Zimbabwe, he said, domestic health financing dropped several percentage points in the last year. “We are de-investing in health,” Molokele said. Boule explained that recipient countries are required to provide a certain percentage of matching money to receive a grant from the Global Fund, though he said that the fund is often more flexible with low-income countries about achieving their targets. He said that despite the economic challenges the world is facing in the aftermath of COVID-19 and as the war is raging in Ukraine, the fund did see around a 30% increase across the board in domestic health financing from recipient countries. ‘It was ambitious’ Another concern raised from the floor came from French MP Jean-Francois Mbaye, who expressed “disappointment” that his country invested $1.6 billion towards a goal it thought was $18 billion but that fell short “It was ambitious,” Boule admitted to Health Policy Watch. “We did raise $15.7 and that is by far the largest amount we ever raised.” The gap came from some of Global Fund’s largest donors not increasing their gifts by the 30% that the fund expected. “The United States, Germany, Japan, Canada and the European Commission all did increase by 30%,” Boule said. “France increased by 23% and Italy increased by 15%. “The only country amongst our largest donors that went down was the UK, although it still pledged $1.2 billion,” Boule continued. “So we very much had strong support from our donors, and in particular, our largest donors.” Number of donors for Global Fund’s 7th Replenishment On the other hand, faltering exchange rates, and hosting the replenishment seven months after the start of the Ukraine war amid rising interest rates had a negative impact. To illustrate if the pledging session had been held on February 23, 2022, which is the day Global Fund had its preparatory meeting, because of exchange rates, it would have raised around $857 million more. In general, Winch said that achieving funding in the current fiscal environment is becoming increasingly more challenging. He cited a recent report by the World Bank that highlighted how even more countries will find it hard to invest in health or in even sustain existing levels of health investment. He said that “an uncertain global macro-economic environment threatens domestic financing for health.” ‘We need to crowd more resources into health’ Boule said that he plans to take some of the parliamentarians’ concerns back to Geneva, such as providing resources for parliamentarians to sit on CCMs and perhaps developing a fixed parliamentary position on the committees. “I wasn’t aware of the point that Honorable Ruth Labode was making from Zimbabwe, that other members of the CCMs received some sort of support and she did not,” Boule said. He also said he would be interested in finding ways to better involve parliamentary feedback as another means to ensure that the fund is asking the right questions and distributing resources in an optimal way. “Our good results are due to a lot of African political leaders, including parliamentarians, really building and sustaining political will to prioritise health,” Boule said. “It is even harder now with food insecurity, debt crisis and rising interest rates. But we are making the point that even now we need to crowd more resources into health.” Image Credits: Maayan Hoffman, Screenshot. US Wants WTO to Delay Decision on TRIPS Waiver Extension for COVID-19 Tests and Treatment 06/12/2022 Kerry Cullinan US Trade Representative Katherine Tai The US Trade Representative’s (USTR) office announced on Tuesday that it supports extending the deadline on whether the World Trade Organization’s (WTO) Ministerial Decision on the TRIPS Agreement should be extended to COVID-19 diagnostics and therapeutics. Trade ministers adopted the Ministerial Decision on the TRIPS Agreement in June, giving members scope to diversify the production of COVID-19 vaccines and override the exclusive effect of patents through a targeted waiver over the next five years. The TRIPS Council has been discussing whether this should be extended to COVID-19 diagnostics and therapeutics. The US decision was informed by wide-ranging consultations over the past five months with over 24 groups with opposing views on the issue, the USTR said in a statement. While all these groups “shared a concern with saving lives, and with striking a balance between the need to promote innovation in these sectors and the need to promote access to the products of innovation”, there were “key differences”. In light of the differing views, the USTR will ask the US International Trade Commission (USITC) to “launch an investigation into COVID-19 diagnostics and therapeutics and provide information on market dynamics to help inform the discussion around supply and demand, price points, the relationship between testing and treating, and production and access”, the USTR said in a statement. “Over the past five months, USTR officials held robust and constructive consultations with Congress, government experts, a wide range of stakeholders, multilateral institutions, and WTO Members,” said Ambassador Katherine Tai. “Real questions remain on a range of issues, and the additional time, coupled with information from the USITC, will help the world make a more informed decision on whether extending the Ministerial Decision to COVID-19 therapeutics and diagnostics would result in increased access to those products,” added Tai. “Transparency is critical and USTR will continue to consult with Congress, stakeholders, and others as we continue working to end the pandemic and support the global economic recovery.” Those in favour of extending the Ministerial agreement “acknowledge a lack of global demand for COVID-19 products, but they believe that market dynamics are suppressing effective demand”, according to the USTR. Opponents’ concerns include that the extension would “allow countries with anti-competitive approaches to innovation, such as China” to “unfairly obtain and use American innovation to benefit their domestic economies”, harming “American industry and workers by undermining investment and research and development”. The USITC study will explore key issues including: An overview of the products, focusing on WHO-approved COVID-19 diagnostics and therapeutics, including key components, the production process, intellectual property protections, and the supply chain (including the level of diversification in the supply chain); The global manufacturing industry for these products, including information on key producing countries, major firms, and production data, if available; The global market for COVID-19 diagnostics and therapeutics, including information on demand and, to the extent practicable, an assessment of where unmet demand exists for key products and contributing factors; market segmentation; and supply accumulation and distribution; Data and information on global trade in COVID-19 diagnostics and therapeutics, if available, or if not, data and information on global trade in diagnostics and therapeutics generally; and A brief overview of the relevant aspects of the TRIPS Agreement and the UN Medicine Patent Pool (MPP) and a listing of countries seeking to use the Ministerial Decision and those utilizing access to COVID-19 medicines under the MPP. Meanwhile, the US reaffirmed the right of its trading partners to “exercise the full range of existing flexibilities in the TRIPS Agreement, such as in Articles 30, 31, and 31bis, and the Doha Declaration on the TRIPS Agreement and Public Health, as well as the flexibilities in the Ministerial Decision”. ‘Multilateralism’ Essential in Battle Against Pandemics, Says President of Portuguese Parliament 06/12/2022 Maayan Hoffman Augusto Santos Silva, president of the Portuguese parliament The battle against pandemics can only be won through multilateralism, according to Augusto Santos Silva, president of the Portuguese parliament. During a keynote address at the UNITE Global Summit on Tuesday, Silva stressed that “viruses and bacteria know no borders. They do not have to show passports and they are not subject to border control. “To manage [a fast response] requires the efforts of all of us – requires multilateralism,” he said. Silvo, a sociologist and university professor, who has served as president since 2002, told the crowd of more than 30 parliamentarians from around the world and several health officials that “the role of parliamentarians is irreplaceable.” Silvo spoke from the center of the Senate Chamber. He said “the COVID-19 pandemic taught us that we should be prepared for the unexpected,” including “what may come up when we least expect it and, in the form, we least expect it to happen.” He called on governments to have deep ties with scientists and professionals in the health arena, but admitted that ultimately, they cannot run the country in the time of a health crisis. Only politicians, he said, can evaluate issues of the economy and democracy alongside health. “There is not an expert that waves us from our moral and political responsibilities,” Silvo said. The theme of the UNITE event, which kicked off on Monday and runs through Wednesday evening, is “from pandemic to prosperity.” He said that “I like the optimistic tone of this theme” but that parliamentarians must be attuned to the challenges that their countries face. Healthcare, he noted, is one of the objectives of the United Nations’ Sustainable Development Goals, but “we all know that the 17 SDGs are interdependent.” Now, he said, is the time for parliamentarians to evaluate their governments’ efforts toward achieving these SDGs and to redirect them if they are off on their goals. “We have to assess what we have achieved so far, to consolidate these achievements, and correct what has to be corrected or whatever is lagging behind,” Silvo said. “This is also work that is up to parliamentarians to do.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman. Indonesia Bans Extramarital Sex 06/12/2022 Kerry Cullinan Indonesia’s parliament passed a new criminal code that bans extramarital sex and criminalises abortion except for rape survivors on Tuesday, Reuters reports. The code applies to both citizens and visitors, and those who have sex outside marriage face up to a year in prison. Indonesia’s economy is heavily dependent on tourism and its tourism industry has warned that the code could dampen enthusiasm from international tourists. However, pre- and extra-marital sex can only be reported by close relatives: a parent, child or spouse. There has been speculation that the code will be used particularly to prosecute LGBTQ people. Same-sex marriage is banned in the predominantly Muslim country, which has become increasingly conservative in the past few years. The new code also prohibits anyone from insulting Indonesia’s president (transgressors face up to three years in prison), spreading views that contradict state ideology, “black magic”, and staging protests without permission. The code was passed unanimously and replaces a code adopted after Indonesia’s independence from the Netherlands in 1946. However, it is expected to only come into force in three years’ time once regulations have been drawn up to enforce its provisions. The country tried to pass the code in 2019 but faced protests, particularly from students. About 100 people reportedly gathered outside the parliament in Jakarta to protest against the code. Image Credits: Nick Agus Arya/ Unsplash. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
In Heated UNITE Event Session, African MPs Call for Greater Inclusion in Global Fund 07/12/2022 Maayan Hoffman Tanzanian MP Neema Lugangira at the UNITE Global Summit in Lisbon A group of African parliamentarians raised a red flag on Tuesday at the UNITE Global Summit when they told representatives that they felt neglected by the Global Fund to Fight AIDS, Tuberculosis and Malaria, which funds billions of dollars of health services in their countries. “Do African parliamentarians only get involved when we have to make an appeal, when it suits our colleagues?” asked Tanzanian MP Neema Lugangira in her remarks at a session titled “The Global Fund Post 7th Replenishment – The Role of Members of Parliament and Domestic Health Financing.” Lugangira said that she was asked to make a fundraising appeal via video on behalf of the Global Fund to the United Kingdom parliament over the summer believes her intervention added value and played a key role in convincing the UK government to provide a more than $1 billion grant. However, despite being in New York in September during Global Fund’s Replenishment event at which donors pledge money for the next three years, she was not invited to attend. Global Fund instead hosted 18 heads of state and governments and many high-level officials from civil society and the private sector at the 400-person event in the city. Lugangira said that “some of my colleagues in Tanzania were surprised I was not invited” because of the video she provided and her deep commitment to public health in Tanzania. “When it is time for the glorious moment, we are not invited,” she said. Lugangira said that Global Fund could generate increased matching domestic financing and distribute its funds more effectively if it worked closely with parliaments, the way it works with civil society. “Civil society was not chosen by our UK parliamentarians to record a clip and make an appeal to parliament. It was me, a member of the African parliament,” she stressed. “It is powerful when you hear the voice of an African parliamentarian representing her people. “Don’t just use us when it suits you. Include us across the entire chain” Lugangira continued. “Parliamentarians should be involved at all levels and be recognised for the impact and power we have.” ‘Confused and surprised’ “The Global Fund Post 7th Replenishment” session on December 6 at the UNITE Global Summit Lugangira had been asked to speak during a panel hosted by the fund that was meant to celebrate the nearly $16 billion it raised in the fall and to examine the positive impact that the more than $55 billion it distributed over the past 20 years has had on health and saving lives. In Tanzania alone, the Global Fund has invested $3 billion to tackle issues of HIV, TB and malaria between 2002 and 2022. Currently, the fund has four core grants in the country totalling $608 million. According to Lugangira, since the fund became involved in her country, there has been a 68% decrease in HIV and people with the virus and a 68% increase – from 18% to 86% – of individuals with HIV enrolled in treatment programs. But after Lugangira and several other parliamentarians criticised the Global Fund for failing to properly leverage local lawmakers and called on it to shift its paradigm, Scott Boule, the Global Fund’s Senior Specialist for Parliamentary Affairs, said he was left “confused and surprised.” “At least one MP sort of implied a feeling of being only utilised when the Global Fund needs to raise funds,” Boule said, “Global Fund is supposed to be a partnership.” ‘You handcuff us’ Some parliamentarians also expressed concerns over the Global Fund model, which involves establishing a Country Coordinating Mechanism (CCM) committee to help distribute funds. Boule said Global Fund mandates that CCMs have broad representation, including from the government, but also from civil society, such as members of the communities that are impacted by the three core diseases. In some countries, parliamentarians sit on the CCMs, but in many countries they are not asked to do so. Moreover, parliamentarians have been ineligible to receive money to help fund their role on these committees. Zimbabwe’s Ruth Labode is one of those MPs. She is a member of her country’s CCM but said she rarely attends meetings due to lack of transport and funding. She only goes when parliament is in session and she has to be in the capital city for work anyway. Otherwise, “it’s too costly” to take part, she told Health Policy Watch. “The CCM has decided not to fund parliamentarians for meetings while they fund members from the civil society, private or any other sector,” Labode said. “The lack of funding shows that the Global Fund is not committed [to the parliamentarians]. It does not think it needs parliamentarians. And yet, when the time comes for replenishment, they are quick to find parliamentarians to lobby for their purpose.” She told Boule during the discussion that “it is about time you advocate for a parliamentary seat on every CCM in every country… If you told them to have a seat for a parliamentarian, it would happen overnight”. Another complaint was that many parliamentarians are not educated about the work of the Global Fund or its accomplishments, which could help them push for further domestic health financing. “You cannot mobilise resources when you are not informed,” said MP Peter Njume from Cameroon. “You work [directly] with the government and then expect us to ask them to be accountable. But parliamentarians are not involved. “You talk about the importance of democracy,” Njume continued. “We represent democracy, but you handcuff us, you make us become vulnerable and helpless. How do you want us to function?” “To own this agenda, we need to be well informed and educated,” Lugangira similarly added. Njume requested that the Global Fund earmark financing for a parliamentary education program. ‘Healthcare financing is a political decision’ Alex Winch, a member of Global Fund’s Advocacy, Health Financing Team speaks at the UNITE Global Summit in Lisbon Global Fund’s Alex Winch acknowledged that “the financing of healthcare is a political decision.” A specialist on Global Fund’s Advocacy, Health Financing Team, he said it is important to understand that the vast majority of the fund’s resources do come from governments prioritising money. “Eighty percent of funding comes from the G7 and the European commission,” explained Boule. “Eleven percent comes from other governments around the world. And 9% comes from the private sector.” To date, the Global Fund is providing 30% of international financing for HIV, 76% for TB and 63% for malaria. The fund gives more money for the battle against TB and malaria than anyone in the world. In addition, about a third of its funding is now going to reward strengthening underlying health systems. The funding has been effective, at least according to the data. Life expectancy, for example, has increased as a result. In sub-Sahara Africa alone, average life expectancy jumped from 52.3 in 2002 to 66.7 in 2019, in large part because of the fund’s efforts. During 2021 in countries and regions where Global Fund invests, some 12.5 million people were reached with HIV prevention services; 670,000 mothers living with HIV received medicine to keep them alive and prevent transmitting HIV to their babies; another 5.3 million people were tested for TB; 110,000 were given treatment for drug-resistant TB; and 133 million mosquito nets were distributed to protect families from malaria, amongst many other efforts. “All of this is made possible by our replenishment,” Boule told Health Policy Watch. “Every third year, we raise funds for the subsequent three years.” Replenishment this year was held on 21 September in New York. Some 47 public and 27 private sector donors pledged $15.7 billion out of the target of $18 billion that the organisation had set to raise for the 2023-2025 period. Boule said that efforts were continuing to try to fill the gap. ‘We are de-investing in health’ But Zimbabwe’s Daniel Molokele said that while the results are stunning, he believes African governments have become too “dependent” on the Global Fund, which puts 72% of its money towards the continent. “I don’t think it is good for Africa, this over-reliance on the Global Fund,” Molokele said. He said that Global Fund’s filling the gap lets off the hook governments who then do not have to commit to fund health in their own countries. In Zimbabwe, he said, domestic health financing dropped several percentage points in the last year. “We are de-investing in health,” Molokele said. Boule explained that recipient countries are required to provide a certain percentage of matching money to receive a grant from the Global Fund, though he said that the fund is often more flexible with low-income countries about achieving their targets. He said that despite the economic challenges the world is facing in the aftermath of COVID-19 and as the war is raging in Ukraine, the fund did see around a 30% increase across the board in domestic health financing from recipient countries. ‘It was ambitious’ Another concern raised from the floor came from French MP Jean-Francois Mbaye, who expressed “disappointment” that his country invested $1.6 billion towards a goal it thought was $18 billion but that fell short “It was ambitious,” Boule admitted to Health Policy Watch. “We did raise $15.7 and that is by far the largest amount we ever raised.” The gap came from some of Global Fund’s largest donors not increasing their gifts by the 30% that the fund expected. “The United States, Germany, Japan, Canada and the European Commission all did increase by 30%,” Boule said. “France increased by 23% and Italy increased by 15%. “The only country amongst our largest donors that went down was the UK, although it still pledged $1.2 billion,” Boule continued. “So we very much had strong support from our donors, and in particular, our largest donors.” Number of donors for Global Fund’s 7th Replenishment On the other hand, faltering exchange rates, and hosting the replenishment seven months after the start of the Ukraine war amid rising interest rates had a negative impact. To illustrate if the pledging session had been held on February 23, 2022, which is the day Global Fund had its preparatory meeting, because of exchange rates, it would have raised around $857 million more. In general, Winch said that achieving funding in the current fiscal environment is becoming increasingly more challenging. He cited a recent report by the World Bank that highlighted how even more countries will find it hard to invest in health or in even sustain existing levels of health investment. He said that “an uncertain global macro-economic environment threatens domestic financing for health.” ‘We need to crowd more resources into health’ Boule said that he plans to take some of the parliamentarians’ concerns back to Geneva, such as providing resources for parliamentarians to sit on CCMs and perhaps developing a fixed parliamentary position on the committees. “I wasn’t aware of the point that Honorable Ruth Labode was making from Zimbabwe, that other members of the CCMs received some sort of support and she did not,” Boule said. He also said he would be interested in finding ways to better involve parliamentary feedback as another means to ensure that the fund is asking the right questions and distributing resources in an optimal way. “Our good results are due to a lot of African political leaders, including parliamentarians, really building and sustaining political will to prioritise health,” Boule said. “It is even harder now with food insecurity, debt crisis and rising interest rates. But we are making the point that even now we need to crowd more resources into health.” Image Credits: Maayan Hoffman, Screenshot. US Wants WTO to Delay Decision on TRIPS Waiver Extension for COVID-19 Tests and Treatment 06/12/2022 Kerry Cullinan US Trade Representative Katherine Tai The US Trade Representative’s (USTR) office announced on Tuesday that it supports extending the deadline on whether the World Trade Organization’s (WTO) Ministerial Decision on the TRIPS Agreement should be extended to COVID-19 diagnostics and therapeutics. Trade ministers adopted the Ministerial Decision on the TRIPS Agreement in June, giving members scope to diversify the production of COVID-19 vaccines and override the exclusive effect of patents through a targeted waiver over the next five years. The TRIPS Council has been discussing whether this should be extended to COVID-19 diagnostics and therapeutics. The US decision was informed by wide-ranging consultations over the past five months with over 24 groups with opposing views on the issue, the USTR said in a statement. While all these groups “shared a concern with saving lives, and with striking a balance between the need to promote innovation in these sectors and the need to promote access to the products of innovation”, there were “key differences”. In light of the differing views, the USTR will ask the US International Trade Commission (USITC) to “launch an investigation into COVID-19 diagnostics and therapeutics and provide information on market dynamics to help inform the discussion around supply and demand, price points, the relationship between testing and treating, and production and access”, the USTR said in a statement. “Over the past five months, USTR officials held robust and constructive consultations with Congress, government experts, a wide range of stakeholders, multilateral institutions, and WTO Members,” said Ambassador Katherine Tai. “Real questions remain on a range of issues, and the additional time, coupled with information from the USITC, will help the world make a more informed decision on whether extending the Ministerial Decision to COVID-19 therapeutics and diagnostics would result in increased access to those products,” added Tai. “Transparency is critical and USTR will continue to consult with Congress, stakeholders, and others as we continue working to end the pandemic and support the global economic recovery.” Those in favour of extending the Ministerial agreement “acknowledge a lack of global demand for COVID-19 products, but they believe that market dynamics are suppressing effective demand”, according to the USTR. Opponents’ concerns include that the extension would “allow countries with anti-competitive approaches to innovation, such as China” to “unfairly obtain and use American innovation to benefit their domestic economies”, harming “American industry and workers by undermining investment and research and development”. The USITC study will explore key issues including: An overview of the products, focusing on WHO-approved COVID-19 diagnostics and therapeutics, including key components, the production process, intellectual property protections, and the supply chain (including the level of diversification in the supply chain); The global manufacturing industry for these products, including information on key producing countries, major firms, and production data, if available; The global market for COVID-19 diagnostics and therapeutics, including information on demand and, to the extent practicable, an assessment of where unmet demand exists for key products and contributing factors; market segmentation; and supply accumulation and distribution; Data and information on global trade in COVID-19 diagnostics and therapeutics, if available, or if not, data and information on global trade in diagnostics and therapeutics generally; and A brief overview of the relevant aspects of the TRIPS Agreement and the UN Medicine Patent Pool (MPP) and a listing of countries seeking to use the Ministerial Decision and those utilizing access to COVID-19 medicines under the MPP. Meanwhile, the US reaffirmed the right of its trading partners to “exercise the full range of existing flexibilities in the TRIPS Agreement, such as in Articles 30, 31, and 31bis, and the Doha Declaration on the TRIPS Agreement and Public Health, as well as the flexibilities in the Ministerial Decision”. ‘Multilateralism’ Essential in Battle Against Pandemics, Says President of Portuguese Parliament 06/12/2022 Maayan Hoffman Augusto Santos Silva, president of the Portuguese parliament The battle against pandemics can only be won through multilateralism, according to Augusto Santos Silva, president of the Portuguese parliament. During a keynote address at the UNITE Global Summit on Tuesday, Silva stressed that “viruses and bacteria know no borders. They do not have to show passports and they are not subject to border control. “To manage [a fast response] requires the efforts of all of us – requires multilateralism,” he said. Silvo, a sociologist and university professor, who has served as president since 2002, told the crowd of more than 30 parliamentarians from around the world and several health officials that “the role of parliamentarians is irreplaceable.” Silvo spoke from the center of the Senate Chamber. He said “the COVID-19 pandemic taught us that we should be prepared for the unexpected,” including “what may come up when we least expect it and, in the form, we least expect it to happen.” He called on governments to have deep ties with scientists and professionals in the health arena, but admitted that ultimately, they cannot run the country in the time of a health crisis. Only politicians, he said, can evaluate issues of the economy and democracy alongside health. “There is not an expert that waves us from our moral and political responsibilities,” Silvo said. The theme of the UNITE event, which kicked off on Monday and runs through Wednesday evening, is “from pandemic to prosperity.” He said that “I like the optimistic tone of this theme” but that parliamentarians must be attuned to the challenges that their countries face. Healthcare, he noted, is one of the objectives of the United Nations’ Sustainable Development Goals, but “we all know that the 17 SDGs are interdependent.” Now, he said, is the time for parliamentarians to evaluate their governments’ efforts toward achieving these SDGs and to redirect them if they are off on their goals. “We have to assess what we have achieved so far, to consolidate these achievements, and correct what has to be corrected or whatever is lagging behind,” Silvo said. “This is also work that is up to parliamentarians to do.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman. Indonesia Bans Extramarital Sex 06/12/2022 Kerry Cullinan Indonesia’s parliament passed a new criminal code that bans extramarital sex and criminalises abortion except for rape survivors on Tuesday, Reuters reports. The code applies to both citizens and visitors, and those who have sex outside marriage face up to a year in prison. Indonesia’s economy is heavily dependent on tourism and its tourism industry has warned that the code could dampen enthusiasm from international tourists. However, pre- and extra-marital sex can only be reported by close relatives: a parent, child or spouse. There has been speculation that the code will be used particularly to prosecute LGBTQ people. Same-sex marriage is banned in the predominantly Muslim country, which has become increasingly conservative in the past few years. The new code also prohibits anyone from insulting Indonesia’s president (transgressors face up to three years in prison), spreading views that contradict state ideology, “black magic”, and staging protests without permission. The code was passed unanimously and replaces a code adopted after Indonesia’s independence from the Netherlands in 1946. However, it is expected to only come into force in three years’ time once regulations have been drawn up to enforce its provisions. The country tried to pass the code in 2019 but faced protests, particularly from students. About 100 people reportedly gathered outside the parliament in Jakarta to protest against the code. Image Credits: Nick Agus Arya/ Unsplash. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Wants WTO to Delay Decision on TRIPS Waiver Extension for COVID-19 Tests and Treatment 06/12/2022 Kerry Cullinan US Trade Representative Katherine Tai The US Trade Representative’s (USTR) office announced on Tuesday that it supports extending the deadline on whether the World Trade Organization’s (WTO) Ministerial Decision on the TRIPS Agreement should be extended to COVID-19 diagnostics and therapeutics. Trade ministers adopted the Ministerial Decision on the TRIPS Agreement in June, giving members scope to diversify the production of COVID-19 vaccines and override the exclusive effect of patents through a targeted waiver over the next five years. The TRIPS Council has been discussing whether this should be extended to COVID-19 diagnostics and therapeutics. The US decision was informed by wide-ranging consultations over the past five months with over 24 groups with opposing views on the issue, the USTR said in a statement. While all these groups “shared a concern with saving lives, and with striking a balance between the need to promote innovation in these sectors and the need to promote access to the products of innovation”, there were “key differences”. In light of the differing views, the USTR will ask the US International Trade Commission (USITC) to “launch an investigation into COVID-19 diagnostics and therapeutics and provide information on market dynamics to help inform the discussion around supply and demand, price points, the relationship between testing and treating, and production and access”, the USTR said in a statement. “Over the past five months, USTR officials held robust and constructive consultations with Congress, government experts, a wide range of stakeholders, multilateral institutions, and WTO Members,” said Ambassador Katherine Tai. “Real questions remain on a range of issues, and the additional time, coupled with information from the USITC, will help the world make a more informed decision on whether extending the Ministerial Decision to COVID-19 therapeutics and diagnostics would result in increased access to those products,” added Tai. “Transparency is critical and USTR will continue to consult with Congress, stakeholders, and others as we continue working to end the pandemic and support the global economic recovery.” Those in favour of extending the Ministerial agreement “acknowledge a lack of global demand for COVID-19 products, but they believe that market dynamics are suppressing effective demand”, according to the USTR. Opponents’ concerns include that the extension would “allow countries with anti-competitive approaches to innovation, such as China” to “unfairly obtain and use American innovation to benefit their domestic economies”, harming “American industry and workers by undermining investment and research and development”. The USITC study will explore key issues including: An overview of the products, focusing on WHO-approved COVID-19 diagnostics and therapeutics, including key components, the production process, intellectual property protections, and the supply chain (including the level of diversification in the supply chain); The global manufacturing industry for these products, including information on key producing countries, major firms, and production data, if available; The global market for COVID-19 diagnostics and therapeutics, including information on demand and, to the extent practicable, an assessment of where unmet demand exists for key products and contributing factors; market segmentation; and supply accumulation and distribution; Data and information on global trade in COVID-19 diagnostics and therapeutics, if available, or if not, data and information on global trade in diagnostics and therapeutics generally; and A brief overview of the relevant aspects of the TRIPS Agreement and the UN Medicine Patent Pool (MPP) and a listing of countries seeking to use the Ministerial Decision and those utilizing access to COVID-19 medicines under the MPP. Meanwhile, the US reaffirmed the right of its trading partners to “exercise the full range of existing flexibilities in the TRIPS Agreement, such as in Articles 30, 31, and 31bis, and the Doha Declaration on the TRIPS Agreement and Public Health, as well as the flexibilities in the Ministerial Decision”. ‘Multilateralism’ Essential in Battle Against Pandemics, Says President of Portuguese Parliament 06/12/2022 Maayan Hoffman Augusto Santos Silva, president of the Portuguese parliament The battle against pandemics can only be won through multilateralism, according to Augusto Santos Silva, president of the Portuguese parliament. During a keynote address at the UNITE Global Summit on Tuesday, Silva stressed that “viruses and bacteria know no borders. They do not have to show passports and they are not subject to border control. “To manage [a fast response] requires the efforts of all of us – requires multilateralism,” he said. Silvo, a sociologist and university professor, who has served as president since 2002, told the crowd of more than 30 parliamentarians from around the world and several health officials that “the role of parliamentarians is irreplaceable.” Silvo spoke from the center of the Senate Chamber. He said “the COVID-19 pandemic taught us that we should be prepared for the unexpected,” including “what may come up when we least expect it and, in the form, we least expect it to happen.” He called on governments to have deep ties with scientists and professionals in the health arena, but admitted that ultimately, they cannot run the country in the time of a health crisis. Only politicians, he said, can evaluate issues of the economy and democracy alongside health. “There is not an expert that waves us from our moral and political responsibilities,” Silvo said. The theme of the UNITE event, which kicked off on Monday and runs through Wednesday evening, is “from pandemic to prosperity.” He said that “I like the optimistic tone of this theme” but that parliamentarians must be attuned to the challenges that their countries face. Healthcare, he noted, is one of the objectives of the United Nations’ Sustainable Development Goals, but “we all know that the 17 SDGs are interdependent.” Now, he said, is the time for parliamentarians to evaluate their governments’ efforts toward achieving these SDGs and to redirect them if they are off on their goals. “We have to assess what we have achieved so far, to consolidate these achievements, and correct what has to be corrected or whatever is lagging behind,” Silvo said. “This is also work that is up to parliamentarians to do.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman. Indonesia Bans Extramarital Sex 06/12/2022 Kerry Cullinan Indonesia’s parliament passed a new criminal code that bans extramarital sex and criminalises abortion except for rape survivors on Tuesday, Reuters reports. The code applies to both citizens and visitors, and those who have sex outside marriage face up to a year in prison. Indonesia’s economy is heavily dependent on tourism and its tourism industry has warned that the code could dampen enthusiasm from international tourists. However, pre- and extra-marital sex can only be reported by close relatives: a parent, child or spouse. There has been speculation that the code will be used particularly to prosecute LGBTQ people. Same-sex marriage is banned in the predominantly Muslim country, which has become increasingly conservative in the past few years. The new code also prohibits anyone from insulting Indonesia’s president (transgressors face up to three years in prison), spreading views that contradict state ideology, “black magic”, and staging protests without permission. The code was passed unanimously and replaces a code adopted after Indonesia’s independence from the Netherlands in 1946. However, it is expected to only come into force in three years’ time once regulations have been drawn up to enforce its provisions. The country tried to pass the code in 2019 but faced protests, particularly from students. About 100 people reportedly gathered outside the parliament in Jakarta to protest against the code. Image Credits: Nick Agus Arya/ Unsplash. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Multilateralism’ Essential in Battle Against Pandemics, Says President of Portuguese Parliament 06/12/2022 Maayan Hoffman Augusto Santos Silva, president of the Portuguese parliament The battle against pandemics can only be won through multilateralism, according to Augusto Santos Silva, president of the Portuguese parliament. During a keynote address at the UNITE Global Summit on Tuesday, Silva stressed that “viruses and bacteria know no borders. They do not have to show passports and they are not subject to border control. “To manage [a fast response] requires the efforts of all of us – requires multilateralism,” he said. Silvo, a sociologist and university professor, who has served as president since 2002, told the crowd of more than 30 parliamentarians from around the world and several health officials that “the role of parliamentarians is irreplaceable.” Silvo spoke from the center of the Senate Chamber. He said “the COVID-19 pandemic taught us that we should be prepared for the unexpected,” including “what may come up when we least expect it and, in the form, we least expect it to happen.” He called on governments to have deep ties with scientists and professionals in the health arena, but admitted that ultimately, they cannot run the country in the time of a health crisis. Only politicians, he said, can evaluate issues of the economy and democracy alongside health. “There is not an expert that waves us from our moral and political responsibilities,” Silvo said. The theme of the UNITE event, which kicked off on Monday and runs through Wednesday evening, is “from pandemic to prosperity.” He said that “I like the optimistic tone of this theme” but that parliamentarians must be attuned to the challenges that their countries face. Healthcare, he noted, is one of the objectives of the United Nations’ Sustainable Development Goals, but “we all know that the 17 SDGs are interdependent.” Now, he said, is the time for parliamentarians to evaluate their governments’ efforts toward achieving these SDGs and to redirect them if they are off on their goals. “We have to assess what we have achieved so far, to consolidate these achievements, and correct what has to be corrected or whatever is lagging behind,” Silvo said. “This is also work that is up to parliamentarians to do.” The UNITE Global Summit runs from Dec. 5-7, 2022. Click here for full coverage. Reporting for this series was supported by UNITE Parliamentarians for Global Health. Image Credits: Maayan Hoffman. Indonesia Bans Extramarital Sex 06/12/2022 Kerry Cullinan Indonesia’s parliament passed a new criminal code that bans extramarital sex and criminalises abortion except for rape survivors on Tuesday, Reuters reports. The code applies to both citizens and visitors, and those who have sex outside marriage face up to a year in prison. Indonesia’s economy is heavily dependent on tourism and its tourism industry has warned that the code could dampen enthusiasm from international tourists. However, pre- and extra-marital sex can only be reported by close relatives: a parent, child or spouse. There has been speculation that the code will be used particularly to prosecute LGBTQ people. Same-sex marriage is banned in the predominantly Muslim country, which has become increasingly conservative in the past few years. The new code also prohibits anyone from insulting Indonesia’s president (transgressors face up to three years in prison), spreading views that contradict state ideology, “black magic”, and staging protests without permission. The code was passed unanimously and replaces a code adopted after Indonesia’s independence from the Netherlands in 1946. However, it is expected to only come into force in three years’ time once regulations have been drawn up to enforce its provisions. The country tried to pass the code in 2019 but faced protests, particularly from students. About 100 people reportedly gathered outside the parliament in Jakarta to protest against the code. Image Credits: Nick Agus Arya/ Unsplash. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Indonesia Bans Extramarital Sex 06/12/2022 Kerry Cullinan Indonesia’s parliament passed a new criminal code that bans extramarital sex and criminalises abortion except for rape survivors on Tuesday, Reuters reports. The code applies to both citizens and visitors, and those who have sex outside marriage face up to a year in prison. Indonesia’s economy is heavily dependent on tourism and its tourism industry has warned that the code could dampen enthusiasm from international tourists. However, pre- and extra-marital sex can only be reported by close relatives: a parent, child or spouse. There has been speculation that the code will be used particularly to prosecute LGBTQ people. Same-sex marriage is banned in the predominantly Muslim country, which has become increasingly conservative in the past few years. The new code also prohibits anyone from insulting Indonesia’s president (transgressors face up to three years in prison), spreading views that contradict state ideology, “black magic”, and staging protests without permission. The code was passed unanimously and replaces a code adopted after Indonesia’s independence from the Netherlands in 1946. However, it is expected to only come into force in three years’ time once regulations have been drawn up to enforce its provisions. The country tried to pass the code in 2019 but faced protests, particularly from students. About 100 people reportedly gathered outside the parliament in Jakarta to protest against the code. Image Credits: Nick Agus Arya/ Unsplash. Posts navigation Older postsNewer posts